Spark Crowdfunding Top 100 Most Ambitious Companies in Ireland 2025

Top 100

Most Ambitious Companies in Ireland 2025

Welcome

As we step further into 2025, Spark Crowdfunding is proud to recognize the Top 100 Most Ambitious Companies in Ireland—a celebration of innovation, resilience, and entrepreneurial drive. This year’s winners come from a broad spectrum of industries, including finance, education, technology, consumer goods, leisure, and healthcare, reflecting the dynamic and diverse nature of Ireland’s business landscape. It is especially encouraging to see so many female entrepreneurs among this year’s honourees, reinforcing the bright future ahead.

Navigating today’s economic challenges has not been easy, yet these companies have demonstrated exceptional growth and determination. Many have not only scaled their businesses but have also created new employment opportunities, defying the odds in a tough trading environment. Their success is a testament to the strength and potential within Ireland’s entrepreneurial ecosystem, and we wish them continued prosperity in the years to come.

Selecting the final 100 was no small feat, given the overwhelming number of impressive entries. We extend our sincere appreciation to all the businesses that participated—those that made the list and those that came close. The sheer level of ambition and innovation we witnessed made this year’s selection process more competitive than ever.

At Spark Crowdfunding, we remain committed to championing Irish businesses. With our extensive network of investors, we are eager to support the continued growth of companies like those featured today.

Chris.

Chris Burge, CEO - Spark Crowdfunding.

Agri Data Analytics Page 04

Align Page 06

All Real Nutrition Page 08

Altach Biomedical Page 10

Amara Therapeutics Page 12

anewmum Page 14

Assay Genie Ltd Page 16

ATXA Therapeutics Page 18

AuriGen Medical Page 20

Aveta Medical Ltd Page 22

Back To Work Connect Page 24

BackAware Page 26

Better Futures Page 28

Brace Page 30

Capri Medical Page 32

Celtic Biotech Ltd Page 34

Circular Food Co Page 36

ClubSpot Page 38

Communify.ai Page 40

Customs Window Technologies Page 42

Cytidel Page 44

Digital Gait Labs Page 46

eAltra Ltd Page 48

EdgeTier Page 50

eStation Page 52

EVERYANGLE Page 54

Examfly Limited Page 56

Feedalpha Page 58

FeelTect Page 60

Field Of Vision Page 62

Gladcloud Page 64

Great Visitor Experiences Page 66

HAON Life Sciences Page 68

Head Diagnostics Page 70

Helgen Technologies Limited Page 72

HoloToyz Page 74

Imvizar Page 76

Klaas kickz Ltd Page 78

Konree innovation Page 80

Kwayga Page 82

LEP Biomedical Ltd Page 84

Liltoda Ltd Page 86

Liroptic Page 88

Loanitt Page 90

Lua Health Page 92

Lvlogics Limited Page 94

Maya Data Privacy Page 96

Mettacomms Page 98

Monthlies Organics Page 100

Moonsyst International Ltd. Page 102

MoveAhead Page 104

My Moves Matter Page 106

myPatientSpace Page 108

MyWord Pal Page 110

NanobOx Ltd Page 112

Net Feasa Page 114

NeuroBell Page 116

Novus Diagnostics Page 118

NUACOM Page 120

Omuu Pet Page 122

OptaHaul Page 124

PacSana Page 126

Payemoji Page 128

Peri Page 130

Pit-Seal Page 132

Positive Carbon Page 134

Prepsheets Page 136

PrimumAi Page 138

ProVascTec Page 140

Pumpinheart Page 142

ReaDI-Watch Page 144

Recruitroo Page 146

Reso Health Limited Page 148

Shopbox AI Page 150

Simple Probate Page 152

Skippio Page 154

Sleek N Easy Page 156

Smart Reactors Page 158

Smile Genius dental Page 160

SomaTech Limited Page 162

SymPhysis Medical Page 164

Tap Retail Page 166

Telegenz Page 168

Thanks Plants Page 170

This is Penny Page 172

Tonisity Page 174 Trave Page 176

Trigr Page 178

Tympany Medical Page 180

Vertigenius Page 182

VoiceTune AI Page 184

Vortech Water Solutions Ltd Page 186

Votechnik Page 188

Well Spent Grain Ltd Page 190

Wellola Page 192

Whole Supp Page 194

WHYZE Health Ltd Page 196

Wrky Page 198

xWave Technologies Page 200

Zarasyl Page 202

Zendra Health Page 204

Jack Pilkington:

CEO and Co-Founder of Agri Data Analytics. Certificate in Agriculture from Ballyhayes College, Cavan. A lifelong farmer, entrepreneur and experienced steel fabricator.

Alan O’Donovan:

CTO and Co-Founder of Agri Data Analytics. BBus in Business from TUS Athlone and MSc in Agricultural Innovation from the University of Galway. An innovator, tech-enthusiast and sports fanatic.

Expected employee numbers

Clonearl, Daingean, Co. Offaly

Jack Pilkington

Alan O’Donovan

Jack Pilkington & Alan O’Donovan

Company Profile

We are tackling to climate crisis with our innovation, the Bovine Breathalyser, an emissions monitoring system that non-invasively measures the enteric methane and CO2 output of cattle. The data we provide enables our clients to reduce livestock emissions while improving yield through genetical, supplementary and dietary optimisations, saving both time and money for stakeholders.

Company Achievements to Date

n Exhibitors at National Ploughing Championships 2023 & 2024 Innovation Arena

n Websummit Lisbon 2024 exhibitors

n Fieldays NZ 2024 Enterprise Ireland and Innovation Hub stand exhibitors

n Carbery Dairy Innovation Recognition Award at National Dairy Awards 2024

n Spark Crowdfunding top 100 most ambitious companies in Ireland 2024

n Agtech UCD Startup award winner at National Ploughing Championships 2023

n Best Agritech Hardware Product Winner at the FBD Better Farming Awards 2023

n Enterprise Ireland New Frontiers Phase 2 and 3 Completion

n Agtech UCD Agccelerator Alumni

n Prep4Seed 2024 Cohort

n Bord Na Mona Accelerate Green 2024 Cohort

Ranelagh, Dublin 6

Est. 2021

Aidan always had an entrepreneurial spirit. At the age of 8 years he started his first business selling sweets. As the middle child in his family he is a social butterfly which led him to joining a number of networking groups. While attending these groups he noticed a trend where businesses suffered from a lack of leads and with little or no pipeline business.

Selling and the art of the sale conversation has been at the heart of his career and he saw an opportunity to create a business to generate solid leads which would bring sales and growth to a business. Align is 4 years old now and we have come a long way. Our clients vary from SMEs to multi billion euro companies but our process is the same and just as effective. He was selected by the Sunday Independent for the 30 under 30 last year and outside of work you will find him enjoying a coffee or a glass of whiskey!

aidan-o-driscoll

Aidan O Driscoll

Company Profile

Align provide quality leads that turn into actual sales. We have ability to contact decision makers directly avoiding gate keepers which saves you valuable time and money avoiding time wasting meetings. We act on behalf of your business to develop interest, qualify and disqualify prospects so your sales team can focus on closing the sale. We are a Irish business with 12 employees and employ a number business students from Irelands leading third level institutions. We offer a number of services including email and phone campaigns. The future of Irish business

Company Achievements to Date

In 4 yrs Align has grown! We now employ 12 staff. We have increased our clients from 3 to 24 and now work with billion dollar corporates (Huawei, Carlsberg Britvic, Amazon). Our services now include: qualifying outbound & inbound leads, coaching sessions, workshops, working at trade events representing our clients and helping to close sales on behalf of our clients. Our campaigns are global targeting Ireland , UK, Europe, Canada and USA. We have upgraded our office space several times and now have a spacious office in Ranelagh. We have a 95% retention rate from our 3 month trial period but most importantly of all our leads have generated millions of sales for our valued clients. “Align have improved our conversation of leads to 82%” Carlsberg Britvic. It is time to Align your leads and sales.

Company Profile

All Real Nutrition, launched in January 2021, is dedicated to environmental sustainability, focusing on premium “real food” nutrition. Our products, made from grass-fed Irish Milk, feature eco-friendly, home-compostable packaging, catering to “Everyday Athletes.” Available in retail and online across Ireland and the USA, we’ve become Ireland’s top natural protein bar brand. Through our partnership with PlasticBank, we’ve successfully prevented nearly 10 million plastic bottles from polluting oceans, emphasizing our strong commitment to sustainability and healthconscious living.

Company Achievements to Date

We have won competitions and awards both home and abroad. Our most prestigious being a Nexty Award for “Best New Functional Food or Beverage” in the worlds largest natural foods tradeshow, Expo West, which is held in Los Angeles. More recently we were a finalist in London’s Natural & Organic Show (NOPE), for Best New Fitness Nutrition Product.

We are proud to say we produce our product ourselves in house which is a bit of a rarity these days. We have now implemented a fully automated production line in Farranfore, Co Kerry.

We’ve built our distribution in Ireland to about 1,000 stores and are now Ireland’s number 1 natural protein bar. Online sales are growing exponentionally now with 20,000 customers and we’re just about to launch our USA ecommerce platform. We also sell our bars into offices and are on sale in tech companies in Dublin, London and San Fransisco.

Expected employee numbers

Est. 2021

Niall Harty: Recognized as one of Ireland’s Best Young Entrepreneurs in 2018, Niall combines a postgrad in Food, Nutrition & Health from UCD with a degree in Manufacturing Management. His early career as an Enterprise Executive for Enterprise Ireland gave him the foundation to transform a kitchen-table idea into a multimillion-euro business spanning Ireland, the UK, and the USA.

Ross McDowell: Founded Stript Snacks in 2012, introducing a successful air-dried beef snack to markets in Ireland, the UK, and four EU countries. His ventures included collaborations with Google and Tesco, leading to Stript’s successful exit in 2017. Thereafter, he teamed up with Niall to launch All Real Nutrition, combining his expertise in branding and market expansion.

ross-mcdowell

niallharty

Ross McDowell & Niall Harty

Company Profile

Altach Biomedical is a MedTech company pioneering joint preservation through biomimetic scaffolds. Our Type II collagen-based technology is designed to regenerate cartilage and bone, addressing osteochondral defects and delaying the progression of osteoarthritis. With a strong foundation in regenerative medicine and collaborations with leading institutions, we are developing next-generation solutions that offer minimally invasive, biologically active alternatives to traditional joint repair. Our goal is to improve patient outcomes by providing clinically effective, long-lasting treatments that reduce pain, restore mobility, and ultimately transform the standard of care in orthopedic treatment.

Company Achievements to Date

Altach Biomedical has made significant progress in developing biomimetic Type II collagen scaffolds for cartilage and bone regeneration. We have successfully raised €1.5 million in funding and are backed by NLC Health Ventures and Enterprise Ireland, designating us as a High Potential Start-Up (HPSU).

On the scientific and regulatory front, we have established a robust preclinical validation program, demonstrating the effectiveness of our scaffold in regenerating hyaline-like cartilage and supporting subchondral bone integration. We have initiated ISO 13485-compliant manufacturing processes, ensuring scalability and regulatory readiness.

A major milestone was the grant of our first US patent, strengthening our intellectual property portfolio and providing a competitive edge in the orthopedic market. We have also partnered with HCM Medical, a leader in advanced medical manufacturing, to optimize our scaffold production for clinical applications.

Additionally, Altach was recognized at the ICRS Innovation Panel, winning the competition for the most promising cartilage repair technology. These milestones position us at the forefront of nextgeneration regenerative orthopedic solutions.

Tomir Kosowski – Co-Founder & CEO

Dublin

Est. 2022

Tomir Kosowski leads Altach Biomedical, driving its mission to transform joint preservation through regenerative technologies. With extensive experience in orthopedic implants and MedTech commercialization, he previously co-founded Komak and played a key role in launching advanced biomaterials.

Dr. David Browe – Co-Founder & CTO

Dr. David Browe, an expert in biomaterials and regenerative medicine, holds a PhD in stem cell biology. He oversees R&D and product development, ensuring scientific and clinical validation of Altach’s Type II collagen scaffold technology.

altach

/tomir-kosowski

Tomir Kosowski, David Browe, Conor Buckley & Daniel Kelly

Galway/San Francisco

Est. 2021

Brendan Staunton, Emma Carr & Geoff Cundiff

brendan-staunton

emma-carr-phd

geoff-cundiff

Brendan Staunton is the founder and CEO of Amara Therapeutics. Brendan is a former Bioinnovate Fellow at University of Galway and has over a decade of experience in Medical device sales and Product Management. Brendan holds a BSc in Neuroscience from UCD, a MSc in Bioinnovation from UG and a MBA from Smurfit Business School. Dr Emma Carr is the co-founder and Chief Operating Officer of Amara Therapeutics. Emma is a chartered health psychologist, experienced in developing and executing digital health interventions and clinical trials.Dr. Geoffrey Cundiff is a co-founder and CMO of Amara Therapeutics. He is also a Professor in the Department of Obstetrics and Gynaecology at the University of British Columbia, where he is a research scientist at the Centre for Health Evaluation and Outcomes Sciences and the Women’s Health Research Institute.

Expected employee numbers

Company Profile

Amara Therapeutics is a Galway-based Digital Health company that is making incontinence care more accessible for the 78 million women in the US who suffer from this condition. Amara is building out a fully virtually treatment pathway so patients can access care in the comfort of their own homes. To facilitate this transition to a virtual care model, the company has developed an app-based treatment Platform, RiSolve, that provides an 8-week care program delivering pelvic floor muscle exercises, behavioural therapy and cognitive behavioural therapy (CBT) direct to patient’s smartphones. The company is focused on the US and is currently recruiting for a groundbreaking Randomised Control Trial across 10 US hospitals including Medstar Health in Washington DC and Stanford in California.

Company Achievements to Date

n Recently achieved CE approval for the RiSolve platform in the EU

n Commenced US RCT with10 US hospitals to validate the efficacy of their digital intervention and gain FDA approval (600 patient study).

n Been granted patent approval for their technology

n Recently published their pilot study data in Urogynaecology journal .

n Recently raised $1.8 million seed round

Amara

Marian Kennedy is the founder of PPR Healthcare Ltd., trading as Anewmum. Marian set up her business after her own personal experience postpartum almost ten years ago and is committed to developing a range of products to support mothers during pregnancy and post partum periods of their lives. Marian has previously worked with the HSE and a past participant of New Frontiers Programme helped build connections with medical professional via the Health Innovation Hub Ireland.

Expected employee numbers

Tipperary Est. 2018

mariankennedyppr

Marian Kennedy

Company Profile

We have developed a range of comfort and hygienic products to help support mothers during pregnancy and post partum. We have built our products backed on scientific studies and are committed to researching womens healthcare during pregnancy and postpartum to help educate them and provide them with safe and effective products that work.

Company Achievements to Date

Successfully undertaken scientific studies at The Centre for Applied Bioscience Research in Ireland of Vaginal epithelial cells focusing on the acceleration of wound healing using our Anewmum Comfort Mist. Selected as one of the five winners of the Visa Ireland She’s Next Winners 2025. Google You’re the business Winner 2024, and the Best Start Up Business Tipperary Chamber of Commerce 2024.

macfhearraigh

therealcolmryan

Sean Mac Fhearraigh & Colm Ryan – Co-Founders, Assay Genie

Dr. Sean Mac Fhearraigh and Dr. Colm Ryan co-founded Assay Genie with a shared vision of accelerating scientific discovery through innovative research tools. With backgrounds in molecular biology and biochemistry, respectively, they have built Assay Genie into a global provider of high-quality reagents, including In Vivo antibodies, ELISA kits, and assay solutions. Their expertise in assay development, bioinformatics, and biotech commercialization has enabled scientists worldwide to access reliable, reproducible products for immunology, oncology, and disease research.

Passionate about bridging the gap between cutting-edge science and practical application, Sean and Colm have driven Assay Genie’s growth by focusing on product quality, scientific excellence, and customer support. Their mission is to empower researchers with advanced tools that enhance experimental outcomes and fuel groundbreaking discoveries in biomedical science. Through innovation and dedication, they continue to expand Assay Genie’s impact in the global life sciences community.

Expected employee numbers

Seán Mac Fhearraigh PhD & Colm Ryan PhD

Company Profile

Assay Genie provides high-quality In Vivo antibodies to support preclinical and translational research. Our extensive portfolio includes monoclonal and polyclonal antibodies optimized for in vivo applications, ensuring high specificity, reproducibility, and efficacy. Designed for immune response studies, oncology research, and disease modeling, our antibodies enable scientists to drive breakthrough discoveries. With a commitment to scientific excellence, Assay Genie delivers reliable and performance-driven solutions, empowering researchers worldwide with essential tools for cutting-edge biomedical research.

Company Achievements to Date

Since its founding, Assay Genie has grown into a trusted global provider of high-quality research reagents, empowering scientists across academia, biotech, and pharma. Our portfolio includes In Vivo antibodies, ELISA kits, assay solutions, and molecular biology tools, supporting cutting-edge research in immunology, oncology, and disease modeling.

One of our key achievements is the expansion of our In Vivo antibody range, offering researchers highly specific and reproducible antibodies for preclinical studies. We have established a reputation for delivering reliable alternatives to traditional suppliers, ensuring scientists have access to performance-driven solutions for their research.

Assay Genie has successfully partnered with leading research institutions and biotech companies, contributing to groundbreaking discoveries in cancer research, infectious diseases, and drug development. Our global distribution network spans over 50 countries, making our products widely accessible to the scientific community.

Committed to innovation and customer support, we continuously enhance our product portfolio to meet evolving research demands. Through our investment in AI-driven product discovery and data analysis, we are transforming how scientists access and utilize reagents. Assay Genie’s mission remains clear: to accelerate scientific breakthroughs by providing high-quality, innovative, and reproducible research tools for scientists worldwide.

Est. 2015

ATXA has an outstanding track-record with numerous achievements to date. In 2018, ATXA secured orphan drug designation for its lead drug NTP42 in PAH from both the EMA and FDA drug regulatory authorities in Europe and the USA. In 2022, ATXA successfully completed a Phase I clinical trial with NTP42, confirming it is safe, well tolerated and only needs to be taken once daily at low doses for the desired clinical effect, offering key pharma benefits. In early 2024, the company completed a second successful clinical trial testing & validating a capsule form of NTP42. As a deep-tech innovative company, ATXA has a stellar reputation for excellence in research, endorsing and strengthening the clinical case for why NTP42 will be superior to today’s PAH therapies or others in development. ATXA drugs are protected by a valuable and growing patent estate, with 16 granted in the US, Europe, Japan, Australia, Canada until 2036 and others filed extending protection to the 2040s globally. ATXA is now focused on advancing NTP42 into Phase II clinical trials in PAH patients, a major milestone including for its investors. ATXA’s advancements are backed by leading institutional and private investors, as well as substantial grant and equity funding from two prestigious European Innovation Council (EIC) programs for Europe’s most innovative companies.

Expected employee numbers

Dublin

/theresekinsella/

Prof. Therese Kinsella

Company Profile

Founded in Dublin in 2015, ATXA Therapeutics Ltd (ATXA) is a clinical-stage pharmaceutical company bringing its proprietary drugs through clinical development in the heart and lung diseases area. In this, ATXA’s initial target diseases are forms of pulmonary hypertension as well as certain types of heart disease. ATXA’s lead drug, called NTP42, along with other pipeline drugs, have a wider potential to treat a range of other blockbuster diseases, also with high unmet medical needs for new and improved therapies.

Company Achievements to Date

ATXA has an outstanding track-record with numerous achievements to date. In 2018, ATXA secured orphan drug designation for its lead drug NTP42 in PAH from both the EMA and FDA drug regulatory authorities in Europe and the USA. In 2022, ATXA successfully completed a Phase I clinical trial with NTP42, confirming it is safe, well tolerated and only needs to be taken once daily at low doses for the desired clinical effect, offering key pharma benefits. In early 2024, the company completed a second successful clinical trial testing & validating a capsule form of NTP42. As a deep-tech innovative company, ATXA has a stellar reputation for excellence in research, endorsing and strengthening the clinical case for why NTP42 will be superior to today’s PAH therapies or others in development. ATXA drugs are protected by a valuable and growing patent estate, with 16 granted in the US, Europe, Japan, Australia, Canada until 2036 and others filed extending protection to the 2040s globally. ATXA is now focused on advancing NTP42 into Phase II clinical trials in PAH patients, a major milestone including for its investors. ATXA’s advancements are backed by leading institutional and private investors, as well as substantial grant and equity funding from two prestigious European Innovation Council (EIC) programs for Europe’s most innovative companies.

Galway

Dr. John Thompson, MD, MBA (CEO)

John leads AuriGen Medical’s financing and strategy, overseeing clinical trial design, reimbursement, and stakeholder engagement. Previously, he worked at Pfizer on commercializing in-market and pipeline assets. He holds a medical degree from the Royal College of Surgeons and an MBA from Smurfit School of Business.

Ms. Siora Maclean (COO)

Siora manages AuriGen’s business operations, including product development, financial planning, and strategy. With 24 years in MedTech, she has successfully brought multiple products to market at Creganna Medical and Abbott Vascular. She holds a Master’s in Chemical Engineering from Queen’s University Belfast.

Mr. Tony O’Halloran (CTO)

Tony leads AuriGen’s technical development and IP strategy. With over 20 years in MedTech, he has worked at Medtronic and TE Medical, developing and commercializing medical devices. He holds a first-class degree in Mechanical Engineering from ATU Galway and an MSc in BioInnovation from NUIG Galway.

Expected employee numbers

Est. 2018

Dr John Thompson, Tony O’Halloran & Siora Maclean

Company Profile

AuriGen Medical is a pioneering MedTech company focused on transforming heart care for high-risk patients with complex medical needs. A spinout from the University of Galway, AuriGen has grown into a team of over 20 experts in engineering, healthcare, and medical device development. The company has secured major funding from the Irish government and the EU, as well as over €3 million through Spark Crowdfunding. With strong leadership, including former executives from Boston Scientific and Medtronic, AuriGen is developing innovative solutions that combine advanced treatment with real-time monitoring, making heart procedures safer, smarter, and more effective for those who need them most.

Company Achievements to Date

AuriGen Medical is transforming the treatment of chronic heart conditions, focusing on higherrisk patients with complex medical needs. The company recently completed the first-ever human implantation of its Zenith device, demonstrating a smoother, more precise procedure with promising early results.

With approvals to move forward with clinical trials, AuriGen is working to bring this life-changing technology to patients worldwide. The company has received major funding from the Irish government and the EU, recognizing its potential to improve care for those who need it most.

Originally a University of Galway spinout, AuriGen has grown into a team of over 20 experts in engineering, healthcare, and medical device development. It has also been Ireland’s most successful MedTech company on Spark Crowdfunding, raising over €4 million.

What sets AuriGen apart is its focus on patients with the most complex needs—its device not only provides treatment but can also include real-time monitoring and advanced therapeutic capabilities. With strong leadership, including industry veterans from Boston Scientific and Medtronic, AuriGen is on a mission to make heart procedures safer, smarter, and more effective for those at the highest risk.

aurigen-medical

Company Profile

AVeta medical is a spin out of the Bioinnovate fellowship program of University of Galway. AVeta Medical is developing a highly disruptive safe effective affordable and accessible technology; the VITA AV medical device to treat Genitourinary Syndromes of Menopause (GSM), a progressive & chronic condition. A fact of life for over 80% of women over 51 years of age. The number further increases in breast cancer survivors who suffer from this condition without any longterm treatment option. GSM is a condition that negatively impacts women’s health, quality of life, relationships, everyday activities & confidence. The technology treats the underlying cause of GSM, healing and restoring the tissue back towards pre menopausal state.

Company Achievements to Date

AVeta Medical have completed animal testing and Design Verification testing to bring the product to design freeze. AVeta Medical have progressed to complete a 12 patient first in human clinical trial with 12 month follow up which showed great indicative data to support the benefits of the treatment. AVeta Medical are now approved by the FDA for a follow on 60 patient Randomized Control Trial. The AVeta Medical technology is patient pending in all major regions. The manufacturing process have been de-risked for large scale production with contract manufacturers selected for worldwide distribution. AVeta Medical were granted EI commercialization funding 2019 and granted a prestigious European Innovation Council funding and have now raised a further €1Milllion and received Enterprise Ireland High Potential Start Up (HPSU) status.

Expected employee numbers

12

45

Galway

Est. 2019

Paula has clinical background is Paediatric Occupational Therapy in the public and private health sector, nationally and internationally. Paula presents with 20 years of varied clinical experience as a Senior Occupational Therapist and Occupational Therapy Manager. In 2017, she graduated from the NUIG BioInnovate fellowship where she identified the unmet clinical need that she is presently exploring. Paula’s time to date with AVeta Medical she has complete the commercialization grant, EIC grant, winner of the EIT Health HeadStart and has participated in the EIT Health accelerator and WildCard programmes.

aveta-medical

paula-newell

Paula Newell

Dublin Est. 2022

Gina Oglesby is an accomplished business leader with a strong background in logistics, strategic business development, and social enterprise. With a career spanning over two decades, she has demonstrated exceptional skills in strategic planning, customer-focused innovation, and results-driven leadership. Her passion lies in fostering positive work environments, leading highperforming teams, and driving impactful change.

Founder & CEO, Back To Work Connect (2018 – Present)

Gina is the founder and CEO of Back To Work Connect, an innovative enterprise dedicated to bridging the gap between midlife workers and return-to-work opportunities. Under her leadership, the organisation has successfully:

n Developed strategic partnerships, implemented a Social Impact Framework aligned with three UN Sustainable Development Goals (SDGs).

n Led the technical development of the platform and ensured customer validation.

n Secured funding through various grants and investment pitches.

n Designed and executed a robust sales and marketing strategy.

n Spearheaded hiring and remote team management, ensuring employee well-being and productivity.

Gina has also participated in several high-potential startup accelerator programs, including Enterprise Ireland’s New Frontiers Phase 1 & 2, Rethink Ireland’s Social Enterprise Development Fund Programme, and Dublin BIC’s Start-up Evolution Programme. She has also recently completed the SheScales programme with AwakenHub and AwkenAngels. These programs have honed her expertise in creative thinking, innovation, and business development.

Expected employee numbers

2025: 5

2026: 6

2028: 10

gina-oglesby

Gina Oglesby

Company Profile

Back to Work Connect is transforming how employer connect with midlife Returners. A talent resourcing platform dedicated to empowering midlife professionals to re-enter the workforce. Bridging the gap for employers seeking diverse, experienced talent while addressing the problem of gender imbalance in their workforce. Back to Work Connect have created an accessible long term solution to support organisations combat the problem of gender balance and gender pay gap. Our platform delivers measurable social and economic impact by unlocking the potential of an often-overlooked talent pool.

Company Achievements to Date

Back to Work Connect have

n 80 employers on their Returner Friendly career hub

n 300 active Returner Friendly roles on their jobs board every week.

n 1500 attendees at their monthly community events to date

n 15k registered users

n 10k unique visitors each month

n Developed a custom AI job description reader to accurately gauge how Returner Friendly a job description is with personalised recommendation to the employer on possible improvements

n Developing an e-Learning platform to support Returners in their first 100 days in their new role

n Developed training programme for HR teams and hiring managers

n Launched into Northern Ireland in Q1 2025

Dr. Eoin Everard is a leading expert in back pain prevention, rehabilitation, and movement optimization. A chartered physiotherapist with a PhD in Biomechanics, he specializes in helping individuals improve posture, prevent injuries, and enhance performance. As the founder of BackAware, Eoin developed the BackAware Belt, a groundbreaking wearable that provides real-time feedback on spinal positioning, empowering users to lift, exercise, and sit with proper form.

Beyond his work in physiotherapy and technology, Eoin is a high-performance athlete, competing internationally as a sub-4-minute miler. His deep understanding of biomechanics, combined with his hands-on clinical experience, makes him a sought-after authority in rehabilitation and movement efficiency.

Eoin is also dedicated to education, offering Pilates and physiotherapy programs through the BackAware app. His mission is to bridge the gap between elite performance and everyday movement, helping people achieve stronger, healthier backs through science-backed innovation.

Kilkenny Est. 2023

eoineverard

Dr. Eoin Everard

Company Profile

BackAware is a pioneering company dedicated to improving posture, movement, and spinal health through cutting-edge wearable technology. The BackAware Belt provides real-time feedback on back positioning, helping individuals lift, exercise, and sit with proper posture. Used by surgeons for client rehabilitation, corporations for employee wellness, and fitness enthusiasts for injury prevention, BackAware blends biomechanics with smart sensor technology. The company also offers Pilates and physiotherapy programs via its app, ensuring a holistic approach to back care. Recognised by Time Magazine as one of the Best Inventions of 2024, BackAware is revolutionising spinal health with innovation, accessibility, and science-backed solutions.

Company Achievements to Date

n Named a TIME Magazine Best Invention of the Year – Recognized for its innovation in wearable technology and its impact on spinal health.

n Adopted by Surgeons & Physiotherapists – Used in rehabilitation programs to help clients recover from injuries and improve posture.

n Peer Reviewed Studies underway investigating its effectivness with back pain patients.

n Corporate Wellness Integration – Implemented by companies, such as Intel, Sisk, Teagasc and more to enhance employee well-being and reduce workplace injuries.

n Expanding Physiotherapy & Pilates Programs – Offering expert-led programs through the BackAware app to complement the belt’s technology.

n International sales in 20 different countries with dramatic YoY growth.

n Recognised by Spark Crowdfunding as Top 100 Most Ambitious Company 2024,

n Named in Business Post Hot 100 Start ups

n Regional Finalist for Seedcorn competition

n Bronze Medal in National Start up Awards 2024 in the Emerging Tech sector.

Anthony Mc Loughlin originally an Aerospace Engineer is an artificial intelligence business leader, with 20 years of unique experience at the intersection of engineering, artificial intelligence, and enterprise software. Over his career, he has helped global manufacturers like Airbus, Mercedes, and Rolls-Royce successfully adopt AI to drive efficiency and innovation.

He has worked at Airbus, AI software pioneers Altair RapidMiner, and Databricks, where he held key leadership positions up to Vice President. This rare combination of deep engineering expertise and AI leadership makes him a global thought leader in AI for industrial applications.

As the founder of Better Futures, Anthony is leading the charge in AI-driven engineering automation with EVA, the first AI Assistant platform for engineers. He is a frequent speaker and recognized innovator, committed to transforming how engineers work in highly regulated industries.

Expected employee numbers

Dublin Est. 2024

amcl

Anthony Mc Loughlin

Company Profile

Better Futures is transforming engineering productivity with EVA, the first AI Assistant platform built specifically for engineers. Engineers spend up to 50% of their time on documentation, verification, and knowledge retrieval—EVA automates these tasks, freeing engineers to focus on high-value work and boosting productivity by up to 3X.

Headquartered in Dublin’s innovation hub, Nova UCD, Better Futures was founded by Anthony Mc Loughlin, a recognized Engineering AI leader. With a first-mover advantage in a new €7B+ global market, the company is already making an impact at leading global manufacturers like Sensata Technologies, with a rapidly expanding enterprise pipeline.

Company Achievements to Date

Since its inception, Better Futures has rapidly emerged as a pioneer in AI-driven engineering automation, gaining traction with major enterprise clients, industry recognition and global media coverage.

Enterprise Adoption: EVA, the first AI Assistant for engineers, is already deployed at leading global manufacturers like Sensata Technologies and Nitrex Group, demonstrating strong early traction. With a €1M+ sales pipeline, including several Fortune 500 companies, and 200+ engineers from over 80 unique companies using EVA, Better Futures is poised for rapid scale.

Industry Recognition: Winner of the Irish Times Innovation Award 2024 (Design & Manufacturing), reinforcing its leadership in AI-driven engineering solutions.

Global Media & Thought Leadership: Featured in Aviation Weekly and Revolution.Aero, highlighting its impact on AI adoption in aerospace and manufacturing.

Strategic Partnerships: Engaged with four signed partners, including industry leaders from Airbus, Rolls-Royce, and Stryker, helping accelerate market entry and product deployment. With a first-mover advantage in a new €7B+ market, Better Futures is redefining the future of engineering automation through Generative AI.

Conor Motyer, Co-Founder & CEO

Conor is a Chartered Accountant (ACA) who graduated from UCD with a Bachelor of Commerce and from the Smurfit School of Business with a Masters in Accounting. Conor gained professional service experience working in KPMG Dublin, before joining Irish EdTech company Learnsignal in an operational role. During this time he completed a Postgraduate Diploma in Technology Commercialisation from NUIG. Conor approached Clinton following a serious sporting injury to develop Brace as a solution to the challenges he faced during the recovery process.

Clinton Sweetnam, Co-Founder & CTO

Clinton qualified from UCC with a Bachelor of Engineering and UCD with a Master’s Degree in Computer Science. He has over 10 years’ experience working as a Senior Software Engineer, Engineering Team Lead and Principal Engineer in successful start-up and early-stage companies, including Trustev, Glofox and Limbo.

Expected employee numbers

conor-motyer

clinton-sweetnam

Conor Motyer & Clinton Sweetnam

Company Profile

Brace is on a mission to make rehabilitation a team sport. Our social injury rehabilitation app leverages community motivation, collective insights, and gamification to support users in adhering to their recovery plans while improving their wellbeing. By transforming musculoskeletal (MSK) rehabilitation into a social and engaging experience, Brace empowers users to stay motivated and connected, enhancing both physical and mental recovery outcomes. We are committed to reshaping how people approach recovery and wellbeing through innovative technology and social support. Our goal is to empower a global community to come back stronger, together.

Company Achievements to Date

n The Brace App is available on both app stores and supports a global community of users from 80+ countries. These users have collectively completed 60,000+ recovery activities and shared 17,000+ community interactions, alongside giving glowing user testimonials of how Brace is supporting them in their health journey.

n Awarded a Commercial Health Pilot by Smart D8 in 2024 to trial Brace as a Public Health Innovation with different stakeholder groups across the Dublin 8 region.

n Successfully completed a Clinical Validation Study in 2024 led by Health Innovation Hub Ireland with a range of medical practitioners across Dublin, receiving positive results and feedback.

n Selected for the Enterprise Ireland/ IRFU Strategic Innovation Partnership in 2023.

n Winner of the InterTradeIreland Seedcorn Investment Competition for Best New Start in Dublin in 2023.

n Shortlisted as the Best New Business in Sport at the 2023 Irish Sport Industry Awards and as a finalist in the Global One-Zero SportsTech Competition in 2024.

Company Profile

Almost 20% of US adults have OSA and the prevalence is growing with the obesity epidemic. OSA doubles the risk of cardiac death and stroke and increases vascular mortality fivefold. Capri’s mission is to make the most effective OSA treatment ACCESSIBLE to everybody.

Since our incorporation, we have developed a novel approach to inject neurostimulation implants & leads. This approach changes the OSA business landscape by disrupting an existing large surgical market.

Our main competitor has a $6B market cap and achieved $803M in revenue in 2024 and projecting $950M in revenue in 2025 and a 25% growth rate. In 2024 our main competitor is still only penetrated 7% of the annual USA market. Current solutions require a 2-hour long procedure, performed under general anaesthetic. The Capri procedure is a 20-minute procedure, performed under local anaesthetic.

Our injectable approach moves procedures out of the operating room and into clinics and offices, significantly increasing patient access and reducing overall cost of treatment.

Company Achievements to Date

Fergal Ward is CEO and Founder at Capri Medical and responsible for Capri’s commercial strategy. Fergal fundraised €20M to date in a mix of grant and equity and named inventor on 12 patent families. Fergal has a master degree in Engineering and an MBA from TCD.

fergalward

Fergal Ward

Dublin

Est. 2020

Company Profile

Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake venom, these product candidates have the potential to increase survival, improve quality-of-life and reduce treatment costs for cancer patients.

Celtic Biotech is focusing its research on solid tumours, including non-small-cell lung cancer (NSCLC), as its initial targets. The Company’s lead candidate, CB-24 (Crotoxin), has been observed to be highly toxic to various tumour cell lines in pre-clinical and early clinical studies.

Company Achievements to Date

n Sept. 2022 granted EI HPSU Client status and awarded Feasibility Grant.

n June 2023 - awarded EIC Accelerator grant (€2.5m) ahead of blended equity finance option (€15m euros).

n July 2023 – One of 4 winners (only Health Science company) of the EIT Health Catapult Regional (Ireland/UK) final and advance to European semi-finals for February 2024.

n Feb 2024 – Voted top Pharma company in Sparkcrowding 100 Most Ambitious Companies and second overall

n May 2024 – Selected and participated as 1 of 15 most innovative European HealthTech companies by EIC to represent the EU in EIC-USA Soft-landing Roadshow in Silicon Valley

Expected employee numbers

2025: 6

2026: 10 2028: 25

Dr. Paul F. Reid, co-founder, seed investor and current CEO. He has a PhD in Neurobiochemistry from Imperial College, London, and BA in Microbiology from Trinity College, Dublin. He is a leading world expert in the therapeutic use of snake venom neurotoxins. Paul is widely experienced in USA medical regulatory affairs and FDA protocols. He was previously CEO of Receptopharm, Inc., a Florida based SME specialising in therapeutic venom technologies. He has extensive experience in drug production, new drug development, clinical trial design, and experimental design. Paul is based in the USA since 1993, where he has an built in-depth knowledge of regulatory eco-system and new drug development.

John Reid, co-founder and seed investor, has a master’s degree in International Business Management from Trinity College, Dublin. John is a director and Chief Operations Officer. He is based in Ireland where the Company is incorporated. Having succeeded in procuring initial seed capital and developing R&D and consultancy agreements, he successfully coordinated the vital start-up activities of business, early funding and angel investments, information dissemination, university and business collaborations, and liaison with legal, financial, medical and scientific advisors in Ireland/USA. John coordinated the successful EI HPSU Client designation and Feasibility grant, EIC Accelerator grant and EIT Catapult applications.

Est. 2021

paulfreid

john-reid

Dr Paul F. Reid & John Reid

Dublin

Tullamore

Ruairi Dooley, Co-Founder & CEO

Ruairi Dooley drives the commercial strategy at Circular Food Co., leading business development, and strategic partnerships. With a background in finance and technology, he combines data-driven decision-making with industry insights to scale the business. Ruairi works closely with food manufacturers to integrate upcycled ingredients into their supply chains, helping them meet sustainability goals and regulatory requirements. He also oversees investment strategy and market expansion, ensuring the company’s growth aligns with the evolving demands of the food industry while delivering measurable impact.

Niamh Dooley, Co-Founder & COO

Niamh Dooley leads operations and quality at Circular Food Co., ensuring the production of high-quality, sustainable ingredients. With a background in food science and sustainability, she specialises in ingredient functionality, process optimisation, and food safety. Niamh manages ingredient development, supply chain logistics, and quality assurance, working closely with manufacturers to optimise formulations and ensure compliance with food safety standards. Her expertise guarantees that every product meets the highest functional and environmental standards.

Expected employee numbers

ruairidooley

niamh-dooley

Ruairi Dooley & Niamh Dooley

Company Profile

Circular Food Co. is transforming food industry by-products into high-value, sustainable ingredients. Co-founded by siblings Ruairi and Niamh Dooley, the company focuses on upcycling spent grain from brewing—over 172,000 tonnes of which are produced annually in Ireland—into functional ingredients that enhance food quality while reducing waste. By providing measurable carbon savings and aligning with ESG and CSRD requirements, Circular Food Co. helps food manufacturers create more sustainable products. With innovation at its core, the company is driving the shift towards a circular food system.

Company Achievements to Date

n Product Innovation – Played a key role in launching one of the world’s first spent grain loaves with Tesco Ireland, showcasing the potential of upcycled ingredients in mainstream food production.

n Award-Winning Excellence – Recognised nationally with multiple awards for best food & drink startup, innovation, and taste, highlighting our leadership in sustainable food solutions.

n Global Food Safety Standards – Achieved global food safety accreditations, ensuring the highest quality and compliance in ingredient production.

n Scalable Manufacturing – Operate a full-scale manufacturing facility in Tullamore, enabling large-scale upcycling of food industry by-products.

n Expanding Upcycling Initiatives – In addition to spent grain, now upcycling surplus bread from bakeries into functional ingredients, further reducing food waste.

n Industry Leadership – Active champion of Ireland’s Food Waste Charter, driving change through measurable sustainability solutions.

n Growing Impact – Built a strong team of 10 employees, supporting the development and expansion of ESG-aligned food ingredients for manufacturers.

John Hyland started ClubSpot having completed a masters in Sport Management in UCD. John has been involved in his local club Gowna GAA since childhood and wanted to provided a better solution for volunteer run clubs and their members. John works tirelessy to help grassroots clubs become financially sustainable and put systems in place to reduce the administration burden on volunteers so that they can focus on coaching and playing of sport!

John Hyland

Company Profile

Started by John Hyland in 2019 ClubSpot provides a complete club management solution to sports clubs of all sizes. From small clubs of just 40 members right up to its largest customers who have 30,000+ users. ClubSpot helps club administrators to automate repritive tasks, create new revenue streams, and engage their supporters in a way no other club management system can. This leads to clubs gaining more members, raising more funds and ultimately being more successful on the field!

Company Achievements to Date

ClubSpot has already helped clubs to raise over €25m. With 400+ customers in 5 countries ClubSpot is quickly growing their offering to help clubs in multiple sports. ClubSpot has raised over €2m and is on track to reach profitability by year end 2025. We have built a team of 30 ambitious staff who want to build a globally recognised product in our space.

cormacfinn1

keithmahonydesign

Cormac Finn

Cormac’s passion for building impact-driven communities and connecting people through technology resulted in the inception of Communify.ai. With years of experience working in and with Fortune 500 companies as well as his time in the startup ecosystem, he saw the true untapped potential of the value that could unlock within these communities, through democratizing knowledge sharing, problem-solving and innovation. Cormac’s focus on customer needs, market trends, and emerging technologies ensures Communify remains on-track to becoming a big disruptor in this space.

Keith Mahony

Keith joined Communify the day he submitted his university thesis, and his creative vision has shaped the platform from the start. Rising from UI Designer to Chief Product Officer, his ability to transform complex ideas into seamless user experiences has been pivotal to Communify’s growth. Keith’s partnership with Cormac, built on trust and shared ambition, continues to propel Communify as a platform that empowers organisations to connect, engage, and innovate.

Cormac Finn & Keith Mahony

Company Profile

A revolution in community engagement and collaboration—where the unique strengths of People and AI seamlessly converge to facilitate connection, exchange knowledge, spark innovation, and drive transformation.

Communify goes beyond engagement for engagement’s sake, ensuring that every interaction drives real value and leads to tangible outcomes. Whether you’re connecting a professional network, managing a knowledge hub, or driving continuous improvement and innovation within a business, our platform provides the tools to harness collective expertise, drive meaningful change, and foster consistent growth.

With our next-gen crowd intelligence platform, Communify makes sure you thrive in an everevolving world.

Company Achievements to Date

Since its inception, Communify has achieved significant milestones on its journey to becoming a leading AI-powered platform for community engagement and innovation crowdsourcing. With very limited resources, we have built a robust and scalable core product that empowers organisations to harness collective intelligence, foster collaboration, and drive meaningful outcomes. Our efforts have been backed by over €200,000 in pre-seed funding, including the support of Enterprise Ireland, further validating our vision and potential.

In addition to securing and retaining early customers, Communify has garnered remarkable feedback from users and strong interest from some of the most innovative brands both nationally and internationally. This validation underscores the platform’s ability to address critical challenges in driving engagement, unlocking knowledge-sharing and innovation. As we continue to refine our product with the help of our customers, Communify is well-positioned to help communities unlock the true potential of their people and thrive in an ever-evolving landscape where speed and agility is paramount. With a solid foundation, growing market interest, and plans to raise €600,000 in our next fundraising round later this year, Communify is set to shape the future of community engagement and collaboration.

Dublin Est. 2022

Johnny Dunne - CEO. He is a Chartered Accountant with 30 years experience of advising and managing various growth-oriented businesses in senior commercial and financial advisory roles with professional services firms, multinationals, export led manufacturing and service companies, software companies and retailer. More recently, he has his own corporate finance advisory business, SME Equity, mainly focused on managing turnaround situations and investing in start up / growth-oriented businesses. Owned Software companies with successful exits.

Brian Murphy- COO. He is a customs and supply chain professional with over 25 years’ experience working for multinational organisation’s in global roles. Brian has extensive experience of international supply chains and the customs and trade facilitation measures associated with them. Brian is highly skilled in delivering customs training and consultancy on customs procedures and trade facilitation measures. And highly proficient in customs rules and regulations associated with customs declaration transactions.

Expected employee numbers

/johnnydunne

brian-murphy

Johnny Dunne & Brian Murphy

Company Profile

Customs Window Technologies Limited provides a comprehensive solution for the entire customs declaration process. Customs Window uses advanced process automation and AI to simplify and manage the data set required by companies for EU & UK customs declarations. The Company provides clients, such as e-commerce companies and logistics providers, with an integrated platform and open API to simplify the customs declaration creation and submission process. This enables clients to increase their declaration clearance rates and at the same time automate their processing of declarations while ensuring effective data management and reporting for compliance and risk management.

Company Achievements to Date

Founded in June 2022, after receiving €200k in Pre Seed funding, Customs Window Technologies Limited closed a seed round of €800,000 in November 2024 from mainly EIIS private investors and Enterprise Ireland as a HPSU client company.

We have refined our commercial growth plans within the high growth e-Cormmerce sector and our AI/ML product roadmap in conjunction with CeADAR/EDIH.

We have grown our team based in NexusUCD, as we onboarded new customers during 2024 and so far this year reaching €20k in MRR with a burn rate of €30k per month.

We have also built out our product platform for the UK market and other EU markets.

Customs Window has gained product market fit in their ideal customer profile of e-Commerce companies and logistics providers.

We have clear commercial growth plans to reach €1 million ARR and a technical product roadmap to be delivered on for 2025 to scale and internationalise the business.

Company Profile

At Cytidel, we help security teams cut through the noise and focus on the security risks that actually matter. Traditional approaches to vulnerability management overwhelm teams with endless alerts, often prioritising the wrong risks. Cytidel solve this by using real-time threat intelligence to surface the top 1% of vulnerabilities that pose a real threat—days or even weeks before other sources catch up. We’re a fast-moving, intelligence-led company built for security professionals who need actionable insights, not endless alerts.

Company Achievements to Date

As a pre-seed startup, Cytidel have secured multi-year enterprise deals supporting organisations across financial services, aviation, and healthcare – a significant achievement at this stage. Cytidel have been recognised with multiple industry awards, including National Startup of the Year and the Fintech Category Award at the 2024 National Startup Awards. Additionally, Cytidel also won the Innovation Award at the National Enterprise Awards 2024, further highlighting the impact the team are having on the cybersecurity space.

Cytidel was founded by Matt and Conor after meeting during their time at Accenture. Having worked on the frontlines of cybersecurity, they saw firsthand how traditional vulnerability management overwhelmed teams with alerts, often prioritising the wrong risks and leaving real threats buried in the backlog.

Cytidel was built to change that. The platform is designed to help security teams cut through the noise and focus on the vulnerabilities that actually matter. Drawing on their expertise in security operations, vulnerability management, and cyber risk intelligence, they developed a system that uses real-time threat intelligence to surface the 1% of vulnerabilities that pose real risk, enabling security teams to proactively prevent security incidents.

The vision is simple: provide security teams with actionable insights, not endless alerts. By ensuring defenders stay ahead of the latest emerging threats, Cytidel help organisations reduce breach risks, eliminate unnecessary late-night emergency calls, and make cybersecurity operations more efficient.

Est. 2022

cytidel

Mayo

conlonmatthew

Matt Conlon, Conor Flannery & Gary Fagan conorflannery gfagan00

Dublin

Est. 2023

Dr Aidan Boran is a seasoned innovator with over 25 years of experience in collaborative research and development roles within the telecommunications industry. He has a practical blend of technical, program, and people management skills, honed through his involvement in large telecom’s infrastructural projects over the last three decades. With a Ph.D. in Computer Science, 10 patents, and over 20 publications to his name, Aidan has made valuable contributions to the fields of edge devices/sensors, computer vision, artificial intelligence, and data analytics during his time as a senior researcher at Bell Labs. Furthermore, he has successfully navigated both startup and corporate environments, to bring his research from the lab to industry. In recent years, Aidan has earned recognition for his medical device research, particularly the GaitKeeper Project, which offers a disruptive motion capture technology platform for gait analysis in healthcare settings.

Expected employee numbers

aidan-boran

Dr. Aidan Boran, Professor Sean Kennelly, Larry Keaveney & John O’Brien

Company Profile

Digital Gait Labs is a health technology spin-out from Dublin City University, specialising in AI-driven, mobile-based gait analysis through its flagship platform, GaitKeeper. The company aims to address the critical need for accurate frailty and fall risk assessment among older adults, a challenge that significantly impacts healthcare costs and long-term care admissions. Traditional gait assessments are often expensive and subjective, while GaitKeeper offers a cost-effective, accessible, and highly accurate solution for measuring gait speed—a key biomarker for detecting frailty, cognitive decline, and fall risk.

Company Achievements to Date

GaitKeeper represents five years of interdisciplinary research spanning academic, clinical, and technological domains. Validated in collaboration with Dublin City University and Tallaght University Hospital, it leverages artificial intelligence (AI) and augmented reality (AR) to provide precise gait measurements, including gait speed, stride length, and step dynamics.

Key contributions of the research include:

n Technological Advancements: fusion of AI and AR algorithms enables precise spatiotemporal measurements, including gait speed, stride length, and joint dynamics, with an accuracy to match or exceed gold-standard systems like Vicon and GAITRite.

n Clinical Validation: Robust testing in healthcare settings, including memory clinics and acute care, highlights GaitKeeper’s utility in identifying fall risks and monitoring rehabilitation progress.

n Health Pathway Integration: Compatibility with HL7/FHIR standards ensures seamless integration with existing healthcare systems, enabling longitudinal monitoring of patient data for more effective care.

In 2024, validation studies have been published in European Geriatrics Conferences and Sensors Journal. Today GaitKeeper is a CE marked, class 1 medical device and is in use in 8 healthcare pathways in Ireland.

gaitkeeper_DGL

Denis Roche has over 25 years experience working in digitalising patient experience for leading hospitals and healthcare providers in Ireland and the UK. With a background in Cognitive Computing and Data Analytics, Denis founded eAltra to tackle global under-capacity in cancer care delivery.

Expected employee numbers

2025: 3 2026: 6 2028: 10

Carlow Est. 2024

roched

Denis Roche

Company Profile

eAltra is a campus company of Trinity College Dublin that develops a conversational AI to exchange routine clinical information and remote assessments for patients receiving cancer treatment in Ireland, UK and USA

Company Achievements to Date

n Spin-in to Trinity College Dublin in 2022 and recipient of Enterprise Ireland Commercialisation Funding.

n Developed the eAltra platform which is in trial in St.James Hospital Dublin and Tallaght University Hospital, Dublin, published in the British Journal of Maxillofacial Surgery.

n Spun-out of TCD in June 2024.

n Enterprise Ireland HPSU funding / status achieved in Dec 2024.

n Closed pre-seed round in Dec 2024.

roched

Shane Lynn PhD, CEO

Dublin Est. 2018

An engineer by training, Shane is a data and visualisation guru with a PhD in machine learning from Maynooth University. Having worked in industries like rocket propulsion and telecommunications, he now leads product, strategy, and customer experience at EdgeTier, driving innovation and overseeing the company’s strategic direction.

Bart Lehane PhD, CCO

Bart, with a PhD in machine learning, specialises in translating complex technology into customer-driven solutions. His expertise spans research, development, and product management, and he’s instrumental in working directly with customers to ensure EdgeTier’s offerings meet their needs and provide real value.

Ciarán Tobin, CTO

Ciarán is a full-stack developer with an M.Sc. in Business Analytics. He ensures the smooth operation of the EdgeTier platform by working with technologies like TypeScript, Python, and SQL. Ciarán plays a key role in technical strategy, making sure the platform is efficient and scalable.

shanealynn

Shane Lynn PhD, Bart Lehane PhD & Ciarán Tobin

bart-lehane

tobin

Company Profile

EdgeTier is an AI-powered conversation intelligence platform that helps customer service teams uncover valuable insights from support and survey messages. By analysing high volumes of multilingual conversations in real-time, EdgeTier detects trends, improves agent performance, and identifies customer frustrations, driving companies to become more customer-centric. With customers like Ryanair, TUI, and Abercrombie & Fitch, EdgeTier operates across Europe and the US, serving industries such as retail, travel, and gaming. Having raised a Series A round, EdgeTier is rapidly growing and was named a finalist for Deloitte’s Fast 50 in 2024 and featured in Sifted’s Top-Growing Startups.

Company Achievements to Date

EdgeTier has achieved significant growth and success since its inception. In 2023, we closed our Series A funding round and opened our second office in Barcelona, Spain, marking a milestone in our expansion. Our revenue has since increased by 85%, and we more than doubled our team to over 60 employees to support our growing customer base.

We expanded our presence internationally, signing major global accounts such as TUI, Abercrombie & Fitch, Ryanair, and Kaizen Gaming. This international expansion was complemented by our entry into new verticals, notably retail in 2024. We also secured larger contracts with existing clients, reflecting the growing trust in our AI-driven customer conversation intelligence platform.

Our technological innovation continues to be a core strength. We were delighted to win the Technology Innovation of the Year award with Ibec in 2024 and continue to see EdgeTier become a key driver of demand. The product has not only streamlined customer support processes and delivered valuable insights but also contributed to the growth of the businesses using our technology.

In recognition of our growth, EdgeTier has been included in Deloitte’s Fast 50 for the past two years, alongside notable Irish startups such as Wayflyer and Tines.

Company Profile

eStation offers a comprehensive EV Charging Ecosystem designed for home, workplace, and public charging needs. The company provides a one-stop solution with full installation services, tailored solutions, ongoing maintenance, and fleet management tools to optimize EV operations. Transparent reporting features real-time cost tracking, energy efficiency insights, and detailed compliance, enabling informed decision-making.

eStation integrates the latest technology, ensuring future-proof compatibility and readiness for advanced energy management technologies such as V2G, V2B, and V2H.

With customer-centric support, 24/7 service, training, and proactive alerts, eStation ensures seamless operations and peace of mind for customers.

Company Achievements to Date

eStation has established itself as a leader in EV charging solutions, providing a comprehensive ecosystem that serves home, workplace, and public charging needs. The company delivers a seamless, end-to-end solution that integrates hardware, software, and support services to ensure efficient EV fleet operations.

eStation has successfully partnered with a diverse range of corporate and public sector clients, including major logistics, transportation, and retail companies. Through 24/7 customer support, training, and proactive issue identification, the company ensures reliability and uptime for clients.

Innovation remains at the forefront, with eStation pioneering smart charging technology, roaming capabilities, and sustainability initiatives, such as carbon footprint tracking and integration with renewable energy sources. Looking ahead, the company’s roadmap includes vehicle-to-grid (V2G) and battery storage solutions, further enhancing energy efficiency. With its focus on scalability, seamless integration, and customer-centric solutions, eStation continues to shape the future of EV charging, making sustainable transportation more accessible and efficient.

Expected employee numbers

Churchtown, Co Dublin

Est. 2015

eamonn-mcsweeney

Eamonn McSweeney, Mark McSweeney & Alan Gaynor mark-mcsweeney alan-gaynor

Eamonn, Mark, and Alan, the visionary co-founders of eStation, established the company in 2015 as a premier provider of integrated electric vehicle (EV) fleet management solutions in Ireland. Pioneering the supply, installation, and support of a diverse range of optimized EV charging systems, eStation has continually set industry standards across the nation. The founders are driven by a commitment to propel Ireland toward a zero-emissions future by offering flexible, reliable, and efficient charging solutions. Their focus on sustainability and innovation has positioned eStation as a cornerstone of Ireland’s EV ecosystem, empowering corporate fleets and consumers alike to embrace a greener future.

e-station-evcharging

David Owens brings over a decade of deep retail analytics expertise and entrepreneurial drive to EVERYANGLE. Having previously led product innovation at a retail-focused software startup, he learned firsthand the data challenges that physical stores face compared to online. Determined to close that gap, David co-founded EVERYANGLE in 2019 to harness AI and computer vision for real-time, in-store intelligence. Under David’s guidance, the team built a platform that transforms any CCTV network into a robust data source for footfall tracking, shopper flow, and customer engagement insights. His passion for marrying cutting-edge tech with tangible retail results has propelled EVERYANGLE onto the radars of top retailers worldwide. A proud advocate for continuous learning, David fosters a culture of curiosity and experimentation, ensuring EVERYANGLE remains at the forefront of AI innovation in the retail space.

Expected employee numbers

dbfowens

David Owens

Company Profile

EVERYANGLE is an Irish technology company turning CCTV into AI-powered retail intelligence. Our platform provides retailers with real-time insights on customer footfall, demographics, engagement patterns, and conversion rates—helping them optimize operations, boost in-store experiences, and increase revenue. By leveraging existing camera infrastructure and powerful computer vision analytics, EVERYANGLE eliminates the need for additional sensors while delivering high-quality data on shopper behaviors. Founded in 2019, the company works globally with leading retailers and franchised groups. Our mission is to bring the clarity of e-commerce metrics into physical stores, empowering businesses with the advanced insights they need to thrive.

Company Achievements to Date

Since launching in 2019, EVERYANGLE has raised over €3 million in seed and growth funding, expanding operations to the UK, Europe, and North America. Our AI platform is currently deployed across multiple tier-one retail clients, from fashion and specialty stores to large franchise operators, providing them with valuable, real-time shopper analytics. In 2022, EVERYANGLE was selected for a high-profile pilot with a major Middle Eastern franchisor, covering 1,000+ stores, significantly advancing our market presence in the Gulf region. We have also formed strategic alliances with Cisco, AWS, and leading system integrators, enabling swift rollouts across diverse retail footprints. Our successful pilot programs—delivering up to 15% increases in store conversion rates—have received recognition in major retail tech publications. Alongside commercial traction, EVERYANGLE maintains a strong focus on product innovation, developing advanced AI models for queue analysis, demographic segmentation, and shelf-level insights. The result is a robust platform that offers retailers a clear path toward data-driven performance improvements.

Company Profile

Examfly is an education technology start-up founded in 2020, which is transforming the learning model for professional exams and continuous professional development. Examfly’s AI-driven learning platform delivers personalised, engaging, and effective learning experiences for those sitting professional exams. The Examfly model recognises the challenges faced by the busy 21st-century student and helps work around them. Working with subject matter experts, software developers, animators and game designers, Examfly have created a learning experience optimised for skill acquisition and reinforcement. Already used by some of the top professional services firms in Ireland and the UK, Examfly is set to expand globally this year.

Company Achievements to Date

Examfly has established itself as a trusted learning solution in the professional services industry, with three of the ‘Big 4’ firms in Ireland integrating the platform into their training programs. In the UK, Examfly is now in its second year of use with one of the top professional services firms.

In 2024 alone, over 1,000 Tax and Accounting trainees across the UK and Ireland used Examfly to enhance their learning experience.

To date, Examfly has raise €2.1 million in funding, backed by successful entrepreneurs and prominent investors like Ray Nolan and Brian Caulfield.

Expected employee numbers

Deirdre Lyons, founder and CEO of Examfly, began her career in tax consultancy and wealth management, working with prominent firms such as PwC and Davy. During her time as a tax lecturer she witnessed many students struggle and fail exams, even diligent and hardworking ones. This experience, combined with a deep interest in learning, psychology, and technology, led her to envision a more effective way to teach complex topics. Thus the idea for Examfly was born.

Dublin

Est. 2020

examfly

deirdre-lyons

Deirdre Lyons

Gary Evans is an innovative entrepreneur, AI strategist, and digital marketing expert with a track record of building high-impact SaaS solutions. As the founder of multiple technology driven ventures, Gary is at the forefront of AI and automation, creating groundbreaking platforms that drive efficiency and transformation across industries.

With a strong background in data analytics, AI development, and business strategy, Gary has successfully secured funding and investment to scale cutting-edge solutions. His latest AI project is revolutionising enterprise AI adoption, offering secure, private AI models for businesses operating behind firewalls.

Beyond technology, Gary is a dedicated leader, passionate about innovation and solving complex challenges. His expertise spans digital marketing, recruitment technology, and SaaS development, with a focus on creating sustainable, scalable solutions. Through strategic vision and relentless determination, Gary continues to shape the future of AI and business automation.

Expected employee numbers

Carlow

Est. 2018

garyevans

Gary Evans

Company Profile

Feedalpha is a cutting-edge AI-powered social media management platform that helps businesses simplify content creation, scheduling, and engagement. Using advanced AI insights, it enables users to craft high performing posts, optimise posting times, and monitor audience interactions - all from a single, easy-to-use dashboard. Designed for SMEs, agencies, and enterprises, Feedalpha allows brands to maintain a strong online presence while saving time and effort. Its powerful AI features and intuitive interface make it a must-have tool for modern digital marketing. Feedalpha is transforming social media management, helping businesses grow and thrive online

Company Achievements to Date

Feedalpha has established itself as one of the most innovative AI-powered social media management platforms, helping businesses streamline content creation, scheduling, and engagement. Over the years, the platform has empowered thousands of businesses to enhance their digital presence, saving time and driving engagement through intelligent automation.

A key milestone was the development of Feedalpha’s AI-driven content generation engine, which enables users to create high-quality, engaging social media posts tailored to their audience. The platform’s intuitive scheduling tool has been widely praised for its ease of use, allowing businesses to maintain consistent and effective social media strategies.

Feedalpha is a High Potential Start-Up (HPSU) backed by Enterprise Ireland and has secured funding from both Enterprise Ireland and a private investor, fueling its growth and innovation. With a robust roadmap ahead, Feedalpha continues to evolve, delivering cutting-edge solutions for businesses worldwide.

Our new AI will enable businesses to deploy secure, private AI models behind their firewalls while significantly reducing energy consumption. Using cutting-edge physics-based algorithms, it lowers hardware requirements, making AI more accessible, efficient, and environmentally sustainable for large organizations. This innovation aligns with our commitment to green technology, helping companies reduce their carbon footprint while leveraging the power of AI.

Company Profile

FeelTect have developed Tight Alright - A pioneering connected-health platform for targeted application, monitoring, and maintenance of optimised compression therapy, redefining models of care for venous leg ulcer and lymphoedema patients.

Company Achievements to Date

n Financial milestones: €1.2M seed (2021), €1.8M pre-Series A (2023) €4.6M DTIF consortium (2023, non-dilutive, €1.3M direct to FeelTect)

n Regulatory milestones: FDA registration (Class I, 510(k) exempt), CE Mark (Class I), TGA/NZ Registration (Class I), ISO 13485 accreditation

n Technical milestones: Design lock achieved on wearable device (DV complete Q2 2025), digital platform completed, in-house manufacturing established

n IP milestones: EPO and USPTO approval of claims for national phase patents on wearable device, national phase filings on data transfer patents

n Clinical milestones: 250 patients scheduled for treatment internationally, UK venous leg ulcer (VLU) patient studies showing dramatically accelerated healing rates compared to standard of care, establishment of an NHS clinic for real-world pilot data, 40 VLU patient study in California commencing in Q1 2025

n Commercial milestones: First sales for training/education purposes to multiple sites in Germany and Switzerland (not yet commercially available for clinical use), first sales for research purposes with groups in Spain (139 patient study) and USA (40 patient study)

Expected employee numbers

2025: 8 2026: 15 2028: 30

Est. 2019

Dr Andrew Cameron, PhD, BEng - CEO 10 years’ experience in Research Commercialisation. Raised over $7 million in funding. Identified an unmet clinical need in wound care as a BioInnovate Ireland fellow in Mayo Clinic. Dr Darren Burke, PhD, BEng - CTO Extensive experience in Quality and R&D engineering roles at well-established medical device companies such as Boston Scientific and Merit Medical. He also holds a Six Sigma Black Belt. Prof. Garry Duffy, PhD, BSc - Professor of Anatomy at University of Galway and Vice Dean for Research, Innovation and Graduate Studies, coordinating several collaborative EU projects involving multiple partners across different countries.

feeltect

Spiddal, Galway

andrew-cameron

Andrew Cameron, Darren Burke & Garry Duffy darrenburke garry-duffy

Dublin

Est. 2021

Field

of Vision

deneher

David Deneher, Omar Salem & Tim Farrelly omar-salem-haptics

timfarrelly

Field of Vision was founded by three close school friends—David, Omar, and Tim—who bring complementary skills to the company. David oversees business development, operations, and strategic partnerships; his background in computer science and business underpins our growth initiatives. Omar leads hardware development, leveraging his aerospace engineering expertise and firsthand experience coaching visually impaired athletes to design products that are both robust and accessible. Tim heads our software and AI systems, drawing on research and practical experience from Cambridge and Oxford to build the technology that powers our real-time tracking and haptic feedback. Together, their combined expertise ensures a balanced focus on technical innovation and practical application, driving the development of solutions that improve the live sports experience for visually impaired fans.

Expected employee numbers

2025: 10

2026: 20

2028: 50

Company Profile

Field of Vision improves sports accessibility for visually impaired fans through an AI-powered camera system and a custom haptic device. Our solution provides real-time tactile feedback that complements audio commentary, allowing fans to better follow live action independently. We have completed pilot projects in major stadiums and received positive feedback from users, proving our approach works in real-world settings. By focusing on practical and user-centered technology, we are helping to bridge the accessibility gap in live sports and make matchday experiences more inclusive and enjoyable for visually impaired supporters.

Company Achievements to Date

Field of Vision has made steady progress in making live sports more accessible for visually impaired fans. Our product uses AI-powered cameras paired with a haptic feedback device to deliver real-time, tactile insights during games. Early support came in the form of a grant from Toyota, which helped us refine our design and technology. We then successfully deployed 40 devices for Telstra at Marvel Stadium, giving fans a new way to experience Australian Rules Football. More recently, we installed 20 devices for Guinness during the 2025 Six Nations tournament, showing our capability to adapt our offering across different sports.

Our work has earned recognition through awards like TIME Magazine’s Best Inventions of 2022 and the James Dyson Award, validating our focus on innovation and practical impact. Feedback from partners such as Manchester City FC and Bohemians FC has been invaluable in shaping our approach. As we continue to listen to our users and improve our product, our goal remains clear: to make live sports a more inclusive experience for visually impaired fans.

Company Profile

Gladcloud empowers national and global brands’ social media marketing with the Complete Channel Partner Marketing Platform, transforming retail partners into brand advocates at scale and ensuring the most efficient and cost-effective campaign activation.

Our platform bridges brands’ budgets and creative assets with the social media pages of its trade customers, enabling brands to effortlessly launch hundreds of hyper-locally customised and targeted social media ads.

Proven across industries, our solution is tailor-made for large brands that sell products or services via large networks of independently owned trade customer locations, such as alcoholic beverages, food delivery, travel retail, automotive, and ultimately any FMCG or similar brand.

Gladcloud is headquartered in Dublin, Ireland, with offices in Amsterdam and London.

Company Achievements to Date

The company now has Long-term Enterprise Service Subscription Agreements in place with Diageo (Global), Puig (Global), Uber Eats (UK & Ireland), Heineken (Global) and Campari (Global), with many other clients in pilot phase on the verge of global rollout

Expected Growth Rates in Revenue:

Est. 2017

Gladcloud’s co-founders met while working together for a year in another AdTech start-up prior to founding Gladcloud in 2017, and have substantial combined experience across location-based software & digital business development:

Keith Curley, CEO & Chief Commercial Officer: 20+ Years of growth hacking specifically in the digital advertising industry, with experience managing multi-market sales teams.

Tony Burke, COO & Chief Product Officer: Ex-Director of Microsoft International with 30+ Years in product development of emerging technologies incl. Location-Based Marketing.

Dun Laoghaire

tonyb62

keithcurley

Tony Burke & Keith Curley

Bunratty, Co. Clare

Est. 2018

Ivan Tuohy is a seasoned tourism industry leader with over 20 years of experience in hotels, visitor attractions and the hospitality sector, including 14 years as a General Manager. Before founding Great Visitor Experiences, an award-winning digital software company, he served as General Manager with Shannon Heritage, Ireland’s largest commercial visitor attraction operator.

As CEO of Great Visitor Experiences, Ivan is at the forefront of developing an experiential visitor app and data-driven content management solution for attractions, museums and AI driven itineraries for Destination Marketing Organisations. His mission is to revolutionize how attractions and destinations connect with in-destination visitors through smart technology, helping them maximise reach, revenue and market share.

Ivan’s expertise spans the entire tourism ecosystem, combining storytelling, cultural appreciation and cutting edge digital solutions to enhance visitor engagement. He specialises in increasing profitability, understanding visitor motivation and developing product strategies that elevate tourism businesses and enhance the customer experience.

Ivan also holds an MBA and is currently pursuing a Ph.D., focusing on how attractions and museums can collaborate with visitors to create better products and gain a competitive advantage.

Expected employee numbers

/ivantuohy

Ivan Tuohy

Company Profile

Great Visitor Experiences is a tourism technology company specializing in AI-powered itinerary solutions for Destination Marketing Organisations and a chatbot for visitor attractions. Our innovative platform enhances trip planning by personalizing recommendations based on visitor preferences, real-time data and local insights. Designed to drive engagement, increase dwell time and boost revenue, our solution seamlessly integrates with tourism businesses to create frictionless, immersive experiences. Currently operating in Ireland with a growing presence in the U.S., we empower destinations to deliver smarter, more memorable travel experiences while leveraging actionable visitor data to optimize marketing strategies and operational efficiency.

Company Achievements to Date

n Recognised as a leader in tourism technology with an award winning digital software solution.

n Acknowledged for innovation in visitor management and engagement solutions.

n Successfully launched and scaled operations in Ireland, with an expanding customer base in Scotland and the U.S.

n Strong pipeline of clients, including leading visitor attractions, museums and Destination Marketing Organisations

n Helping tourism businesses increase revenue, improve visitor satisfaction and optimise operations through smart technology solutions.

n Over 1 million visitors in Ireland have direct access to our visitor app

n Over 600 B2B customers

Dr. Moayed Hamza & Mr. Mark O’ Neill FCA

moayed-hamza mark-o’neill-fca

Dr. Moayed Hamza MD , qualified physician with over 8 years industry experience working on R&D from concept through preclinical and clinical development, global regulatory strategy and clinical operations at a Chief Medical Officer level.

Mr. Mark O’ Neill FCA , Deloitte qualified chartered accountant with 20 years company building experience, 13 of which spent translating novel drug concepts into clinical development programmes at a CEO and CFO level.

Moayed and Mark have both worked together closely for over 8 years in different biotechs.

Expected employee numbers

Company Profile

HAON are developing CanVas-001, a potential world first therapeutic drug for newborn brain injury.

Our lead indication for CanVas-001is one of the largest global unmet needs, hypoxic ischemic encephalopathy (HIE). HIE is brain injury due to decreased brain oxygenation around birth. HIE causes 22% of infant deaths and 30% of cerebral palsy with no approved therapies.

HAON’s proprietary CanVas platform can unlock paradigm-shifting treatments for a range of neurologic and other serious diseases including rare blood disorders. CanVas is powered by endothelial colony forming cells (ECFCs) and mesenchymal stromal cells (MSCs).

Company Achievements to Date

HAON acquired the base technology from a University in Australia and generated preclinical data to support additional platform applications and new IP.

HAON were finalists in the European Innovation and Technology (EIT) Wild Card paediatric accelerator late 2023.

Late 2024, HAON received fast track status to stage 2 of 3 for potential EIC accelerator funding€2.5m grant and €10m matching equity.

Early 2025, a HAON led consortium (along with UCC Infant Centre, NIBRT, HiTech Health) have been shortlisted for potential substantial DTIF funding to advance CanVas-001 to clinic.

haon-life-science

Company Profile

Head Diagnostics has developed an innovative technology and an associated handheld medical device for the diagnosis of concussion (mTBI), Parkinson’s Disease (PD), MS and other neuro degenerative diseases. Our technology and bio marker provides a rapid assessment of brain function in a non invasive 3 sec eye test to assist clinicians with the diagnosis of brain diseases and injury, as well as the management of neuro diseases. Our vision is to help people live a healthier life for longer.

Company Achievements to Date

Multiple neuro clinical studies running with well recognized organisations including Beaumont Hospital / RCSI, University of Northumbria, National Optometry Centre etc, Full stack medical development team in Dublin, FDA pre sub meetings completed, Irish Medtech Awards 2024 - Top 3; Top 5 Medtech Innovator 2019, 2022; Intertrade Ireland Top 3 2019 ; EIT Headstart Winner 2019 ; George Sigerson Award UCD for Scientific Innovation in Biology 2024, Best Application of AI in Healthcare Ireland Awards Winner 2023

David van Zuydam, Dr Mindaugas Norkus & Killian O’Sullivan

davidvanzuydam

killianosullivan mindaugas-norkus

David van Zuydam: CEO and entrepreneur with vast experience in driving revenue, creating markets, fundraising and exits in Blue Chip Companies and with SME’s. Passionate about Medtech with a focus on neurodegenerative disease. Senior Roles in Accenture, Microsoft, Philips, Flextronics, Advanced Medical Optics.

Dr Mindaugas Norkus: CTO and previously a Researcher at Trinity College Dublin with 6 years research track record on ocular micro tremor. Passionate engineer with a PhD in Bio Medical Engineering as well as backgrounds in electronics and computer/software engineering.

Killian O’Sullivan: An experienced Engineering professional delivering innovation from unmet need to product reality. His career has included positions such as start-up founder, consultant, CTO to systems architect in SMEs to Fortune 500. With 30+ years of experience he has covered many technical aspects of engineering design, HW and SW coding, project management, building technical teams, specification and intellectual property while keeping abreast of latest developments.

headdiagnostics

Dublin

Est. 2018

Est. 2021

Leopoldo Rodríguez Salazar is a highly accomplished engineer with a PhD in Automation Engineering, Electronics, and Telecommunications from the University of Seville (2018, Magna Cum Laude), an MSc in Aerospace Vehicle Design focusing on Avionics Systems from Cranfield University (2013), and a BS in Mechatronics Engineering from ITESM-CEM, Mexico (2008). His graduate coursework includes Systems Identification, Control Systems Design, and Advanced Python Programming. A co-founder and CEO of Helgen Technologies, he also co-founded SafetekLabs and All Robotics. With over 15 years of experience in robotics and autonomous systems, his expertise spans aerospace, mechatronics, and industrial automation. Rodríguez Salazar’s multidisciplinary background and leadership in innovative startups position him as a key figure in advancing technology across multiple sectors.

Dublin

leopoldorodriguez

Leopoldo Rodriguez Salazar & Julio Vidrio Rodriguez

Company Profile

Helgen Technologies, founded in 2021 and based in Dublin, Ireland, accelerates digital transformation for industries like container ports, waste management, mining, and construction. Offering a business intelligence platform with digital twin technology and advanced technology maintenance, Helgen enhances operational efficiency and decision-making. With a presence in Ireland, the USA, UK, and Mexico, the company, backed by investors like Techstars and Stanley Black and Decker, aims to expand across multiple sectors, delivering innovative, data-driven solutions for a sustainable industrial future.

Company Achievements to Date

2024 we achieved 1 million dollars in total revenue, and in 2025 we have achieved 100K USD in MRR for our maintance service and about 20K USD in MRR for our platform. We have pivoted to only digital twin and data analytics platform in 2024 as well.

Kate Scott is the CEO and Founder of HoloToyz, with a background in creative and advertising, she has a deep passion and understanding of how to connect brands with audiences through engaging storytelling and immersive experiences. Leveraging her expertise, she has successfully led HoloToyz to secure major licensing deals with Mattel (Barbie & Hot Wheels), and Nickelodeon (Paw Patrol), while expanding into global retailers like Walmart and closer to home, Tesco.

Declan is the Founder and Sales Director of HoloToyz. He also founded Bash Products who manufacture and distribute the iconic Red Party Cup along with over 60 skus of partyware and drinkware products to multiples such as Tesco, Asda and Morrisons in the UK and Ireland after spotting a gap in the market. With over 15 years of sales experience at Independent News & Media as Head of Digital and Agencies, he has a strong background in sales, and brand development.

Expected employee numbers

Meath

Est. 2020

kate-scott

Kate Scott, Declan Fahy & Paul Cosgrave declanfahy

Company Profile

At HoloToyz, we love to combine physical and digital worlds to bring kids’ toys to life through the magic of our free HoloToyz app. Our innovative approach allows children to interact with their toys in new and exciting ways, creating an immersive and engaging play experience. With HoloToyz, the possibilities are endless!

Company Achievements to Date

HoloToyz has rapidly emerged as a pioneering brand in the toy industry, blending traditional play with cutting-edge augmented reality (AR) technology. Since its launch in 2020, the company has secured key retail partnerships, including a major milestone with Tesco Ireland, bringing its innovative products to a wider audience and soon to launch in Walmart U.S.

The brand has garnered global recognition, exhibiting at the prestigious Nuremberg Toy Fair and receiving overwhelmingly positive feedback from industry leaders, retailers, and investors. HoloToyz won the Irish Times innovation award for Manufacturing and Design in 2022. They also won Silver at the London Toy Fair in 2022 and then won Gold at the Nuremberg Toy Fair in 2023 for their partnership with Paw Patrol. HoloToyz’s commitment to quality and innovation has led to collaborations with some of the world’s biggest brands, further solidifying its position as a leader in AR-enhanced toys.

Consumer response has been phenomenal, with children and parents embracing the magic of HoloToyz’s interactive experiences. The company continues to expand its product range, ensuring it stays ahead of the curve in an evolving industry. With a strong foundation, growing retail presence, and a vision for the future, HoloToyz is set to revolutionize playtime for the next generation.

holotoyz

Company Profile

Imvizar is at the forefront of transforming real-world spaces into storytelling experiences through innovative location-based Augmented Reality (AR) experiences. With a collection of over 100 immersive storytelling experiences available in 11 countries and growing, Imvizar is redefining how people interact with their surroundings.

Their clients include prominent organisations such as Salesforce, Grant Thornton, Bupa, Calor, Spike Island, and many more, demonstrating the significant impact they are delivering across a wide range of sectors, including tourism, employee engagement, and sustainability.

This year they will launch Lureo, their game-changing creator platform which enables anyone to create world-class immersive experiences without any code!

Company Achievements to Date

n Delivered over 100 experiences in 11 countries

n Created the worlds first no-code AR storytelling platform

n Secured €1.5m investment from Delta Partners, Enterprise Ireland and prominent angel investors

n Recognised internationally at SXSW, Augmented World Expo, Web Summit and more

n Built an incredible team positioned to transform storytelling in the coming years

Michael is the CEO and Founder of Imvizar. He has a passion for utilising immersive technologies to tell better stories and deliver better experiences. He has delivered over 100 storytelling experiences across nine countries. He is a thought leader in the immersive experiences industry and has delivered keynotes in industry leading events such as Augmented World Expo (x3), SXSW, Web Summit, Museums & Heritage and many more.

He is an accomplished leader with expertise in building and enhancing startups and innovationdriven enterprises. While working with Dublin City Council, he created their smart districts strategy, including the award winning Smart Docklands programme. He specialises in Smart Cities, Immersive Technology, and 5G, and has advised major companies such as Google, SoftBank, Microsoft, and Mastercard on product development and market routes.

Dublin Est. 2021

michaelbguerin

Michael Guerin

/imvizar

/imvizar

imvizar

Mullingar Co Westmeath

Mark Connaughton is a soccer coach for the last 15 years in Ireland & USA. He completed a level 8 degree in business & sport in Sligo IT and brought this knowledge into his business.

Mark has played for teams such as Shelbourne and Longford Town and represented Ireland at College Level.

Mark aims to help kids around the world learn to fall in love with soccer through a fun & inclusive approach.

mark-connaughton

Mark Connaughton

Company Profile

Klaaskickz & The Klaaskickz Academy has created a new colour coded football boot that helps beginners in soccer and GAA learn through colours.

We use our Klaaskickz Football Boots in over 150 primary schools & clubs around Ireland teaching kids basic skills and to learn to love football.

We sell our boots in 48 shops around Ireland and the UK & recently launched in the USA.

Each part of the foot is represented by a colour that makes it easier for kids aged 3-8 to learn sport easier & quicker.

Company Achievements to Date

n National Start Up Award Winners

n Most Ambitious Company in the Product & Manufacturing category 2024.

klaas-kickz

Company Profile

Konree Innovation is solving the #1 problem preventing the salmon aquaculture industry from growing and scaling. This is a sea lice problem that costs Euro 6-7 billion every year in an industry worth ca. Euro 21 billion. Konree has a deep-tech solution to reliably manage and control sea lice in a non-fish contact, sustainable way, for happier, healthier, heavier fish.

Company Achievements to Date

n Established in March 2021, Galway

n 2022 Michael Flynn joins Konree Innovation as CTO & cofounder

n Aug/Sept 2024 Two R&D Biologists join

n Enterprise Ireland PSSF to max €100k secured in Dec 2022 - legals signed and work commences May 2023

n Bradán Beo Teoranta – early adopter customer secured February 2024

n 1st Engineering Prototype January 2024, 2nd Engineering Prototype August 2024

n Machine vision/machine learning & AI model development – feasibility study complete April 2024

n 5th June 2024 - European Patent filed (EP10544GB) in UK (application #2408013.7) and Norway (NO20240587).

n Dec 2024/Jan 2025 - 2 grants secured to develop the MV/ML/AI model for total Euro 250,000

Expected employee numbers

2025: 8 2026: 12 2028: 17

Galway

Est. 2021

Margaret Rae: Scientist and Founder of Konree Innovation. Former Director at Marine Institute Ireland - Irish State agency for marine research, technology development and innovation and former Chair of the Atlantic Ocean Research Alliance’s Marine microbiome Working Group. Margaret has a PhD in physical chemistry, MSc in Environmental Studies and a BSc in Chemistry and Biochemistry.

Michael Flynn: Mechanical Engineer and Cofounder of Konree Innovation. Former CTO and cofounder of Cathx Ocean, a successful sub-sea imaging company, has strong problem-solving and expertise in subsea design, machine vision and learning, cameras /imaging design. Between them the founders have over 30 years experience in the marine sector.

margaret-rae

michael-flynn

Margaret Rae & Michael Flynn

Konree innovation

Kwayga was co-founded by Mike McGrath and Martin Fitzgerald, leveraging their combined expertise to transform supplier sourcing in the food and drinks sector.

Mike McGrath, CEO, has 15 years of experience in sourcing and procurement. He previously founded Arvo (2010) and the pioneering eSourcing platform supply.ie. In 2012, his expertise was recognised by the European Commission, appointing him to the e-tendering Expert Group, shaping the EU’s public procurement strategy. Earlier in his career, he held key roles at Microsoft and HP.

Martin Fitzgerald, COO, brings 20 years of experience in business development, marketing, finance, and leadership, with a distinguished background in banking at KBC and AIB. His expertise in due diligence and strategic growth complements Mike’s deep sourcing knowledge, driving Kwayga’s success.

Expected employee numbers

Mike McGrath & Martin Fitzgerald

Company Profile

Kwayga is an AI-driven supplier-sourcing software for European supermarket and food service buying teams. Our platform reduces sourcing times and connects buyers with 110,000+ verified suppliers across 60 countries, providing instant transparency and benchmarking. Kwayga has helped supermarkets save millions annually by streamlining sourcing. Our AI-managed data offers the efficiency of a 1,000-person sourcing team, ensuring seamless buyer integration and enhanced management oversight. Trusted by leading supermarkets and food service companies, Kwayga equips buying teams with cutting-edge tools to achieve optimal results, securing a competitive edge in procurement.

Company Achievements to Date

Kwayga is a leading AI-driven supplier sourcing software, transforming procurement for European supermarkets and food service buying teams. Our platform connects 110,000+ verified suppliers across 60 countries, cutting sourcing times by 40% and saving up to 10% in costs.

Trusted by Aldi, Dunnes Stores, and Aramark Europe, Kwayga helps major retailers future-proof supply chains, and has delivered a €2 million annual saving on a single SKU. Our AI-powered supplier matching and automated KYB checks enhance procurement compliance and efficiency.

Recognised for innovation in sourcing technology, Kwayga has been featured in Irish Examiner and FoodNavigator Europe and shortlisted for major industry awards, including KPMG Global Tech Innovator Ireland 2024 and Cork Chamber’s Cork Company of the Year Awards 2025.

With backing from Enterprise Ireland and Redesdale Food Fund, Kwayga is expanding its product and tech teams to enhance AI capabilities, buyer productivity tools, supplier verification, and user experience, ensuring continuous improvement in procurement processes.

By advancing AI-driven procurement solutions, Kwayga is setting new standards, making supplier sourcing smarter, faster, and more cost-effective, reinforcing its leadership in transforming food and beverage supply chains across Europe.

kwayga

Company Profile

Founded in 2023, LEP Biomedical is a pharmaceutical controlled release company with a core mission to simplify and improve post-operative care for patients undergoing ophthalmic surgeries via the HyaGuard platform.

HyaGuard is a proprietary controlled release platform created to specifically address the high failure (14-46%) and reoperation (2-27%) rates associated with bleb-forming glaucoma surgeries.

HyaGuard is designed with both patient and surgeon in mind. It is lightweight, biodegradable, rapidly inserted under the conjunctiva in <30 sec and not externally visible. This simplifies surgeries while ensuring patient comfort and is aesthetically pleasing.

Company Achievements to Date

Initial pre-clinical studies in post-trabeculectomy rabbits found that use of HyaGuard™ resulted in significantly better tolerability and safety scores compared to traditional post-op care. In parallel, use of HyaGuard™ did not require co-application of anti-metabolites to maintain statistically significant >20% decreases in starting IOP up to the 4-week study end point. LEP Biomedical have now completed a pre-seed raise of €110,000 for a 12-month runway in which to close a €4 million seed raise. In addition, LEP have now launched a €10,000 innovation partnership with Munster Technical University to further strengthen their competitive moat. Seed round objectives include GMP manufacture, full GLP pre-clinical validation and clinical trials application filing.

Expected employee numbers

2025: 5

2026: 6

2028: 18

Alan Hibbitts Colm O’Brien & Ronan MacLoughlin dr-colm-o-brien ronanmacloughlin

alan-hibbitts

The LEP Biomedical team are experts in their fields. Alan Hibbitts is the lead inventor of the HyaGuard Platform with 15+ years’ experience in pharmaceutical innovation, business and intellectual property. Colm O’Brien is a co-inventor of HyaGuard and a field leader in glaucoma surgery and clinical trials. Ronan MacLoughlin has 25 years of experience in management, MedTech and clinical development.

/lep-biomedical

Kildare

Est. 2023

Company Profile

We are an academic spin out from UCC and the INFANT Maternal and Child Health Research Centre. Launched in 2021 following 7 years of development: our aim is to harness touchscreen and gaming technology to improve the detection of early learning delay in young children. Our team combines expertise in paediatrics, clinical research, software development, games development and clinical trial and medical device regulation. We have developed non-verbal touchscreen based tools for use in pre-school children. Our ambition is to create a sea-change in the way that young children are assessed. We have worked with Key opinion leaders to optimise this product and are ready for market launch in 2025.

Company Achievements to Date

Liltoda Ltd was established in Nov 2021 as an academic spin out from UCC with license agreements with UCC and Hello Games, UK. Our first product CogniTOT is clinically validated, having demonstrated its effectiveness through five comprehensive clinical investigations conducted across 12 countries, ensuring its reliability and accuracy in diverse settings. Developed through 10 years of research and testing with over 1000 children in 10 countries. We have worked with key opinion leaders and academic researchers in The National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH), Washington DC, USA; the SafeBoosC-III (Safeguarding the brain of our smallest children) Clinical Trial sites in 12 European countries; the Copenhagen Clinical Trial Unit, Denmark; the Baba Center at the University of Helsinki, Finland and the CusackLab at Trinity College Dublin, Ireland. Followig 2 years of product development, informed by our beta testers, in late 2023 we raised pre-seed funding of 100,000 euro from Enterprise Ireland (PSSF award) which enabled on CTO to move full time into the company and to hire a part-time software programmer to improve our user interface and data platform. We have completed early market analysis and are now ready to market to paediatric and child psychology clinics in the US and UK.

Expected employee numbers

2025: 3.4

2026: 4

2028: 5

Deirdre Murray, Mike Cunneen, Mairead Murray & Sean Murray

deirdre-murray

mcunneen

mairead-murray

Liltoda’s leadership team is its key differentiator. Prof. Deirdre Murray, the CEO, is a distinguished clinician-scientist and a key opinion leader in early-brain development, providing invaluable insights into paediatric health. Mike Cunneen, the CTO, leverages his expertise in Full Stack Health Application Development and his experience in startups and clinical research to drive innovation in the company’s software solutions. Mairead Murray, the Clinical-Research Lead, brings over a decade of experience in clinical research, ethics, and regulatory affairs, ensuring that Liltoda’s solutions are both effective andcompliant with industry standards. Sean Murray is the founder and director of Hello Games, Guildford, UK and award winning independent video games company built from scratch to now have >50 employees and a yearly profit of more than 30 million GBP.

Cork

Est. 2021

liltoda

Simon Forsyth (CEO), background in Financial services - worked in the banking sector until 2009, entered the Irish “Startup Eco System” as a Director of both Nines Photovoltaics (high Tech Engineering) and Incereb (MedTech), experienced in raising monies from private, institutional and state bodies.

Dominic Zerulla (CTO), a professor of Physics at UCD with over 25+ years of photonics expertise & a PHD in Chemistry. 120+ publications and patents. Won the 2020 SFI Future Innovator Prize, 2021 EI Big Ideas Award – Public Choice Award, and 2022 Innovator of the Year UCD.

Joe O’Keeffe (CCO), an experienced entrepreneur & founder of multiple start-ups. Ex VP of Research (Augmented Reality) at Meta. Founder/CEO of InfiniLED, an innovator of MicroLED display technology (acquired by Facebook in 2016), and the Founder/CEO of SensL (acquired by ON Semi in 2017).

Dublin

Est.

simon-forsyth

Simon Forsyth, Prof. Dominic Zerulla & Joe O’Keeffe

Company Profile

Based in Dublin, Ireland, LirOptic commenced trading in mid-2024 and is a spin out of University College Dublin, Physics Department.

The company is working to commercialise a solid-state tuneable lens technology that offers significant improvements in size, cost-efficiency, and functionality for optical lenses that can be used in a wide range of applications - from consumer devices (including smartphones and AR/VR) all the way to earth observation & satellite communications.

The technology delivers groundbreaking features for compact camera modules (CCMs), including optical zoom, optical focus, advanced image correction and lens module size reduction.

Company Achievements to Date

In 2024 the company secured Pre-Seed Start Funding (PSSF) from Enterprise Ireland to put the requisite corporate infrastructure in place to assist with raising Seed funding – since then we have secured further grant funding from the European Space Agency (ESA) and are in the process of deepening our relationship and involvement here.

On the commercial side, in late 2024 we entered on a milestone based, paid contract with a Tier1 multinational consumer electronics group to advance their mobile applications. In addition we have also entered into a collaborative agreement with an AR/VR company based in the USA and are working to move that engagement toward a paid NRE contract.

Company Profile

Loanitt is Ireland’s largest finance intermediary, providing a fast, simple, and stress-free way to access financing. Our technology-driven platform connects consumers and businesses with the best financial solutions, making financing easier than ever.

We specialise in Car, Agri, Commercial, and Personal Loans, ensuring our customers get the best value from trusted lenders. In addition, we compare a range of insurance products to help you find the most suitable options. At Loanitt, we believe finance should be straightforward, and we work hard to make the process as seamless and efficient as possible.

Company Achievements to Date

Since our launch in early 2020, Loanitt has rapidly grown to become Ireland’s largest finance intermediary. After securing our credit intermediary license, we quickly established ourselves as a trusted provider of finance solutions. In August 2020, we moved into our Kilkenny office, and later that year, we were honoured with the Top County Enterprise Award by Local Enterprise Office Kilkenny.

Our growth continued with the addition of an Open Banking License from the Central Bank of Ireland in 2021, a European-wide authorisation that strengthened our ability to streamline financial services. In the same year, we expanded further by obtaining both Mortgage and Insurance Intermediary Licenses, allowing us to offer the best options for our customers from our lending and insurance partners. Internationally, we secured a credit broker license from the UK’s Financial Conduct Authority (FCA) and launched in Northern Ireland in 2024, extending our services across borders. We’ve also formed key partnerships with industry leaders such as Daft, DoneDeal, Cars Ireland, Carzone, and Used Cars NI, making it even easier for customers to access financing directly from these platforms.

At Loanitt, we focus on what matters—speed, simplicity, and connectivity—ensuring a seamless finance experience for our customers.

Expected employee numbers

Kilkenny

Est. 2019

John Duggan – Co-Founder & CEO, Loanitt

John Duggan, a Kilkenny native, is the Co-Founder and Chief Executive Officer of Loanitt. Since 2019, he has played a key role in transforming the finance sector, making borrowing easier and more transparent for consumers and businesses.

With a strong background in credit risk and financial strategy, he previously held senior roles at AIB, The Funding Corporation, and MBNA, specialising in credit analytics, risk management, and financial innovation. His expertise spans portfolio risk, credit acquisition strategies, and regulatory compliance.

John holds an MSc in Computational Finance from the University of Limerick and has a deep understanding of the fintech landscape. At Loanitt, he continues to drive growth and innovation, ensuring customers have access to the best financial solutions through cutting-edge technology and expert financial guidance.

Padraig Nolan – Co-Founder & COO, Loanitt

Padraig Nolan, a Limerick native, is the Co-Founder and Chief Operating Officer of Loanitt. Since 2019, he has played a key role in revolutionising access to finance, making the lending process more efficient and customer-focused.

With a strong background in global financial services, he previously held key positions at AFEX and Barclays Investment Bank, specialising in foreign exchange, corporate account management, and risk analysis. His expertise spans financial modelling, operational strategy, and compliance.

Padraig holds an MSc in Computational Finance from the University of Limerick and a BSc in Finance from University College Cork. At Loanitt, he continues to drive operational excellence and innovation, ensuring customers benefit from a seamless and technology-driven borrowing experience.

dugganj

padraiganolan

John Duggan & Padraig Nolan

Mihael is a founder of Lua , a workplace well-being startup that leverages advanced AI to detect and address well-being challenges early. With a background as a research fellow at the Data Science Institute at the University of Galway, he specialized in natural language processing, knowledge graphs, and neural machine translation architectures. His research focused on applying language technologies to real-world problems, including dialogue systems and multimodal data analysis. At Lua, Mihael applies this expertise to develop innovative, data-driven solutions that empower organizations to support employee well-being proactively, grounded in decades of psycholinguistics research from the University of Galway.

Expected employee numbers

5

10

20

Galway

Est. 2023

mihael-arcan

Mihael Arcan

Company Profile

Lua is a business intelligence company specializing in workplace well-being. Our advanced AI platform delivers actionable insights to help businesses attract top talent, minimize attrition, and cultivate a thriving workforce culture. By analyzing key indicators of mental well-being, we empower organizations to identify risks early and implement targeted, preventative strategies. As a spinoff from the University of Galway, Lua leverages decades of psycholinguistics research to provide reliable, data-driven guidance. Our mission is to equip companies with the intelligence needed to enhance employee satisfaction, performance, and loyalty—ensuring long-term success in today’s competitive talent landscape.

Company Achievements to Date

Lua Health is an AI-driven business intelligence company transforming workplace well-being through advanced psycholinguistics and real-time data analytics. As a spinoff from the University of Galway, Lua leverages decades of research to identify early indicators of burnout, stress, and anxiety, helping businesses implement preventative interventions. The platform analyzes communication patterns across tools like Slack, Microsoft Teams, and HR systems, delivering actionable insights that support healthier, more resilient workplaces.

Lua has successfully collaborated with diverse stakeholders, including pharmaceutical multinationals, global insurers, and large-scale service providers. These partnerships have helped validate the platform’s impact, demonstrating significant reductions in burnout and turnover while enhancing workforce satisfaction. A recent pilot with IntouchCX, for instance, achieved a threefold improvement in support effectiveness through early stress detection.

Beyond corporate engagements, Lua actively participates in industry events such as CIPD conferences and has been shortlisted for the 2024 National Startup Awards. By providing objective, data-driven insights rooted in peer-reviewed research, Lua empowers businesses to attract top talent, minimize attrition, and foster a culture of well-being. As global investment in employee wellness grows, Lua Health remains at the forefront, delivering innovative solutions to meet the evolving needs of modern workplaces.

Carnaross, Kells, Co. Meath

Est. 2018

Barry Finnegan & Eileen Finnegan

eileen-finnegan

barry-finnegan-msc

Barry Finnegan, CEO has Masters of Science from Queens University Belfast. He has 20 years’ experience in developing sensor-based equipment including 10 years working as technical director and general manager of Kingspan Sensor Systems. During this time he developed and led the deployment of numerous products including the deployment of over 30,000 connected oil tank monitoring devices across the world. Prior to joining Kingspan, he developed the Climote remote heating controller (textsmart) before licensing it to Smarthomes/ Climote in Dundalk. He also previously worked in Japan for Canon as an engineer.

Eileen Finnegan, Co- Founder and CFO. Chartered Accountant with over 25 years’ experience. Worded for 13 years for a multinational plc - Kingspan Group, based at their Head Office in Kingscourt, Co. Cavan in various roles, including 5 years in the Head of Tax role for the Group. Consulted to Agrinet, managing the development and testing of a web based cash management system for farmers.

Expected employee numbers

Company Profile

Company Achievements to Date

Lvlogics has made significant strides in the field of solids monitoring systems since its inception in 2018. We have deployed >1,000 of our SiloSpi sensors across 18 countries, in industries as diverse as fish farming, milling, farming and more recently in paint and plastics manufacturing plants.

Lvlogics won numerous awards including the “RDS Sustainable Rural Start-Up” Award 2024. In addition to this, Lvlogics was a finalist in the “Manufacturing and Design” category of the Irish Times Innovation Award 2022

We also won the Agri-Technology Award at the Enterprise Ireland Innovation Arena Awards during the National Ploughing Championships in 2023.

These recognitions highlight Lvlogics’ commitment to innovation and excellence in the industry, showcasing our ability to develop solutions that enhance efficiency, reduce costs, and promote sustainability and worker safety.

Lvlogics is a pioneering company specializing in levels monitoring systems. Founded in 2018 and based in Kells, Co Meath, Lvlogics offers innovative solutions for accurate and reliable silo / storage bin level monitoring. Their technology utilizes remote sensors to provide realtime data on silo levels, catering to end-users, distributors, and manufacturers of animal feeds, wood pellets, and other bulk solids. This system addresses the challenges of dust and harsh silo environments, ensuring optimal feed delivery, reducing costs, enhanced worked safety and minimizing carbon footprints. Lvlogics is committed to enhancing efficiency and sustainability in the bulk solids industry. Lvlogics

Company Profile

MAYA is a Deep Tech company in “Data for AI” enabling mid & Large Enterprises with data usage challenges (while complying to AI Act, GDPR, NIS2, DORA, CCPA in US, DPDPA in India and others across the globe).

MAYA is rich in Intellectual Property with a patent filed in Oct ‘23 and progressing well.

Attached is also a slide deck with work we have done with clients. Also our website has more use cases published with customer consent.

Using our core technology an organisation can ensure below, while exchanging data between 2(multiple) points within an organisation, or from organisation A to organisation B.

n Data in original form is visible at source only. Transformed at source itself when required.

n Data visible at destination with anonymity (GDPR, CCPA, PIPEDA, others compliant)

n Data is not stored on any other platform or during transit by any other party.

Our products are available for deployment in on-premises, cloud or hybrid environments. These can handle high volumes of data which is needed in Enterprise data exchanges.

Company Achievements to Date

n Jan 2025: MAYA AppSafe listed on SAP store to accelerate 60000+ companies migration to S/4HANA (New Generation ERP)

n Nov 2024: MAYA FileSafe listed on AZURE Marketplace to enable privacy preserved data usage for AI in client environment

n Oct 2024: Closed seed round with private investors and Enterprise Ireland

n Sept 2024: US patent filed following patent filed with EPO

n Aug 2024: Reference clients in Public sector, Hospital and Financial services sector using AI to accelerate operations and improve productivity

Expected employee numbers

Aaloka is the founder and CEO of Maya Data Privacy in Dublin Ireland.

Aaloka is an innovation-driven professional with extensive experience in leadership roles. He is the Founder and CEO of Maya data privacy, an engineering driven, Privacy AI company. With passion for enabling organizations to adopt new technologies and improve lives, Aaloka has excelled in leading new product initiatives, defining business transformation strategies, and facilitating market rollout of technology products. Aaloka has extensive research in Enterprise Data Privacy technologies with several publications. He actively contributes to academia through teaching and research at NCI, Dublin and at Aarhus University, Denmark. In addition, Aaloka is a multi-talented individual with interests in music, trekking in snow, and community service.

Dublin Est. 2022

aaloka

Aaloka Anant

Company Profile

Mettacomms is a powerful Communications Intelligence platform which accesses pre-verified sources across politics, economics, public opinion, academics and media. The platform gives users 100% confidence in their sources, and offers a breadth of data to enable strategic decision making. Powered by AI, Mettacomms provides insightful data, across multiple filters, for worldwide or country-specific information. Misinformation and disinformation cost the US economy $900 billion in lost productivity annually. We make users smarter, faster and more profitable.

Company Achievements to Date

n Assembled a worldclass team of AI, Tech, Visual and Communications experts to design and build the Mettacomms platform, currently on its third-iteration.

n Using cutting-edge Artificial Intelligence to harness insights from vast, human-validated sources.

n Won the prestigious Stevie International Award for PR Industry Technology 2024.

n In Q4, 2024, we secured investment from Women TechEU, a unique investment vehicle for female founders of deep-tech companies. One of only 40 European companies selected in the first round from 857 applications

n Trialling with Journalism and Content Creation students at 3 universities in the USA.

n Commenced sales to PR Consultancies and Lobbying Companies in Washington DC.

Expected employee numbers

2025: 6

12

52

Dublin Est. 2019

Ellen Gunning has over 30 years’ experience in the PR/Comms industry. She is a crisis comms expert, journalist, broadcaster and media commentator. She has written the academic text studied at 3rd. Level internationally.

As an industry expert and public speaker, Ellen is internationally networked and excellently placed to understand the needs of the PR/Communications industry.

Ellen Gunning

Company Profile

Monthlies Organics is redefining period care with our eco-friendly, customizable ‘Build a Box’ solution—giving customers full control over their essentials. Our premium organic products support both wellness and sustainability, meeting the needs of conscious consumers. In 2025, AI integration will elevate personalization, streamlining the shopping experience and strengthening customer loyalty. Monthlies isn’t just a product—it’s a future-proof platform at the intersection of technology and personal care. As the demand for custom, ethical solutions grows, Monthlies is positioned for scalable success in a rapidly evolving market.

Company Achievements to Date

Monthlies Organics has rapidly established itself as a pioneering force in sustainable period care. Founder Jessie has been recognised as a 30 Under 30 to Watch in Tech by The Business Post for two consecutive years, highlighting Monthlies’ innovation in the sector. In 2023, we were finalists for the Start Up Awards, and in 2024, we were invited to 10 Downing Street for a roundtable discussion on the future of business. That same year, we took part in Unrest, London’s leading impact accelerator, further strengthening our vision for sustainable, inclusive period care.

Our social media presence has been a key driver of growth, with multiple viral TikTok videos, including one reaching 2.1 million views, sparking conversations around period care. With a 40% year-on-year increase in turnover, Monthlies continues to expand, gaining media attention and industry panel invitations. As we enter 2025, we are gearing up for our seed investment round, leveraging our achievements to scale our AI-driven, customer-first platform and revolutionize how people buy period care.

Expected employee numbers

3

5

12

Jessie Bennett, founder of Monthlies Organics, is a digital journalist and social media strategist turned entrepreneur, driven by a passion for sustainable period care and menstrual equity. Through years of research and advocacy, Jessie explored the intersection of health, sustainability, and inclusivity, writing extensively about eco-friendly solutions and challenging outdated narratives around menstruation.

Frustrated by the lack of representation in traditional period care marketing, Jessie founded Monthlies to create a brand that includes everyone who menstruates. With customizable, organic products and a mission to remove shame from the conversation, Monthlies is redefining period care for a new generation. Now, with AI-powered personalization launching in 2025, Jessie is leading a tech-forward, impact-driven brand that meets the evolving needs of conscious consumers.

A firm believer in education, empowerment, and sustainability, Jessie’s vision is clear: better periods for all.

Wexford Est. 2022

/jessicabennett95

Jessie Bennett

Desmond Savage is qualified with a Master’s in Advanced Manufacturing Technology from the University of Limerick and has over 20 years’ experience deploying software solutions within the manufacturing industry. In 2019 he switched his focus to how the latest technologies could benefit farming. From engaging with family members involved in farming, he focused on how monitoring the rumen of cattle could provide useful insights to both Dairy and Beef farmers. In November 2020 he founded Moonsyst International as a joint Irish/Hungarian venture. Moonsyst’s first sales came in 2021 and received seed investment funding in 2022. They won the IFAC best newcomer award in Sep 2021 and were awarded a place in the Enterprise Ireland Innovation Arena at this year’s National Ploughing Championships in Laois.

Expected employee numbers

Cork Est. 2022

desmondsavage

Desmond Savage & Peter Gesler

Company Profile

The Moonsyst Smart Rumen system monitors Cattle from within for Health, Reproduction and Sustainability, an ‘Ingestible FitBit’ for Cows! The Bolus-Sensor can measure; Rumen Temperature, Body Activity, Water Intakes, pH and ORP and has expected battery life of 6+ years.

The solution has been deployed to Dairy Cows, Sucklers, Calves, Goats, Sheep and Buffalo. Alerts are sent directly to the farmers phone for; oestrus/heat, calving, abnormal water intake, fever and other health related anomalies. Using Artificial Intelligence models, Moonsyst provide further insights from inside, enabling real-time health monitoring, a healthy rumen = a healthy cow!

Company Achievements to Date

Moonsyst has worked with dairy farmers from the South West of Ireland to incubate our technology. We believer that designing a solution that works for a grass-fed model of dairy farming i.e. grazing paddocks 9+ months and indoor for winter, is a great basis for all dairy systems globally. Since starting the initial trials in 2020 we now are proud to have over 40 Irish farming customers, the majority of which are based in the South West of Ireland, along with more and more international customers i.e. deployments in 35+ countries. Moonsyst have won a number of awards but we are especially proud of ‘The West Cork Farming Award’ we received from the Southern Star in April 2024 and ‘Technology Innovation’ award we received from National Dairy Show in Millstreet, October 2023.

Ireland

Est. 2022

Dr. Johann Issartel & Dr. Jamie McGann

johann-issartel

jamie-mcgann-ph-d

MoveAhead was co-founded by two experts in movement science and technology, combining academic research with innovative AI solutions to enhance physical literacy and engagement.

Dr. Johann Issartel is a world leader in AI-driven motion tracking and movement analysis, with over 15 years of research in motor skills development. His work has shaped global benchmarks for children’s movement proficiency, influencing youth sports, education, and health initiatives.

Dr. Jamie McGann brings extensive experience in technology, driving MoveAhead’s scalable solutions across multiple industries. With expertise in AI integration and product development, they have led partnerships with major sports organisations, schools, and brands, ensuring MoveAhead’s technology is both accessible and impactful.

Expected employee numbers

11

Company Profile

MoveAhead is a global leader in AI-driven motion tracking and movement analysis, specialising in enhancing children’s physical literacy through innovative technology. The company develops the Movement Assessment Platform (MAP) for motor skills evaluation and MAP games, active video games that promote engagement and fitness. MoveAhead collaborates with major sports organisations, schools, and brands to create immersive, motion-based experiences. With a strong foundation in research, MoveAhead scales solutions for youth development, fan engagement, and healthcare applications, offering data-driven insights to optimise movement skills while ensuring accessibility through hardware-free AI solutions.

Company Achievements to Date

MoveAhead has revolutionised AI-driven motion tracking, transforming how children engage with movement, sports, and physical literacy. Since its inception, the company has achieved significant milestones across sports, education, and health, delivering cutting-edge technology that seamlessly blends real-world activity with digital engagement.

Key Achievements:

n Global Partnerships – Collaborated with leading sports organisations, including the IRFU, ATP Tour, and major sports brands, to enhance youth engagement through motion-based experiences.

n Education & Schools – Integrated AI-powered movement assessments in schools and PE programmes, helping thousands of children improve their motor skills.

n Innovative AI Technology – Developed hardware-free, scalable motion tracking, setting new industry standards for accessibility and accuracy.

n Commercial Growth with the like of the Kinder App - Applaydu – Secured strategic partnerships and multi-year contracts, demonstrating real-world demand and business scalability.

n Healthcare & Research Impact – Leveraged over 15 years of research to create data-driven tools that support early movement development and physical activity.

With a strong foundation in AI, sports, and education, MoveAhead continues to push boundaries, shaping the future of movement analytics while delivering fun, engaging (>70 million users), and impactful experiences for children and families worldwide.

Richelle Flanagan & Rene Reinbacher

richelleflanagan rene-reinbacher

Richelle Flanagan, CEO, Co-Founder

11 years sales and marketing experience in IT & food sector, 21 years registered dietitian, 16 years self-employed, past board member of Irish Nutrition & Dietetic Institute; EUPATI fellow; World Parkinson Congress Ambassador Alumni, founding member of the PD Avengers, Co-founder of the Women’s Parkinson’s Project.

Rene Reinbacher, PhD, CTO, Co-Founder

16 years of industry experience, holding leadership roles in Quantitative Analytics, Data Science, and Risk within major global investment banks. In-depth expertise in advanced data analytics, encompassing its creation and application to address critical business needs, leveraging the available data and technology.

Expected employee numbers

2025: 7

12

40

Dublin

Est. 2022

Company Profile

My Moves Matter Ltd is a digital health company empowering people with Parkinson’s to self manage through personalised nutrition solutions. We use modern technology to scale access to nutritional care.

Company Achievements to Date

My Moves Matter Ltd has developed a self management app which is used by over 1600 people in 47 countries; successfully won a 200K grant from France Parkinson to run a pilot study on the impact of the menstrual cycle on Parkinsons symptoms; successfully collaborated on pilot study with UCC on a global study on the impact of hormonal stage on symptoms in women with Parkinson’s with support of EI Innovation voucher and a private investor; won EI Pitch Battle winning 5K; received PSSF funding to enable development of digital nutrition solutions for Parkinson’s. Won 13K innovation funding from Parkinson’s UK to market test our first avatar delivered online nutrition programme MediPD. Expanded team with 2 registered dietitians.

Company Profile

myPatientSpace is an award-winning digital health company, focused on transforming remote patient care. The company partners with leading healthcare providers and life sciences organizations to deliver scalable, personalized care pathways across various disease areas, including oncology, diabetes, COPD, sleep and other conditions on its platform. With a focus on patient engagement, remote monitoring, and care coordination, myPatientSpace is committed to improving healthcare outcomes by integrating innovative AI technologies that streamline remote monitoring and empower patients and providers. myPatientSpace has strong clinical evidence, awards, and recognition, positioning the company as a leader in the digital health space and helping power the future of healthcare delivery.

Company Achievements to Date

myPatientSpace is revolutionizing digital health, with its innovative platform now deployed in four global regions. Partnering with leading healthcare institutions and life sciences organizations, myPatientSpace delivers scalable, proven solutions across diverse disease areas, including oncology, diabetes, sleep, renal and chronic respiratory conditions. Its impactful programs have garnered multiple top-tier awards, both in Ireland and Europe, showcasing its leadership in digital health.

The company has been featured extensively in media outlets, with success stories shared through research papers, posters, and news coverage. Recognized for its innovation, myPatientSpace was selected for a European H2020 European Cancer Program. Additionally, the company is an Enterprise Ireland client, high ORCHA and customer ratings, along with selections on frameworks such as NHS G-Cloud and Microsoft ISV.

With the recent launch of its U.S. market entry and the establishment of a U.S. entity, myPatientSpace is poised for further growth in one of the world’s largest healthcare markets. In the past year, the company’s team has doubled, reflecting its rapid expansion. myPatientSpace has achieved profitability and demonstrated strong organic growth, firmly establishing itself as a leader in digital health innovation.

Expected employee numbers

Una Kearns is the CEO and Founder of myPatientSpace, an award-winning digital health company transforming remote patient care. With over 30 years of experience in global enterprise technology, including more than 7 years in digital health, Una has a proven track record in leading product development, innovation, and M&A strategies. Before founding myPatientSpace, she held senior roles at EMC and Documentum in Silicon Valley, where she led large-scale initiatives in advanced research and product development, earning numerous innovation awards and patents and leading many globally recognized products.

Una is passionate about leveraging technology to improve patient outcomes and healthcare delivery. Under her leadership, myPatientSpace has become a leading digital health platform, focusing on AI-powered, scalable care pathways that enable better patient engagement, remote monitoring, and new models of care. Una is a graduate of Trinity College Dublin.

Dublin Est. 2018

ukearns

Una Kearns

sarah-mcguire-mywordpal

sarah-lumsden-watchorn

Sarah McGuire and Sarah Watchorn are experts in Dyslexia, teaching children with dyslexia to read. Sarah McGuire, an honours Master’s graduate in Special Education, taught in a special reading school for 17 years, serving as Deputy and Acting Principal. Sarah Watchorn, also an honours Master’s graduate in Special Education, taught in the same setting for 20 years.

After extensively researching reading interventions, they developed their own programme, successfully teaching over 450 children and training more than 50 teachers. They founded Foghlaim SDL, Ltd, trading as MyWordPal, to provide cutting-edge reading intervention.

Expected employee numbers

Sarah McGuire & Sarah Watchorn

Company Profile

Sarah McGuire and Sarah Watchorn are experts in Dyslexia, teaching children with dyslexia to read. Sarah McGuire, an honours Master’s graduate in Special Education, taught in a special reading school for 17 years, serving as Deputy and Acting Principal. Sarah Watchorn, also an honours Master’s graduate in Special Education, taught in the same setting for 20 years. After extensively researching reading interventions, they developed their own programme, successfully teaching over 450 children and training more than 50 teachers. They founded Foghlaim SDL, Ltd, trading as MyWordPal, to provide cutting-edge reading intervention. MyWordPal is a web-based reading app that combines their specialised teaching methods with children’s voice recognition technology to teach reading. This innovative, accessible, and cost-effective tool supports children with dyslexia worldwide, making high-quality reading intervention more available than ever.

Company Achievements to Date

n MyWordPal secured CSF funding in Dec 2021.

n Completed high-fidelity prototype with Learnovate Research Centre, Trinity College

n Showcased at Dublin Tech Summit

n Showcased and presented at Bett London 2023/2024

n Named in ‘The Best New Business Start-Up Ideas in Ireland Today’

n Member of Microsoft for Start-Ups Programme.

n Sept 2024 featured in Focus on Diversity’s ‘50 Irish Companies, Programmes or Initiatives Making Education More Diverse and Inclusive’

n Participated in the Trinity Executive MBA Scaling Project

mywordpal

Company Profile

NanobOx has developed breakthrough water treatment technology using nanobubbles to increase the economic and environmental sustainability of bioprocesses, including food production, food and beverage processing, and industrial water and wastewater treatment.

Nanobubbles are proven to increase yield and lower cost of production of plants, animals and microbes, and to clean and sanitise water and equipment without using chemicals.

NanobOx’s novel, solid-state nanobubble generation is highly energy efficient and low maintenance, substantially reducing cost of ownership and lowering the barrier to adoption of nanobubble water treatment in a €10 billion+ addressable market.

Company Achievements to Date

Since winning the ‘One to Watch Award’ at Enterprise Ireland’s 2022 Big Ideas Showcase NanobOx has gone on secure €1.5 million in investment funding field trials of its nanobubble water treatment equipment with producers and channel partners in agriculture and aquaculture in Europe and USA. Energy savings of 100x for nanobubble generation have been achieved compared to competing technologies.

NanobOx nanobubble aeration equipment is proving to be highly effective in stimulating plant growth enabling up to 50% reduction in fertiliser usage while also increasing root health and crop yield. In aquaculture the technology is reducing the energy cost of adding oxygen to water while also stimulating growth.

The company recently achieved a world-first by generating oxygen nanobubbles in open water without needing to add air or oxygen. The equipment can be solar-powered providing a sustainable solution for increasing water quality in agriculture and inland fisheries by suppressing growth of blue-green algae, enhancing breakdown of organic pollutants by aerobic bacteria, and increasing aquatic biodiversity.

NanobOx is on track to launch its first generation products in 2025 that can be retrofitted to existing water handling and storage systems in agriculture and aquaculture.

Expected employee numbers

mohammad-reza-ghaani

CEO and co-founder, Dr John Favier, is a serial entrepreneur and technology business consultant with over three decades of experience in biosystems engineering R&D, business development and leadership, serving Fortune 500 industrials and SMEs globally. He has founded three start-ups, growing one to a global market leading position at acquisition by an industry major, and provided business consulting services to early stage science and engineering-based technology companies in the USA and Europe.

CTO and co-founder, Dr Mohammad Reza Ghaani is renowned for his ground-breaking work in nanobubble technology with over a decade of R&D experience in interaction between electric fields and materials, and developing new materials for renewable energy applications. He played a leading role in development of NanobOx’s electric field nanobubble generation technology in academic research and now leads product R&D at NanobOx.

Dublin

Est. 2022

johnfavier

John Favier & Mohammad Reza Ghaani

Company Profile

Net Feasa is a global IoT connectivity provider revolutionizing maritime and logistics with smart tracking solutions and Agentic AI-driven insights. Our flagship products, IoTPASS™ and the Agentic Control Tower™, deliver real-time visibility, security, and efficiency across supply chains. With patented technology, satellite connectivity, and AI-driven automation, we provide shipping lines, 3PLs, and port operators with actionable intelligence to reduce costs, enhance security, and optimize asset utilization. By seamlessly integrating AI-powered decision-making, Net Feasa and its partners are transforming container and vessel tracking into a dynamic, predictive, and scalable ecosystem.

Company Achievements to Date

Net Feasa has rapidly established itself as a leader in IoT and AI-driven solutions for global supply chain visibility. Through strategic partnerships, including a key collaboration with Carrier, the company is actively deploying IoTPASS™ and Control Tower solutions to global shipping lines, transforming how container tracking and fleet management are handled.

Innovation is at the heart of Net Feasa’s success. The company pioneered the first IoT Vessel Network for container monitoring with a U.S. shipping line and launched IoT Port Networks, enhancing port visibility and connectivity. The commercialization of IoTPASS™ marked a major milestone—introducing the first removable and reusable container tracking device with a patented mechanical locking mechanism, delivering real-time tracking, door open alerts, geofencing, and movement-based tracking across global trade routes.

With the introduction of Vessel Control Tower, Net Feasa has expanded beyond hardware, offering an AI-driven predictive analytics platform that seamlessly integrates with shipping company’s connected cargo. This innovation enhances fleet management by providing real-time analytics and supply chain intelligence, resulting in the automation of manual tasks.

Security and connectivity remain a priority for us. IoTPASS includes satellite fallback and hybrid connectivity, ensuring uninterrupted tracking across land, sea, and remote areas using NB-IoT, LTE, LoRa, and 2G technologies.

With its commitment to cutting-edge technology and sustainability, Net Feasa is driving a smarter, more connected, and more efficient global supply chain. Through AI-powered automation and IoT-enabled carbon reduction, the company is reshaping how cargo moves across the world, reducing operational costs while improving security, efficiency, and environmental impact.

Dingle, Kerry Est. 2015

mike-fitzgerald

Mike Fitzgerald has over 30 years of experience in software and wireless networking companies. After 10 years with Ericsson Mike went on to be a Vice President of two NASDAQ-quoted companies, ADC Telecommunications and interWAVE Communications. Between 1999 and 2019 he was a founding investor or board member of a number of companies including; Net Feasa, Altobridge, NewBay, AMCS Group, Mianach (VC) and Microcellular Systems Ltd. He graduated from University College Cork in 1988 and Stanford University Graduate School of Business in 2008. In 2009, he was named Ernst & Young’s Entrepreneur of the Year (Emerging category) and a Technology Pioneer at the World Economic Forum in 2012. Today he heads up Net Feasa, as Chairman.

Mike Fitzgerald net-feasa

Cork Est. 2023

Mark O’Sullivan PhD, CEO, has led NeuroBell’s development in UCC since 2016. Mark has a background in engineering, founding the IP during his PhD and Postdoctoral research. Mark has led the commercialisation since 2019, securing over €800k in grants and €2.1m in private funding. Alison O’Shea PhD, CSO, co-invented the IP and has a successfully developed state of-the-art deep learning algorithms for both industry and research, resulting in multiple publications. Colm Murphy, CTO, brings several years of start-up and medical device design expertise to the team having led product and engineering designs from concept through to market launch.

Expected employee numbers

20

25

markosullivan

Mark O’Sullivan, Alison O’Shea & Colm Murphy; alison-o-shea colm-p-murphy

Company Profile

NeuroBell is a medical device company based in Cork, Ireland, developing novel brain monitoring solutions to provide early detection of brain injury in infants. NeuroBell’s first product, NeuroBell Luna, is a pocket-sized and wireless EEG monitor providing automated seizure detection at the bedside, so that infants can be treated at the onset of their seizures, instead of hours or days later.

Company Achievements to Date

NeuroBell leverages more than 10 years of research of the INFANT Research Centre, UCC. Technical work on the device began in 2016 with innovations in electronics, deep learning, and edge-AI, resulting in a patent being filed by UCC in 2020. The device is currently undergoing clinical trials across Ireland and the US, including trials at Cork University Maternity Hospital, Parkview Women & Children’s Hospital (Indiana, US), and Texas Children’s Hospital (Houston, US).

NeuroBell has raised €2.1m in private funding, and employs 13 people at their office in Cork. NeuroBell is expected to recieve FDA clearance for their first product, NeuroBell Luna, in Q4 2025.

neurobell

Company Profile

At Novus Diagnostics, we specialise in cutting-edge microfluidic diagnostic technology to improve the detection and treatment of life-threatening infections. Our flagship innovation, SepTec, is a rapid point-of-care diagnostic system that detects bloodstream infections, one of the leading causes of sepsis, in just 15 minutes. Current methods take 1–5 days, delaying treatment and increasing patient risk and mortality. SepTec consists of a sample loader, a disposable test cartridge, and an automated bedside analyser, providing real-time results to guide clinical decisions. Our highly skilled team brings expertise in microfluidics, biomedical engineering, and regulatory science, driving innovation to advance infection diagnostics and improve patient outcomes.

Company Achievements to Date

n €13.8M raised to date, including a €4.6M equity financing round (Dec 2024), led by BVP Investments, Trinity Biotech, and Irrus Investments, supporting SepTec expansion.

n EIC Accelerator Award (€7.4M) – Only Irish company to receive a €2.4M grant and €5M equity offer in the most competitive EIC Accelerator call (0.8% success rate).

n DTIF Funding – The Thorax Project (€3.3M over three years) – Developing an AI-driven monitoring system and diagnostic test for patients at high risk of sepsis and pneumonia.

n Advanced prototype stage for SepTec, with cartridge, loader, and analyser successfully demonstrated in a laboratory. The cartridge has been redesigned for mass manufacturing.

n Clinical validation of SepTec in two pilot studies, with over 180 patients showing 100% sensitivity and 97% specificity. A 350-patient validation study is planned for the advanced prototype for H2 2025.

n First company awarded mentorship at Roche Diagnostics and Enterprise Ireland Incubator Programme (2022), securing a 12-week mentorship to advance disruptive diagnostic technologies.

n Published research on the cost-effectiveness of rapid point-of-care (PoC) tests for bloodstream infections, demonstrating potential for cost-saving and improved targeted antimicrobial treatment.

n Team expansion with a highly specialised, multidisciplinary team of scientists, engineers, regulatory experts, and project managers to support SepTec’s development and commercialisation.

Expected employee numbers

Glasnevin, Dublin Est. 2020

elainespain

kellieadamson

Dr Keith O’Neill, CEO of Novus Diagnostics since 2021, has 20 years of global experience in healthcare technology, investment, and commercialisation. Formerly with Abbott, Enterprise Ireland, the Biomedical Diagnostics Institute, MIT Broad, and Harvard Bioscience, he brings extensive expertise in advancing medical innovations and driving business growth.

Dr Elaine Spain, COO and co-founder of Novus Diagnostics, is the co-inventor of SepTec, a patented rapid sepsis diagnostic. With 15+ years of expertise in analytical chemistry and biomedical diagnostics, she leads strategy, funding, and operations, driving the company’s growth and innovation in cutting-edge diagnostics.

Dr Kellie Adamson, CSO, co-founder, and co-inventor of SepTec, leads the commercialisation of Novus Diagnostics’ assay. With over 15 years of experience in advanced biomaterials and microfluidics, she spearheads research and development, focusing on SepTec while expanding the company’s diagnostic pipeline.

The founders met during their PhDs and later co-founded Novus Diagnostics after developing SepTec during post-doctoral research at DCU (2014–2020). Supported by €1.4M in Irish State funding and multiple awards, the company spun out in 2020. With €2.4M EIC backing in 2021, Novus Diagnostics has since grown to 16 staff and raised €13.8M, including a €4.6M funding round in December 2024.

novusdiagnostics

Elaine Spain & Kellie Adamson

Igor Toma, Founder and CEO of NUACOM, has been pivitol in advancing business communication solutions since October 2009. He recognized that traditional phone systems were outdated—expensive, rigid, and unfit for the digital era. Determined to change this, he developed MyCleverPhone, an innovative VoIP solution that quickly gained traction in the Irish market.

In 2016, Igor rebranded the company as NUACOM, expanding its vision beyond voice calls to an integrated cloud phone system. In 2024 he successfully led the team to incorporate AI into its feature set. Making NUACOM, Irelands first business phone system to offer AI features.

Expected employee numbers

Maynooth

Est. 2009

igor-toma

Igor Toma

Company Profile

NUACOM provides advanced VoIP business phone systems designed to enhance communication, streamline workflows, and improve customer interactions. With features like call recording, analytics, IVR, mobile app, and CRM integrations, NUACOM helps businesses manage calls efficiently. Our cloud-based system ensures reliability, scalability, and security, making it ideal for industries like real estate, healthcare, call centers and more. Whether you need local numbers, call routing, or team collaboration tools, NUACOM delivers a feature-rich, ISO/IEC 27001:2022-compliant, and user-friendly solution. Empower your business with seamless, professional communication—anytime, anywhere.

Company Achievements to Date

NUACOM has consistently set the standard for excellence in business communication, earning multiple industry awards. Recognised by G2 as a Leader in Europe, NUACOM has also received top accolades for Best Support, Easiest Software to Use, and more. With an average customer rating of 4.8/5 across G2, Trustpilot, Google, and Capterra, our commitment to quality and service is evident.

Our system reliability averages at 99.999% uptime, ensuring uninterrupted communication. In 2023, NUACOM surpassed 25,000 users on our system. In 2024, NUACOM became Ireland’s first business phone system to offer AI-powered features. That same year, we achieved ISO/IEC 27001:2022 certification, reinforcing our dedication to security and compliance.

Company Profile

Omuu Pet creates innovative Veterinary products to improve the lives of our pets and help the environment at the same time. Our multifunctional Veterinary diets and treats contain insect protein and helps dogs suffering from multiple medical conditions like gastrointestinal disease, allergies or dental disease. Dogs with allergies react to the protein source in their diet. Not the grains which is a common misconception. Insect protein is unique in that it is a novel protein. It passes the immune system undetected and doesn’t cause an allergy flare up. The name Omuu comes from the work ‘Om’, which means ‘One Universe’. It’s a brand that connects pet parents with their pets and the planet at the same time.

Company Achievements to Date

Omuu Pet got to the final of the Seedcorn competition, representing Leinster. Won gold in the product category of the national start up awards and received the best pitch in Enterprise Ireland’s Prep4Seed investor ready programme. Omuu Pet is currently onboarding as an Enterprise Ireland HPSU to expand internationally and grow the Omuu Pet team.

Expected employee numbers

Drogheda, Co. Louth

Est. 2021

Dr. Frank Clarke is a small animal Veterinarian and the solo founder of Omuu Pet. He is passionate about helping dogs with medical conditions and sees a direct correlation with medical conditions and nutritional choices. Dr. Frank has volunteered in the Amazon rainforest and abroad and see firsthand the devastation cattle farming and global warming is having on our planet and environment. The idea to use insect protein for dogs came from humans eating insects in Thailand and other countries around the world.

As a UCD Vet graduate, Dr. Frank adds domain expertise but also adds invaluable connections within the sector. Backed by Enterprise Ireland and UCD clinical trials, Omuu is currently expanding into international Veterinary markets and focusing on team growth. Dr. Frank recently spoke about insect protein at the London Vet Show which is the biggest Veterinary gathering in the EU. Omuu is created by a Vet to helps pets and the planet!

frank-clarke

Dr. Frank Clarke

Kells, County Meath

Est. 2021

Gary Gallagher founded OptaHaul in 2021 after a dairy company approached his previous employer to build a custom solution to help reduce their transport costs. During the project Gary was surprised to learn that this important sector was neglected from a technology perspective and therefore decided to pursue the significant opportunity to optimise the global supply chain for the $750Bn dairy market.

Gary has 20+ years experience in technology sales and consulting and holds a Bachelor of Arts Degree in European Business and Languages along with a Masters in Computer Science.

Expected employee numbers

Gary Gallagher

Company Profile

OptaHaul helps dairy cooperatives to provide higher returns to their farmer producers, reduce greenhouse gas emissions and meet their sustainability goals by optimising their farm to plant milk transport.

OptaHaul’s AI driven optimisation platform analyses thousands of data points relating to milk collection and load delivery to provide its users with new opportunities for efficiencies in the dairy supply chain.

As the global leader in farm to plant milk transport optimisation, OptaHaul’s team comprises a unique blend of technology, optimisation and dairy industry experts based in Ireland, Hungary and the United States.

Company Achievements to Date

OptaHaul boasts bluechip customers in Ireland, UK, Europe, the United States and Canada such as Dairygold Ireland, Dale Farm UK, Horizon Organic in the United States. A previous winner of the AGTechUCD Accelerator award, the team was recently recognised as ‘Tech Startup of the Year’ in the 2024 National Startup Awards. With offices in Ireland and Hungary, OptaHaul has recently opened a new outpost in the east coast of the United States to assist with significant forecasted growth in 2025.

optahaul

Company Profile

PacSana is a remote care platform that leverages 24/7 wearable technology with a one-year battery life to provide real-time insights into mobility, daily activity, sleep patterns, and fall risks. Designed for home care and senior living providers, PacSana empowers caregivers with proactive data to enhance safety, reduce hospitalizations, and support independent living.

Company Achievements to Date

PacSana’s remote care platform is transforming home care and senior living by providing realtime insights into mobility, daily activity, sleep, and fall risks. Since launch, we have:

n Partnered with leading home care organizations and senior living communities across the U.S., UK, and Ireland.

n Developed AI-driven analytics that empower care providers to enhance safety, reduce hospitalizations, and extend independent living.

n Secured strategic partnerships with major industry players in the U.S.

n Expanded into the PACE (Program of All-Inclusive Care for the Elderly) market, supporting organizations focused on keeping seniors in their homes.

n Worked with Veterans across the U.S. to provide affordable care options.

n Achieved significant traction among home care franchise owners, helping them integrate technology into care delivery.

PacSana is pioneering a data-driven approach to aging in place, ensuring that families and caregivers have the information they need to provide proactive, personalized care.

Expected employee numbers

Dublin & US

Est. 2018

Feargal Duignan’s journey to founding PacSana began with a deeply personal moment. After finding his mother on the floor following a fall and witnessing her challenging, weeks-long recovery, Feargal was moved to ask: how could technology have prevented her pain? With a strong background in technology sales and complex customer engagements, he explored the market, only to find that available solutions were reactive rather than truly preventive. This experience ignited a passion to create something better—a platform designed to offer realtime insights and proactive care for older adults. Guided by empathy and driven by personal experience, Feargal is committed to ensuring that seniors can live safely and independently in a place of their choosing.

feargal-duignan

Feargal Duignan

pac_sana

Pacsana

pacsana

Company Profile

Payemoji is a conversational engagement, payments & commerce company. Payemoji enables businesses to engage customers, sell products & services, accept digital payments, book appointments, provide any customer journey through everyday messaging apps like WhatsApp. With Payemoji, businesses can provide a better customer experience, without the complexity and cost of a mobile application.

Company Achievements to Date

Opportunity – 600M daily users, $290B Tam with Conversation commerce

€4M+ – raised so far (passive investors)

Conversational AI feature rich cloud native product

Success – Vodafone, AIB, Covermore, Pizza Hut, 42 crunch, Bearing Point ..

Experienced team – Exits, messaging, cloud ..

Awards – META future of communication 2023, Top 100 Irish Startups 2024, Business Platform of the year UK 2024, Silver Fintech Award Irish Startups, PWC Scale 2025

Expected employee numbers

Ireland

Est. 2021

We are experienced founders, We are 3 friends who have worked and known each other for a long time.

A history of successful exits: Asavie acquired by Akamai ( 2020), Accanto acquired by IBM ( 2019), GoTalk acquired by Tel.Pacific ( 2012)

As an example, we launched a 100M ARR A2P SMS and Global IoT platform in our last roles.

message-my-customer

mick-higgins

Mick Higgins, Damien Stephens & Daryl O’Regan

heidi-davis

donal-o-gorman

Heidi Davis and Dr. Donal O’Gorman are scientists turned entrepreneurs, driven to transform women’s health. Heidi, CEO and co-founder of Peri, has a background in nutrition and molecular medicine, with over a decade in R&D. She leads the launch of Peri, a first-of-its-kind perimenopause health tracker debuting in June. Donal, co-founder and COO, is an expert in human physiology and disease prevention. A former professor at Dublin City University, he led major research projects (€15M+ funding, 80+ publications) before leaving academia in 2022 to focus on Peri. Passionate about closing the gap in women’s health research, he brings deep scientific expertise to drive innovation.

Expected employee numbers

Dublin

Est. 2021

Heidi Davis & Donal O’Gorman

Company Profile

Peri is a first-of-its-kind wearable perimenopausal health tracker that accurately monitors perimenopause symptoms, cycles, sleep, and lifestyle to provide women with objective data, actionable insights, and encouragement to help them navigate perimenopause with confidence. Removing the guesswork from this traditionally confusing phase of life gives women unprecedented power to pursue personalized symptom management and treatment efforts on their own terms.

Company Achievements to Date

After five years of R&D—during which we built our own database to address the gaps in women’s health data, designed a consumer-centric wearable device, developed the first algorithms to detect menopausal symptoms from raw sensor data, and created an AI engine to provide personalized guidance for perimenopause—Peri is set to open pre-orders in May 2025 in the U.S., with the first devices shipping in June 2025.

Company Profile

Pitseal is revolutionising farm safety and sustainability by replacing traditional plastic covers on silage pits. Founded by Marion Cantillon, the company offers an innovative, eco-friendly solution that eliminates the need for waste tyres and large plastic sheets, reducing environmental harm and enhancing farm safety. With a strong commitment to innovation, Pitseal has expanded across their tests across Ireland and Europe, with sights set on global markets like New Zealand, Australia, and the U.S.

Company Achievements to Date

Pitseal is making waves in agricultural innovation, developing a safer, more sustainable alternative to traditional silage covers. While still in the testing phase, the company has successfully conducted trials across Ireland and Europe, with ongoing research in New Zealand and Australia to explore global scalability.

Founder Marion Cantillon has received widespread recognition for her groundbreaking work. She was named Visa’s She’s Next Innovator of the Year 2023, an AIBF All-Star Top Young Innovator 2023, and a Women Mean Business Newcomer of the Year nominee. Pitseal also won National Startup Sustainability-Focused Startup Gold Winner 2023 and was listed as AgTech FBD Ireland’s One to Watch 2023. Marion made her Web Summit main stage debut and was shortlisted for the European Forbes 30 Under 30 Summit.

Internationally, she was invited to San Francisco’s Thrive SVG and was awarded Outstanding Young Agri Entrepreneur of the Year at AgriNext Dubai 2024. She has also been honored with three 30 Under 30 awards (2022 & 2023).

Expected employee numbers

Kerry

Est. 2021

Marion Cantillon is the founder of Pitseal, an innovative agri-tech company transforming silage storage by replacing traditional plastic covers with a safer, eco-friendly alternative. Growing up on a family farm, Marion saw firsthand the dangers and inefficiencies of existing silage pit coverings. Her “lightbulb moment” came while pursuing a master’s in nutritional science, inspiring her to develop a solution that would benefit farmers worldwide.. In addition to running her business, she is also pursuing a PhD in the mitigation of greenhouse gas emissions on farms, furthering her commitment to sustainability in agriculture.Marion believes in problem-driven entrepreneurship and encourages aspiring business owners to trust their instincts while staying adaptable. Her mission is clear: to innovate, solve real-world problems, and create a lasting impact in agriculture.

marioncantillon

Marion Cantillon

Positive Carbon partners with organisations to eliminate waste, leveraging over 50 years of combined team experience across Ireland and the UK. Our cutting-edge food waste monitoring technology empowers kitchens to identify and reduce waste effectively. Using advanced sensors, our system tracks and analyses discarded food, providing data-driven insights into specific waste patterns. This information allows chefs to pinpoint waste sources and implement targeted reduction strategies, streamlining operations and minimizing unnecessary expenses. By gaining visibility into their food waste, businesses can optimize processes, reduce costs, and contribute to a more sustainable food system. We work with our clients, providing expert guidance.

Expected employee numbers

Dublin

Est. 2020

mark-kirwan

Mark Kirwan

Company Profile

Positive Carbon helps food businesses eliminate waste. Our experienced team, with over 50 years combined expertise across Ireland and the UK, provides cutting-edge food waste monitoring technology. Using advanced sensors, our system tracks and analyzes discarded food, offering data-driven insights. This helps kitchens identify waste sources and implement targeted reduction strategies, streamlining operations. Gaining visibility into food waste empowers chefs to optimize processes, minimize costs, and contribute to sustainability. We partner with clients to achieve significant waste reduction and maximize the impact of our technology.

Company Achievements to Date

Positive Carbon has established itself as a leader in AI-driven food waste management, securing key partnerships and industry recognition.

In November 2023, the company raised €2.3 million to expand its impact across the UK and EU. By October 2024, Positive Carbon partnered with Levy Ireland, a top sports and entertainment hospitality provider, to launch a groundbreaking food waste reduction initiative. The company also began expanding its operations in the UK.

Positive Carbon has been nominated for multiple prestigious awards, including:

Startup of the Year (Global Startup Awards, 2025 Edition 11)

Innovation of the Year Award at the 50th Business & Finance Awards 2024

Finalist for the All Ireland Sustainability Awards 2024 in the category of Food Waste Initiative of the Year 2024

The company has secured partnerships with leading hotel chains and food service providers, integrating its machine learning technology to track and analyse real-time food waste data. By leveraging AI-driven insights, Positive Carbon helps businesses reduce food waste, cut costs, and meet sustainability goals.

With continued innovation and expansion, Positive Carbon is cementing its position as a pioneer in sustainable food waste management across Europe

Est. 2021

Tara, with a BSc in Statistics, transitioned from multinational corporations to founding Mange Tout in 1998. She expanded it to include SI Cafés, launched The Caterwaiter recruitment firm, and transformed their kitchen tool into Prepsheets.com. Tara also serves as a Lead Entrepreneur with Going for Growth. Brian, a Michelin-trained chef, co-piloted MangeTout’s growth and co-founded The Caterwaiter in 2007. In 2021, alongside Tara, he co-founded Prepsheets, leveraging three decades of hospitality expertise

Expected employee numbers

tarabeattie

brian-beattie

Tara Beattie & Brian Beattie

Company Profile

Prepsheets - multi award winning EI backed kitchen operating software. We enable the creation of cost efficient and margin making recipes whilst giving data on portion size, allergens and nutrients. Prepsheets also creates food to go labels and supplier ingredient orders on all recipes stored in the system.

Company Achievements to Date

n Customer Base growth over 100% YoY

n Managed Database of over 30,000 supplier ingredients

n Working with Multinational Hotel Groups and customers in Ireland, UK and Dominican Republic.

n Jan 2025 - Shortlisted Best Food Service Technology Product - Front and Back of HouseWinners announced 20th February at Catex 2025

n Jan 2025 - Most Innovative Recipe & Nutrition App 2025 - Irish Enterprise Awards

n Nov 2024 - Enterprise Ireland New Frontiers Startup Bronze Winner

n Nov 2024 - Web Summit Alpha Start up - Chosen by the Web Summit to showcase in Lisbon as part of their 50 selected startups to be offered complimentary packages

n Sept 2024 - Sunday Business Post 100 hot start ups

n Mar 2024 - Prepsheets featured on Launch Pad - Tech X Stage at HRC in London

n Feb 2024 - Finalist for the IFEX Innovation Awards 2024

n Dec 2023 - PSSF

n Jan 2023 - Winner Best Food Service Technology Product - Back of House - CATEX 2023

prepsheets

prepsheets

Shailesh Sharma is a visionary entrepreneur and solution architect with over nine years of experience driving innovation across multiple industries. Having developed mobile and web solutions for over 200 global businesses, including Fortune 500 giants like AOL, Nokia Siemens, and Intuit, Shailesh is a proven leader in technology. His expertise extends to MedTech, where he has designed and implemented advanced ERP systems. As a UCD MBA graduate, Shailesh blends technical excellence with a strategic understanding of global business, particularly the Irish market.

As a co-founder of PrimumAi, alongside a General Practitioner and a commercial development expert, Shailesh is committed to revolutionizing healthcare. PrimumAi harnesses cutting-edge AI to streamline medical practice operations and improve patient care. Shailesh’s extensive experience in technology and business strategy positions him at the forefront of transforming the healthcare sector, making it more efficient and patient-centered across Europe.

Dublin

2024

shailesharma

Shailesh Sharma

Company Profile

PrimumAi is a pioneering Irish AI healthcare cloud company revolutionizing the landscape of primary care. By seamlessly integrating state-of-the-art AI agents, PrimumAi optimizes key operational functions—finance, administration, communication, and consultations—within medical practices. As a leader in innovation, PrimumAi drives transformative efficiencies, significantly curtailing costs and enhancing the patient experience. Its cutting-edge solutions empower general practitioners to reclaim over 2.5 hours each day, enabling them to refocus on high-value patient care. Developed in close collaboration with medical professionals, PrimumAi delivers sophisticated, AI-driven practice management solutions, engineered to alleviate the administrative burden.

Company Achievements to Date

PrimumAi is now live and making waves in the healthcare sector with its suite of groundbreaking solutions. The company has already launched its Transcribe Agent, Pre-Consultation, Appointment Management, and Payment Solutions, empowering over 40 doctors across 20 medical practices to streamline operations and save more than 1 hour per day. PrimumAi has transformed the way medical professionals document patient consultations, allowing doctors to focus on delivering exceptional patient care rather than on administrative tasks.

With its innovative technology, PrimumAi is revolutionizing the primary care experience. The company has secured €500,000 in cloud infrastructure credits from global tech giants such as AWS, Microsoft Azure, and Google, underscoring the value it is delivering to the healthcare industry. Additionally, PrimumAi successfully completed the NDRC Pre-Accelerator Cohort, further validating its potential to drive significant change in the healthcare landscape. By leveraging cutting-edge AI technology, PrimumAi continues to provide real-time solutions that improve workflow, enhance patient experiences, and empower medical practitioners to focus on what truly matters—patient care.

primumai

Cork

Est. 2021

Dr. Holger Mueller & Prof Noel Caplice, MD, Ph.D.

dr-holger

noel-caplice-professor

Dr. Holger Müller studied Chemistry at the Leibniz University in Hanover, Germany and at the Imperial College London, United Kingdom and obtained his PhD from the Swiss Federal Institute of Technology Zurich, Switzerland. Following his academic career, Holger started his professional career with Bain & Company, a leading management consultancy and subsequently joined Novartis. After a ten year career he joined the cell therapy start-up Cell Medica (now Athenex), served as Chief Commercial Officer of the proteomics start-up Biognosis and as Chief Operating Officer at Spiden, a spectroscopy driven medical device company, before joining ProVascTec as CEO.

Noel Caplice MD, Ph.D., is a Clinician Scientist with more than 30 years experience receiving medical and scientific training in Ireland, Australia and USA. Having held senior positions at Mayo Clinic he is currently Chair of Cardiovascular Science, Professor and clinical / interventional cardiologist at UCC. He has vast experience in vascular and molecular biology with specific interests in the fields of vascular biology, experimental animal models, cardiac cytoprotection post myocardial infarction, vascular stem cell biology, gene therapy, novel therapeutics, medical devices, microbiome and cardiometabolic disease.

Expected employee numbers

Company Profile

ProVascTec is a pre-clinical stage cell therapy company with a proprietary technology to increase the efficacy of cell therapies by increasing the pay-load delivery and prolonging the viability of cells. Co-founded by a leading vascular biologist and an experienced pharma manager, ProVascTec’s lead product aims to improve the life of patients suffering from blocked arteries in the lower extremeties, a medical condition referred to a critical limb ischemia. With 5.0m patients in the US, Europe, and Japan, ProVascTec targets a market of € 16bn.

Company Achievements to Date

Since Holger joined ProVascTec in 2023, ProVascTec, turned its patent applications in both the US and Europe into granted patents, securing the commercial foundation of the company. Together with the Swiss-based research institution Empa and the Swedish start-up Cellcolabs, ProVascTec established a European consortium that leverages established manufacturing capabilities to accelerate the development of ProVascTec’s lead for the treatment of critical limb ischemia. This collaboration was awarded with a € 2.1m Eurostars grant by the European Union. As part of the seed round investor roadshow ProVascTec participated in AixsBIC’s Venture Academy, where it was recognized as most investable company. Since the successful conclusion of its oversubscribed seed round financing, ProVascTec expanded its team by welcoming Florence Herisson as group R&D manager. Going forward Florence and a growing team of technicians will execute crucial scientific experiments in ProVascTec’s proprietary lab at Gateway UCC, the startup accelerator of the University College Cork.

Company Profile

Royal College of Surgeons in Ireland (RCSI) spin-out Pumpinheart is developing a transcatheter implantable heart pump to treat advanced stage Heart Failure with preserved Ejection Fraction (HFpEF aka Diastolic Heart Failure), an unmet medical need. The total addressable market of approximately 640k advanced HFpEF patients in the USA, Canada, UK and EU is estimated to be a $32B TAM, an $8B SAM and a $3.2B OAM. The goal is Left Atrial Pressure (LAP) reduction of 3 to 5 mmHg that is known to deliver therapeutic benefit. Preclinical trials have consistently demonstrated LAP reduction of two to three times the target.

Company Achievements to Date

Awards and Pitch Competition Finals: TCT 2024 Shark Tank Finalist (Washington DC); MedTech Category National Startup Awards: Silver Medal (2022, 2023) and Gold Medal (2024); AIMS Gold Medal for Innovation 2023; MedTech Rising MedTech Connect Finalist 2023 & 2024; MedTech Innovator Accelerator 2023 Best Video Finalist; Termis Americas Business Plan Competition Winner 2022 (Toronto); Funding Awards: €10,000: European Society for Clinical Investigation (ESCI, Aamir Hameed) Award 2020; €500,000: Enterprise Ireland Commercialisation Fund Grant 2019; €3.14M: Disruptive Technologies Innovation Fund DTIF 2022; Fundraising: €100k EI PSSF 2023; €60k Friends & Family 2024; €551k Spark Crowdfunding campaign 2024.

Expected employee numbers

Dublin

Est. 2022

donald-hickey aamir-hameed

Darragh Colgan, Aamir Hameed, Donald Hickey & Andrew Malone darraghcolgan andrew-malone

The founder team is a mix of clinical, engineering and business development expertise. CMO Dr Aamir Hameed MBBS MD trained as a Cardiothoracic Surgeon before becoming an Anatomy Lecturer and Senior Research Fellow at the RCSI, inventing the diastolic heart pump ‘PReduction’ in 2018, and was a Visiting Scientist at HCA Healthcare, MIT Boston, CÚRAM NUIG Galway and TCD Dublin. CEO Donald Hickey MDes (RCA) BABAI is a tech start-up business developer that co-founded edtech developer Ossidian (1999-2018) and then pivoted to MedTech. CTO Dr Darragh Colgan, ex-VP R&D Structural Heart Boston Scientific is a Medical Device R&D leadership executive known for delivering innovative and pioneering medical devices to market. CSO postdoctoral research medical physicist Andrew Malone PhD, previously with FIRE1, built the initial bench test rig that emulated Pressure Volume conditions on the left side of the heart and demonstrated the Left Atrial Pressure reduction potential of the device.

Pumpinheart

Dave Byrne is the driving force behind ReaDI-Watch, helping companies embrace and unlock Innovation and R&D (RD&I) through an AI-assisted expert service platform. As Co-Founder and CEO, he has successfully scaled the business across Ireland, the UK, and Canada since its launch in 2023.

Founded during the Covid pandemic, ReaDI-Watch has grown—bootstrapped—to a team operating in three markets. With a vision to become a global leader in digital solutions for RD&I management, funding, and collaboration, the company has earned prestigious accolades, including Tech Startup of the Year (Ireland National Startup Awards 2023).

Dave’s background includes an MSc in Finance (UCD Smurfit) and an Alternative Investments Programme from Harvard Business School. Prior to ReaDI-Watch, he was a Founding Board Member of GB Innovation Ltd, leading a team of 10 consultants in RD&I strategy. His expertise has been featured in the Irish Times and presented to global innovation bodies.

Expected employee numbers

Dublin Est. 2021

Dave Byrne, Aisling Kirwan & Prof. Gerry Byrne

Company Profile

A new way to Innovate with Confidence.

- Overwhelmed by the incessant demands of R&D and Innovation for your business?

- Embrace and unlock your Research, Development and Innovation potential with our award winning service and platform.

ReaDI-Watch delivers hands-on expertise and seamless digital tools that are tailored to support your business to become RD&I Ready.

Designed for companies with limited resources, we help you efficiently build, manage, and fund your R&D strategy, while protecting your intellectual property.

Company Achievements to Date

Since its inception during the Covid pandemic, ReaDI-Watch has rapidly grown into a leading force in Innovation and R&D (RD&I) management. Bootstrapped from the ground up, the company has expanded across Ireland, the UK, and Canada, building a team and establishing itself as a trusted partner for businesses seeking to enhance their innovation strategies through AI-assisted solutions. ReaDI-Watch has a strong list of customers across many sectors and sizes, including Combilift, Modular Automation, Keelings Group, Equal1 Laboratories, Mincon, Magrowtec and more.

ReaDI-Watch has received significant industry recognition, winning Tech Startup of the Year at the Ireland National Startup Awards 2023 and being a finalist in the Irish Times Innovation Awards 2023. Other notable accolades include SFA Small Business (Emerging) Winner 2022 and recognition in Ireland’s 30 Under 30 Entrepreneurs (2021). The company was also an IMR Product Innovation & Design Finalist 2022 and a Dave Byrne was nominated runner-up in the AMBA & BGA Entrepreneur of the Year 2025.

Beyond awards, ReaDI-Watch has successfully participated in accelerator programmes, including Euronext’s IPO Ready Programme, Web Summit’s Rise Summit, and Furthr’s Investor Ready Programme. Aisling Kirwan has also achieved ISO56002 certification for Innovation Management, reinforcing its commitment to best practices in RD&I.

With an ambitious goal to become a global leader in digital innovation solutions, ReaDI-Watch continues to expand its impact, helping businesses drive real-time innovation success.

stephen-maccarthy

shanekiernan

Shane Kiernan is the CEO & Co-Founder of Recruitroo, responsible for business operations, strategic growth, and market expansion. Shane has co-founded multiple ventures in Nigeria, Philippines and Ireland in recruitment, agriculture, and tech, including Sustansiya, Tomato Jos, and Iamus Technologies.

Stephen MacCarthy is the CTO & Co-Founder of Recruitroo, driving the development of the platform’s automation and AI-driven hiring solutions. Previously, he worked in product management and consulting at Accenture and EY, specializing in automation and AI solutions.

Expected employee numbers

Stephen MacCarthy & Shane Kiernan

Company Profile

Recruitroo is an online platform that streamlines international hiring for Irish and UK companies using AI and automation tools. Companies in construction, engineering, healthcare, and manufacturing can connect with qualified global candidates.

The platform manages the entire hiring process with:

n Talent sourcing with media-rich profiles

n Interview scheduling and hosting

n Automated visa and permit processing

n End-to-end relocation support

n Immigration compliance and documentation management

By automating these complex processes within one app, Recruitroo helps companies reduce costs, improve efficiency, and maintain immigration compliance while solving labor shortages.

Company Achievements to Date

n Awarded UCC Startup of the Year in 2023

n Backed by Enterprise Ireland as a High Potential Startup and successfully raised a pre-seed funding round in April 2023 to accelerate growth and market expansion.

n Currently at 12 employees and growing every month

n Facilitated over 100 successful international placements in Ireland

n Currently expanding into the UK market

n Trusted by companies including Rockwell Engineering, Energywise, Gaffney Mechanical, Kilsaran, Kearys, and many more.

recruitroo

2021

Our founders, Ken O’Shea, former Head of R&D and Site Lead at EirGen Pharma is a scientist with a background in developing complex cancer treatments. He holds degrees in Environmental Science and Pharmaceutical Science, an MBA from Smurfit UCD and is a Lean 6 Sigma Black Belt. Dermot O’Riordan, who also held senior management roles at EirGen, is an engineer and expert in operations and supply chains, bring a wealth of experience from two decades in the Pharma Industry. He holds a degree in Manufacturing Engineering, Masters in Biopharma Engineering, a PG Diploma in Innovation Management and is a qualified Project Management Professional Our combined skills in product development & commercialisation and proven track record in the Pharma industry have shaped the strategic direction of our company.

Tramore, Waterford Est.

Dermot O’Riordan & Ken O’Shea

Company Profile

Reso Health is transforming the supplement industry by combining science and technology to deliver personalised nutrition. Using individuals’ personal data, we create customised supplement drinks, with a precise blend of nutrients tailored to meet specific needs. With our MVP already developed and our seed funding round complete we are gearing up for commercial launch with an initial customer pilot scheduled for Q2 2025.

Company Achievements to Date

n MVP complete, preparing to execute commercial pilots in Ireland in Q2 2025 with Compass Ireland

n Commercial interest received from Suntory Japan and Sodexo US.

n Trademark submitted & IP application in progress

n Seed round complete for €800k. €500k private and €300k EI

Dublin Est. 2020

Alan Gormley & Tariq Zaki

alangormley

tariqzaki

The founders combine 45 years experience in the AI industry with 20 years experience just in AI startups. Both have been at the cutting edge of developments in AI, from the early days of real time AI scoring, the introduction of ground breaking Optimization software in retail to using online behaviour data in real time to model browsers needs.

Before starting Shopbox both held C-level positions in AI startups where they worked on new approaches to automating and scaling AI initiatives.

Expected employee numbers

Company Profile

When added to your current eCommerce platforms (Shopify, Magento etc. or even homegrown), Shopbox AI transforms it from a generic store for all customers into a unique store for each customer, increasing conversion rates by 2x to 3x and basket sizes from 7% to over 40%.

Our proprietary Contextual AI discovers the “intent” of the customer after just 1 click, working with 100% of your traffic, even anonymous first time visitors and can be added to your existing platform in days.

Company Achievements to Date

From a business perspective Shopbox is running on over 90 retailers spanning small to 170m+ in online revenue. In that time we have won many industry accolades from Best AI Startup to best Retail Software Solution.

From an innovation perspective Shopbox has introduced completely new concepts in online shopper enegagement driven by a propriety AI engine which has been proven to handle enormous retailers - 12m products - completely automatically.

isabella-hughes

Isabella Hughes, John Noonan & Oisin Dolphin john-noonan oisin-dolphin

Isabella, CEO, was a Legal Executive at a Dublin-based firm, specialising in probate, giving her deep industry expertise. While studying law, she volunteered with the Free Legal Aid Centre. Her network has connected the company with top legal experts. She has built brand recognition through The Irish Times, The Fifth Court podcast, and being named in the Sunday Independent’s 30 Under 30. As a pro athlete, she brings a competitive edge to the team. ; Oisín Dolphin, CTO, has 8 years of software development experience, working with startups in Dublin and London. A first-class honours graduate from Trinity College, he has tackled technical challenges in early-stage companies and worked as a contractor. His experience in building and scaling digital products gives him a strong understanding of product-market fit. ; John Noonan, Chief Product Officer has 5+ years in B2B SaaS and legal tech. At Clio EMEA, he worked closely with law firms on product discovery, feature launches, and technology adoption. Previously, he was an early hire at Sitemate, a B2B SaaS startup that has scaled to 150+ employees. His experience in product management and startup growth will help drive execution.

Expected employee numbers

Dublin

Est. 2024

Company Profile

Simple Probate is a B2B legal tech platform that streamlines and simplifies probate for solicitors and their clients (Executors). By automating tasks and reducing paperwork, it cuts solicitors’ workload by 50% while improving client experience. Together we are transforming the way probate is done today, benefitting solicitors, their clients, and society.

Company Achievements to Date

Simple Probate launched in November 2024 after a successful beta testing period. Since then we have onboarded 10+ firms bringing in our first revenue. We have raised 25% of our angel round to date with fundraising ongoing. Our first AI tool for probate solicitors is currently in development with anticipated launch in April this year.

Daniel founded Skippio in 2022, a platform revolutionising the fan experience at live events. With a deep passion for technology, hospitality, and seamless event experiences, Daniel identified a major frustration—long queues at stadiums, festivals and arenas—leading to the creation of Skippio.

With a background in operations, Daniel and the Skippio team have built Skippio into a gamechanging solution for venues, vendors, and fans. The platform allows users to pre-order food, drinks, and merchandise, reducing wait times and enhancing event engagement all on one app.

Skippio has partnered with leading venues and event organisers across the UK and Ireland, delivering a frictionless, cashless, and queue-free experience. Passionate about fan experience, engagement, innovation, and operational efficiency, Daniel continues to drive Skippio’s mission: to keep fans enjoying the action—not standing in queues.

Expected employee numbers

2025: 8 2026: 12 2028: 15

Dublin

Est. 2022

daniel-coen

Daniel Coen

Company Profile

Skippio is a fan experience platform that enhances live events by eliminating queues. Designed for stadiums, arenas, and large-scale venues, Skippio allows fans to pre-order food, drinks, and merchandise through the app, receive real-time notifications, and collect orders seamlessly. This reduces wait times, boosts vendor sales, and ensures a frictionless event experience. Trusted by major venues and partners, Skippio revolutionises event hospitality, keeping fans engaged in the action instead of standing in line. With seamless integrations, real-time tracking, and exclusive offers, Skippio makes every event faster, smarter, and more enjoyable. Skip the queue, not the action!

Company Achievements to Date

n Enterprise Ireland HPSU startup.

n Secured Enterprise Ireland’s PSSF &HPSU funding.

n The Irish times Innovation Award Winner for IT & Fintech

n Voted ‘Best Pitch’ in the Enterprise Ireland HPSU Prep4Seed programme by investors.

n Winner of ‘Best Pitch’ – Furthr’s PitchJam.

n One of 3 companies selected onto the final phase of New Frontiers accelerator.

n Regional finalist in Ireland’s largest startup competition, Seedcorn.

n Listed as Ireland’s 30 under 30 in Tech by the Business Post.

n Listed as Ireland’s 30 under 30 in Business by the Irish Independent.

n Startup of the month (Business Post – May 23).

Skippio skippio.io

Company Profile

Sleek N Easy – The One-Stop Shop for Female Athletes

Sleek N Easy started as a high-performance, aerosol-free haircare brand, but we’re evolving into the go-to destination for female athletes and women in sport. Our mission is to provide innovative, sweat-resistant beauty and lifestyle solutions that fit seamlessly into active routines. Committed to sustainability and community, we support local sports through sponsorships and our Athlete Ambassador Program. With a focus on performance, convenience, and empowerment, Sleek N Easy is redefining self-care for women in sport—on and off the field.

Company Achievements to Date

Sleek N Easy is quickly becoming a trusted name for those who demand high-performance beauty solutions. Our sweat-resistant, aerosol-free haircare is used by WSL players, members of the Irish national football and hockey teams, and athletes who need products that can keep up with their active lifestyles.

Beyond the world of sport, our products are also favoured by professional makeup artists and hairstylists, proving their versatility in both performance and everyday use. Our commitment to quality has earned us recognition, with shortlists for the HI Style Beauty Awards and the National StartUp Awards.

With an ongoing partnership with Uniphar, we’re proud to be stocked in Ireland’s largest retail chains and pharmacies, and our products are now reaching customers across the UK and Europe.

Through our Athlete Ambassador Programme and local team sponsorships, we continue to support and empower women in sport, providing them with the products they need to look and feel their best, no matter where their day takes them.

Expected employee numbers

Kildare

Est. 2021

Founder Profiles – Katie & Hayley Nolan

Katie, a dedicated PE teacher, and Hayley Nolan, a professional footballer for Crystal Palace, founded Sleek N Easy to create high-performance, sweat-resistant beauty solutions for female athletes and women in sport. They recognised the need for haircare and lifestyle products that could keep up with active routines while being convenient, effective, and eco-friendly.

What began as an aerosol-free haircare brand has evolved into a one-stop shop for female athletes, providing products designed for performance both on and off the field. Passionate about empowering women in sport, they launched the Sleek N Easy Athlete Ambassador Programme and sponsor local teams to support the next generation of female athletes.

With Katie’s expertise in sports education and Hayley’s experience as a professional athlete, they are committed to making Sleek N Easy a trusted brand for active women, helping them look and feel their best every day.

katie-nolan

Katie Nolan

Company Profile

Smart Reactors is a trusted provider of medical device coating technologies to the medical device landscape. We differ to the competition by providing a real coating solution to reduce thromboembolic complications, while promoting Cell Proliferation & Healing in the case of implant devices (ie-neurovascular, flow diverters, venous stents, structural heart devices etc).

Company Achievements to Date

n Secure >€2M funding

n Revenue generating

n State of Art R&D facility

n Novel innovative technology for implants devices to reduce clotting and promote healing.

Expected employee numbers

Leading the Company, Brian brings 25 years’ experience in the medical device industry. Holder of a degree in manufacturing and a post graduate Quality Assurance. Brian spend 13 years in Abbott Vascular, whom acquired Biocompatibles International, MedNova during this tenure. Subsequently, Brian co-founded Coxon Medical, supplying plastic injection moulded components to medical device companies on an international basis, with manufacturing More recently he consulting with several companies in supply chain, sales and operational planning processes as well as management of new product introduction from R&D into full scale operations. Brian’s strategic business development skills and commercial experience provides for maximum value to its shareholders.

Galway

Est. 2019

Brian haddigan

Brian Haddigan

Company Profile

Smile Genius is a cutting-edge B2B SaaS platform revolutionizing the dental industry by serving as the Operating System (OS) for dental labs, clinics, and DSOs. We specialize in streamlining workflows, enhancing communication, and improving efficiency across the entire dental ecosystem. Our brand-agnostic platform integrates seamlessly with existing systems, enabling labs and clinics to reduce operational inefficiencies, increase case acceptance rates, and unlock new revenue streams. With advanced features like patient tracking, remote monitoring, and robust integrations, Smile Genius creates high switching costs while driving measurable growth. Our long-term vision is to become the Salesforce of dental, empowering professionals worldwide.

Company Achievements to Date

n Smile Genius has rapidly emerged as a leading dental software provider, empowering labs, clinics, and aligner businesses with cutting-edge solutions. Since our inception, we have:

n Grown to a healthy revenue and have demonstrated strong market demand and adoption.

n Launched industry leading Doctor App to assist dentists be on top of their profession

n Secured pilots with major industry players, including Image Orthodontics, to showcase Smile Genius’s impact on patient management and treatment efficiency.

n Expanded our customer base across SME dental labs and clinics, helping them streamline workflows and scale their operations.

n Developed a comprehensive SaaS platform tailored for clear aligner providers, differentiating ourselves from traditional dental and lab management software.

n Launched industry thought leadership initiatives, including the Digital Dentistry Deep Dive podcast

n Engaged in strategic partnerships, opening doors to collaborations with key industry stakeholders.

n These achievements lay a strong foundation for our ambitious growth trajectory, reinforcing Smile Genius as a game-changer in digital dentistry.

Expected employee numbers

Dublin Est. 2021

Nipun Kathuria, Vikas Nag Prasanna & Mark-Anthony Shepherd,

nipunkathuria

Nipun Kathuria is the Founder and CEO of Smile Genius, a visionary leader with a passion for transforming the dental industry. With extensive experience in B2B SaaS and a background in scaling innovative solutions, Nipun has positioned Smile Genius as a trailblazer in dental lab and clinic management. His expertise in creating interconnected, brand-agnostic platforms has been instrumental in bridging gaps across the dental workflow lifecycle.

Under his leadership, Smile Genius is redefining efficiency and growth opportunities for dental labs and clinics globally. Nipun is committed to building a sustainable competitive advantage through technology, network effects, and customer-centric solutions.

Beyond his work with Smile Genius, Nipun is a seasoned entrepreneur, podcast host, and advocate for digital transformation in healthcare. His ability to identify market needs and execute innovative strategies has made him a recognised name in the dental technology space.

Est. 2023

Tony is an expert in fungal ecology, biotechnology and in large scale fermentations from the mushroom industry & biogas industry. With nearly 30 peer reviewed publications, Dr Callaghan has a foundation in academic research in herbivore gut microbiology & fungal cultivation where he has a track record of developing new techniques and processes. He also has 8 years’ experience in industry working with leading governmental (UK, Ireland, Germany) & academic institutions to translate research into commercial innovations. Dr Callaghan has several world firsts in his field with a track record of outside the box thinking with successful project management, process improvement and of taking new innovative products from benchtop to pilot to commercial realization.

Expected employee numbers

Ballybay County Monaghan

tony-martin-callaghan

Tony Callaghan

Company Profile

SomaTech develop sustainable solutions for converting fibrous agri-food by-products into high value, functional, and healthy ingredients & additives.

Our unique technology utilizes Solid State Fermentation with fungal mycelium, ensuring a completely natural and zero-waste process while enhancing desired functionalities.

Our process creates nutritionally dense, vitamin rich ingredients with improved digestibility, bioavailability and flavor. We are targeting high value ingredients, food supplements (e.g., pre & post biotics) and targeted functional animal feed additives (e.g. improving animal health, growth rate, methane emissions).

Company Achievements to Date

SomaTech have build a state of the art production facility at the Ballybay Food Hub, Ballybay County Monaghan. This includes new types of bespoke equipment for scaled up production of fermented ingredients.

Leveraging this capacity SomaTech have built an extensive portfolio of fermented ingredients produced using a wide range of locally available feedstocks (e.g. plant based side streams such as bran, spent grains & press cakes) & fungal strains.

Using this knowhow & IP, we are engaged with several major Irish & UK based food producers in paid commercial projects to further validate applications for, optimize & scale production of these ingredients.

somatech-ltd

The concept for releaze was established during the BioInnovate programme, a Stanford Biodesign affiliated fellowship, when Tim Jones and Dr. Michelle Tierney were fellows of the 2017-2018 cohort focusing on Interventional Pulmonology (a sub-set of respiratory medicine). Immersion in clinical settings in Ireland and the US, including the world-renowned Mayo Clinic, provided the team with a unique perspective to identify the most undermet medical needs.

CEO Tim Jones, an entrepreneur with over 20 years in medtech and entrepreneurial ventures, possesses a unique blend of engineering and commercial acumen. His previous roles include successfully running a start-up in the UK and serving as a Senior Research & Development Engineer at Medtronic, where he led cross-functional and cross-site teams.

Dr. Michelle Tierney, Chief Scientific Officer, has over 15 years of experience in the life sciences sector. In her prior role at the global Clinical Research Organisation, ICON plc, she contributed as a Senior Member of the Medical Affairs team and specialised in developing digital training for healthcare professionals and patients.

Expected employee numbers

michelle-tierney

tim-jones

Tim Jones & Dr. Michelle Tierney

Company Profile

SymPhysis Medical is an Irish start-up that is developing a breakthrough solution for managing malignant pleural effusion (MPE), fluid in the chest resulting from terminal cancers. Led by CEO Tim Jones and CSO Dr. Michelle Tierney, the SymPhysis Medical team has been developing the releaze technology for over 6 years and in that time has conceptualised and validated a groundbreaking solution for addressing this debilitating condition that often leaves vulnerable patients breathless and in pain.

Company Achievements to Date

n Developing the first significantly novel device to treat MPE in over 25 years called releaze, which includes: novel anchor technology, smart home drainage and remote patient monitoring

n NHS Digital Market Access Accelerator – The Hill 2021

n HealthTech Ireland Best Indigenous Healthcare Startup in December 2022

n Health Innovation Hub Ireland (HIHI) 20 Health Innovations to watch for 2022

n Granted Patented Technology

n Best Collaboration in MedTech Award at the Irish Medtech Association awards in 2023

n Best Pitch Company at the MedTech Rising conference in 2023

n 7 Usability Studies in the UK and US – Focusing on Patient-Centric Design

n Over €9 million in funding to date; €6.2 in equity funding and €3m in grant funding

n Commercial manufacturing underway

n Strong support and excitement from Key Opinion Leaders in the medical community eager to adopt our transformative solution

n Anticipating a market opportunity of over €1b in the US and EU alone, expanding into Rest of World soon after

n Highly experienced team taking this new technology to the next level with a pipeline portfolio driven by the needs-led approach

Stephen Hallahan is the Founder & CEO of Tap Retail, an Enterprise Ireland-backed HPSU (High Potential Start-Up), which helps local retailers compete and thrive by offering local customers online shopping and flexible and click & collect options.

In association with Foxrock Village & Dun Laoghaire- Rathdown County Council, Tap Retail launched Ireland’s First Digital Retail Village in November 2024, bringing seven local retailers together on a single online platform. For the first time, customers in Foxrock Village can shop from multiple local retailers in a single transaction, with their items being delivered in one delivery. The Tap Retail Digital Retail Village gives local businesses the tools they need to compete with the big online platforms while keeping the personal touch and community feel that makes towns and villages like Foxrock so special.

Under Stephen’s leadership, Tap Retail has been recognised at the National Startup Awards, National Digital Awards & were named as one of Ireland’s Top 100 Most Ambitious Companies. Stephen has recently been invited to join Enterprise Nation’s Small Business Tech Consortium with Global leaders Google, Amazon & GS1to help Irish SMEs to effectively adopt & use Digital Technologies, highlighting his standing in the industry.

Expected employee numbers

Dublin

Est. 2023

stephen-hallahan

Stephen Hallahan

Company Profile

Tap Retail, an Enterprise Ireland-backed HPSU (High Potential Start-Up), helps local retailers compete and thrive by offering customers online shopping and flexible delivery and click & collect options. We empower small retail businesses to digitalise in an extremely cost-effective way & enable them to sell online on our award-winning app & website and serve customers in their town and community. We work with closely with SME retailers, business associations, county councils & Business Improvement Districts to drive change in local towns.

Our company is at the forefront of innovation in our space & in November 2024, Tap Retail launched Ireland’s first ever Digital Village with Foxrock Village in South Dublin. For the first time ever, local customers will be able to purchase from all participating retailers in the town & have their items delivered in a single delivery.

Company Achievements to Date

n Recognised as one of DBI’s Top 5 Tech Companies to Watch in 2023

n Closed seed round in Summer 2023 with some of Ireland’s leading businesses to grow our team, invest in our product and drive growth.

n Runner-Up in DBI National Digital Awards 2024 in Food, Beverage & Hospitality Website of the Year

n Received Enterprise Ireland HPSU Funding in Summer 2024

n Silver Medal Winner in National Startup Awards in 2024 in eCommerce & Retail Startup

n Launched Ireland’s First Ever Digital Retail Village with Foxrock Village & DLR County Council in November 2024. For first time ever, customers can shop online from all participating retailers in their village & receive their items in a single delivery, helping to combat congestion & shortage of parking in their town.

n Working with BIDs, Chambers, Town Teams & Councils to roll out Digital Retail Village platform in 2025 & beyond with plans to launch our first international market in 2025.

Dublin Est. 2021

Dr Maimoona Azhar is the founder and CEO of Telegenz. She is a medical professional and software developer, with over 15 years of experience spanning clinical practice, surgical education, and research. She has insightfully blended her healthcare knowledge and technology background to redefine remote learning through Telegenz – a scalable platform that bridges global professional training and real-world applications, in healthcare and beyond.

Expected employee numbers

maimoona-azhar-

Dr Maimoona Azhar Salim

Company Profile

Telegenz provides a highly adaptable platform designed to meet the unique requirements of diverse industries. Its flexible and innovative architecture supports a wide range of content types and training methodologies, ensuring seamless customization for various applications. Purposebuilt for clinical training and professional development in healthcare, Telegenz transforms the way health professionals are trained and deliver care, with a particular focus on telehealth and mental health interventions. Beyond healthcare, the platform extends its capabilities to technical, vocational, and legal sectors, enabling effective technician training, client assessment simulations, and discovery call practice, making it a versatile solution for modern professional education.

Company Achievements to Date

Telegenz is being used by 6 university programs in Ireland and abroad, i.e, USA, Tanzania and the UAE, across various healthcare disciplines - Medicine, Nursing, Physiotherapy, Pharmacy. Also, Telegenz is bringing a novel pediatric mental health intervention - The Happiness Toolkit, globally, with pilots lined up in Sub-Saharan Africa, Ukraine and Greece.

telegenz

Company Profile

Thanks Plants was born of taking real food like pearl barley, cannellini beans and veggies, and turning these into sausages, burgers and roasts that no meat lover could turn away. We use ingredients that most people would recognise rather than a complicated set of chemicals that would remind them of a school chemistry class. We’re not trying to be meat and we’re trying to minimise the processing of fundamentally good ingredients. We’re just ourselves, full of protein, a source of fibre and with no compromise on taste or texture.

Company Achievements to Date

n We are stocked in 4 of the 5 major retailers in Ireland - Tesco, Dunnes, SuperValu and ALDI.

n We have successfully launched 10 products to date and we are planning more launches for 2025.

n National start up award 2022 – silver

n Top ten start ups for 2023 – as listed by enterprise ireland in the irish independent

n Green food and beverage award – winner 2021, best sme

n WMB female newcomer award – finalist

n Business post top 100 start ups 2024

n Origin green certified

n Enso certified

Expected employee numbers

Aisling Cullen set up Thanks Plants in 2020 having previously operated a coffee house and restaurant before shifting to manufacturing. IN 2015, whilst living in Malaysia, Aisling opened a coffee house and when she moved back to Ireland in 2017, she continued her food journey and started creating delicious plant-based recipes made with whole foods and homemade recipes. And so, Thanks Plants was born.

Dublin

Est. 2020

aisling-c

Aisling Cullen

Company Profile

Penny is a software company focused on developing innovative technology that benefits society – starting with digital pensions. Our purpose-driven solution democratises retirement planning for historically underserved female professionals to drive higher engagement compared to traditional pension providers.

Company Achievements to Date

Research-backed, 7+ years of global ethnographic research on women & money. Regulated b y Central Bank of Ireland. Backed by Enterprise Ireland and world-class private investors. Technology platform designed and built. Over 1m in assets under management.

Lesley is a entrepreneur with a deep passion for fixing the future, today. Founder and CEO of Penny, she was, formerly Head of Design Thinking for Bank of Ireland, has worked extensively in the financial services, fintech, agtech and insurtech. Lesley holds MPhil from Goldsmiths (London) and Trinity College Dublin and Bachelor of Design from Institute of Art, Design and Technology. She sits on the Board of Governors for National Museum of Women in Washington and previously National Gallery of Ireland and Institute of Designers in Ireland.

Dublin

Est. 2020

lesley-t

Lesley Tully

With over 50 years of experience in building and managing technological innovation projects, entrepreneurship, and motivational team management Arie co-founded Tonisity in 2015. Arie’s passion is to identify and invest in business opportunities where nobody else would, using creativity and research to escape the comfort zone and explore the new and unknown. He has built two multinational companies within the concept of disruptive technology, and continues to research and invest in innovative technologies in various areas. His mission is to make a positive impact on the world through technology and innovation.

Expected employee numbers

Dublin

Est. 2015

halpernarie

Arie Halpern

Company Profile

Tonisity is a global animal health and nutrition company dedicated to improving the health and welfare of all animals. Founded in 2015, Tonisity now distribute products in over 60 countries globally. Tonisity is committed to the innovative development of cutting-edge nutritional products. We challenge everyday animal health standards to bring improved animal welfare to all.

Company Achievements to Date

Tonisity has distributors in over 60 countries for its range of gut health and hydration solutions for pigs, that has directly fed over 70 million pigs to date. In 2021, the company launched its companion animal range of gut health and hydration solutions for cats and dogs under the DoggyRade (www.doggyrade.com) brand umbrella. This multi-award winning range is used by search and rescue dogs, military dogs, high performance athletes including world sled racing champions, canicross world champions, and last years Best in Show at Crufts. Last year, Tonisity launched its range of gut health and hydration solutions for young ruminants (calves, lambs, goat kids) which is showing similar positive results as its swine range and is currently being launched across Europe. Tonisity’s technology is transferable to other species and the company plans to expand their reach into further species in the coming years.

Paul, the founder and CEO of Trave, started his career with a plumbing apprenticeship before studying building engineering, transitioning from on-site work to back-office roles where he gained a deep understanding of construction management processes. Witnessing inefficiencies in traditional workflows, he became increasingly interested in technology’s potential to transform the industry. Working closely with construction SMEs, he recognized the need for digital solutions to streamline operations. This blend of trade experience, engineering expertise, and a passion for innovation led him to create Trave. Under his leadership, Trave has rapidly grown into an industry-leading SaaS platform.

Expected employee numbers

Cavan

Est. 2021

paul-gilcreest

Paul Gilcreest

Company Profile

Trave is a cutting-edge construction management platform designed to help small to mid-sized contractors streamline operations, improve financial visibility, and enhance project efficiency. Designed to serve construction SMEs globally, our platform enables construction businesses to scale profitably by reducing administrative burdens and improving cash flow management. With a focus on user-friendly workflows and deep industry expertise, Trave is redefining how contractors manage their projects, labour, and finances, ensuring they stay competitive in an evolving industry.

Company Achievements to Date

n Established a successful service and consultancy business, providing bespoke digital construction management solutions, and won a Local Enterprise Office Innovation Award for our approach.

n Identified a market gap for a SaaS solution and collaborated with George Washington University’s Lean Startup Programme to validate it.

n Bootstrapped our MVP and built an early customer base, demonstrating strong demand for the platform.

n Secured a funding round to accelerate growth and expand operations.

Company Profile

Trigr is a B2B SaaS platform tailored for the media production industry, offering workflow and budget management tools. Designed to simplify complex production processes, Trigr helps teams streamline project management, optimise resources, and reduce operational costs. By providing real-time collaboration, financial tracking, and seamless integrations with existing tools, Trigr empowers media professionals to deliver high-quality projects on time and within budget. With a focus on innovation and efficiency, Trigr is committed to transforming the way production companies manage their operations, providing them with the tools they need to stay ahead in a competitive industry.

Company Achievements to Date

Since its founding, Trigr has achieved significant milestones that highlight its impact in the media production industry. Key achievements include:

In 2024, Trigr successfully onboarded a major Netflix-affiliated animation studio, expanding its client base within the entertainment sector and solidifying its position as a trusted tool for highprofile production companies.

Trigr attended prestigious international events, including the Cannes Lions Festival, where it showcased its innovative platform to a global audience and forged valuable industry connections. Trigr has steadily expanded its team to support product development, customer success, and business growth, positioning itself for continued success as it scales.

Trigr has raised a €500k pre-seed round from UK-based venture capital firms, providing the company with the resources needed to accelerate product development and expand its market presence.

Trigr’s platform has continuously evolved, with new features like enhanced budget management and real-time collaboration tools that have been embraced by its growing client base. These milestones showcase Trigr’s ability to scale, innovate, and make an impact in the highly competitive media production industry.

Gavin Duffy is a seasoned entrepreneur with over a decade of experience in the media and tech industries. As the founder and former CEO of Trigr, Gavin led the development of a B2B SaaS platform designed to streamline workflow and budget management for media production companies. Under his leadership, Trigr achieved recognition as one of Ireland’s most scalable startups. Gavin’s background also includes founding a successful PR agency in London, where he worked with major clients like the BBC, Spotify, and The Times. He holds an MBA and has a proven track record in driving product innovation, agile project management, and building strategic partnerships. Gavin is passionate about creating impactful solutions that drive efficiency and collaboration in the creative industries. His leadership and expertise in product management, UX development, and team-building have shaped Trigr’s mission to revolutionise media production operations.

Galway

gavinpeterduffy

Gav Duffy

Galway Est. 2018

liz-m

Led by CEO Dr Elizabeth McGloughlin, Tympany Medical is led with clinical excellence as a core value, with Dr McGloughlin holding membership of the College of Anasthesiologists of Ireland, and having significant experience in the surgical setting. Dr McGloughlin also holds an MSc in Bioinnovation and has led Tympany Medical since it’s it’s inception on the prestigious Bioinnovate programme. Her Co-Founder, Rory O’Callaghan, is an award winning Industrial Designer and Engineer, having been awarded the renowned Red Dot Award for his work in the design space for endoscopy. He is also a Fellow of the Bioinnovate programme, and a graduate of the renowned Umea Institute of Design.

Expected employee numbers

Elizabeth McGloughlin & Rory O’Callaghan

Company Profile

Tympany Medical is generating a next generation endoscope platform to revolutionize the way surgical imaging is carried out within the hospital setting. Tympany’s first product, Solascope, is designed to be the worlds first chip on tip endoscopic system which not only delivers best in class image quality, but is single use, sustainable, and sterile. This system will address a growing market shift to single use sterile sustainable devices with significant image quality enhancements & major technical uplift on currently available products. Solascope is seen as a breakthrough in endoscopic imaging by surgeon KOLs and will deliver clinical and cost benefits to hospitals, surgeons and patients.

Company Achievements to Date

Tympany’s vision is to create groundbreaking, ergonomically designed technologies that are not just better for patients and medical professionals, but for everyone. Since the company’s founding, Tympany have been funded through various national and EIT Health programmes. The CEO was named as National Runner-Up in Ireland’s Best Young Entrepreneur. Additionally, Tympany has raised over €6m in private investment from Irish investors including Atlantic Bridge University Bridge Fund, Ascentifi, Western Development Commission, and Enterprise Ireland. To address the failures of visualisation with current endoscope technology, Tympany has developed “Solascope” to TRL 6. In 2025, this product will be certified with the FDA for sinus surgery. The team are raising further funding to demonstrate Solascope’s safety and usability, and to develop Solascope for a wide range of clinical indications including sinus, neuro/skull ear, arthroscopy, and laparoscopy.

tympany-medical

Dara Meldrum & Mark Barry

dara-meldrum

markpatrickbarry

Dr. Dara Meldrum is Associate Professor in TCD and has a decade of globally recognised vertigo research experience in TCD and RCSI. Dara has been a practicing vestibular therapist for over 30 years and still treats vertigo patients every week. She is regularly invited to speak at international conferences and is a key opinion leader in the use of technology for vertigo care.

Mark is an experienced business leader, board member and investor with over 25 years of international management experience in deep tech companies including Analog Devices and S3 Connected Health. He has had direct responsibility for up to 400-person teams and full P&L ownership of >€1B annual revenue businesses. Having brought over 80 new products to market, Mark has strong commercial and entrepreneurship skills.

Expected employee numbers

2025: 10 2026: 19 2028: 27

Company Profile

Vertigenius is a global leader in the delivery of care for vertigo. Each year, 1 in 20 people suffer from debilitating vertigo, accounting for 3% of all emergency department visits. Yet wait times for treatment often exceed 6 months, and clinicians are unable to monitor patient treatment progress remotely. Vertigenius offers a clinician portal, patient app, and head sensor medical device. Software automation tools cut assessment and treatment prescription time in half reducing waiting lists, while the head sensor provides real-time feedback on treatment to clinicians enabling remote monitoring of patients for the very first time.

Company Achievements to Date

In December 2023, Atlantic Bridge led a €2.2M seed investment round in the company. The company has built a very strong leadership team including experienced commercial, operations, regulatory, quality, science and technology leaders. Vertigenius holds ISO 13485 certification, is registered in Europe as an MDD class I medical device and in the US as an FDA class II medical device allowing it to be sold on the market in the US and Europe. Two published scientific clinical studies at Beaumont and St. James’s reported very positive scores proving the products value in improving the delivery of care for vertigo. A software-only product launched in 2024 in UK/ Ireland with 7 customers to date and over 2,000 patients onboarded. The head sensor is set for volume release in 1H25. A US usability study with positive initial results is due to complete in Q125 and the company is ready to launch in the US market in early 2Q25 where demand is already high.

Dr. João Cabral (CEO) was awarded a PhD on Text-to-Speech synthesis in 2010 at the University of Edinburgh. He has always been passionate to research speech emotions and he believes that one day we can make computers sound as expressive as humans.

Christian Saam (CTO) holds a Master’s degree in Computational Linguistics and Phonetics from Universität Trier (2001). He is as passionate about building systems in the real world as he is about understanding the science behind them. After working as a freelancer in Berlin’s nascent start-up scene, he went back to academia, where he has been gaining strong experience in scientific research and technology transfer.

João and Christian met 15 years ago when they both joined Trinity College Dublin as research fellows. They left the university to work full-time in the spin-out, in 2022.

Their key strength is that they are experts in Speech Signal Processing and Machine Learning.

Expected employee numbers

Dublin

Est. 2022

cabraljoao

christian-saam

João Paulo Cabral & Christian Rudolf Saam

Company Profile

VoiceTune AI is a SaaS and generative AI Start-up. We develop Text-to-Speech software that automatically converts text into expressive speech with emotions. Our solutions enable companies and creatives from the Entertainment and Media Industry to add human sounding voice to their productions, or localise their content into multiple languages in a cost-effective and fast way. What would take weeks more with voice-over and studio recordings, with VoiceTune they can do it in a single day at a fraction of the cost. VoiceTune spun-out from Trinity College Dublin in 2022 and our cutting edge technology results from many years of research.

Company Achievements to Date

n Received Pre-Seed Start Funding from Enterprise Ireland

n Participated in the Startup Accelerator Program Prep4Seed

n Completed successfully Proof-of-Concept Projects with large companies, including a global localisation service provider in the video games industry

n Launched the Beta Product (Could-based Web Service) in 2024

Company Profile

Vortech is transforming the global aeration systems market with Vortex Powered Aeration™ (VPA™), a new class of technology that revolutionises wastewater treatment.

VPA™ harnesses the power of a vortex to produce the fine bubbles critical for efficient aeration— delivering the benefits of diffused air systems without the complexity and maintenance challenges that have burdened operators for decades.

The technology has been proven, with a combined 12 years of operational use, having been assessed and adopted by state-owned water utility companies, municipalities, and industrial entities such as Danone, Coca Cola, Abbott, Irish Water, Yorkshire Water and the Water Corporation.

Company Achievements to Date

n Development of a new class of wastewater technologies from an initial kitchen table demonstration model, to serve large scale municipal and industrial facilities around the world

n 5 international patents (granted and pending).

n Inaugural Winner of the 2020 Irish Times Social Innovation Award

n Winner of the 2020 Irish Times Innovation Award in the Sustainability Category

n Winner of silver in the EmergeTech category at the 2020 National Startup Awards

n Winner of SEAI’s Excellence in Energy Research and Innovation Award

n Shortlisted for the UK Water Industry Awards Groundbreaker Category in 2024.

n Team organised and completed an Irish Three Peaks Challenge charity fundraiser for multiple sclerosis in 2020 and raised €90k in the process.

sean-mulligan-ph-d

Sean Mulligan envisioned Vortex Powered Aeration™ (VPA™); a retrofittable solution combining the efficiency of fine bubble diffused aeration with the simplicity and durability of mechanical systems. Vortech was subsequently spun out of the University of Galway, Ireland to commercialise the technology, and today wastewater treatment system operators across the globe are harnessing the power of vortex flows to eliminate the operational and maintenance challenges traditionally associated with aeration systems.

Sean started his career in civil engineering, focusing on commercial applications of hydraulic engineering to solve global water challenges. He completed a PhD in vortex flows and hydraulic structures in 2015 and subsequently drove the development of the VPA™ category of technologies from an initial kitchen table demonstration model, to large scale international deployments. At Vortech, Sean is responsible for execution and management of the company’s commercial and strategic objectives, along with providing vision for future innovation and growth opportunities.

Galway

Est. 2019

Sean Mulligan

Dr. O’Donoghue along with the University of Limerick are the core founders behind Votechnik. Dr. O’Donoghue led the original development of the core technology under EPA funded research at the University of Limerick. Dr. O’Donoghue is a celebrated materials scientist and metallurgist having won a number of awards for her contribution to science and technology as well as commercialisation of the technologies. She possesses vast breath of knowledge, crossing sectors from biomedical devices, and aerospace to recycling and recovery technologies. In addition to this, her astute knowledge of intellectual property strategy, commercialisation strategy and in-depth market knowledge have allowed her to develop disruptive strategies to introduce these revolutionary technologies to the market.

Expected employee numbers

Limerick

Est. 2011

lisaodonoghue

Lisa O’Donoghue

Company Profile

Votechnik is a deep tech company delivering the alchemy of the 21st century. This alchemy involves transforming the proverbial lead to in gold where waste to transformed back into valuable materials. The technology at the heart of this, is the beating heart needed for industry of the 21st century and represents the fifth industrial revolution. Votechnik has developed a series of technologies that are truly futurist utilising robotics to separate and isolate materials of value from complex waste streams such including display technologies, solar photovoltaics, electric vehicle batteries among more.

Company Achievements to Date

Votechnik took their deep-tech from the lab to the market in 7 years launching the ALR3000 on the Irish market in 2018 representing the first fully commercial automated recycling plant for LCD displays. Votechnik became an EIC funded company to further develop the technology expanding the product range to LCD TVs, Monitors and LED displays. Votechnik then upgraded its Irish Deployment to the ALR4000 in 2022 which was a game changer where the one plant was capable of processing 80% of the entire countries waste displays in the one plant and stopping the exportation of that waste stream. Votechnik next launched the technology abroad with a replica plant in Sweden in 2023 to again change the landscape from exporting waste LCDs to lower cost economies for manual disassembly to now inhouse processing of the waste to generate significant revenue per plant. In tandem, Votechnik developed its IND2000 and SUP2000 technologies to tackle the growing waste streams of solar photovoltaic, electric vehicles batteries and touch screen displays. The new innovations are tackling the explosion of renewable energy technologies and requirement to access critical raw materials such as indium, gallium, silicon, lithium and cobalt.

Company Profile

We are Well Spent Grain Ltd

We take Brewers Spent Grain, the largest by product of the beer brewing process, upcycle it and create Tasty value added snack bites

Delicious, Sustainable and packed full of nutrition.

We rescue this spent grain from local breweries, such as Rascal’s Brewing Company, process it into a key ingredient to make our Born Again Snacks. They are Honest, Delicious and Sustainable. We are committed to breaking the cycle of food waste in the supply chain whilst promoting the circular food economy and sustainable snacking lifestyles.

Company Achievements to Date

Getting selected for the Lidl Kickstart Programme where we produced 5,082 pouches in three weeks from our home kitchen.

Expected employee numbers

I studied Hotel & Catering Management in Cathal Brugha Street, and more recently completed a Higher Diploma in Science in Digital Marketing at DBS.

I have extensive experience in sales and running a SME.

I have been working and growing my family business for almost 2 decades where we supply catering and refrigeration equipment’s to both end users and the trade. The company was founded in 1975 and has 5 full time employees as well as over 40 independent contractors allowing us to service the island of Ireland. This gives us access to a large business network and resources.

Dublin

Est. 2022

patrick-nagle

Patrick Nagle

Wellola is led by an highly experienced clinical team, including Sonia Neary (Founder, CEO), Dr. Greg Martin (CMO), Lyndsey Watson (COO), and Jay Ross (CTO). This team combines clinical leadership, technical innovation, and operational expertise to deliver cutting-edge solutions that align with healthcare providers’ needs.

Sonia Neary is a chartered physiotherapist with over 15 years of experience in both public and private healthcare sectors. As the CEO and co-founder of Wellola, Sonia has led the company from its initial concept to its current position as a leader in digital health solutions. Her leadership is characterised by a deep commitment to innovation and patient-centred care, drawing on her extensive clinical experience and her passion for patient empowerment.

Expected employee numbers

Dublin Est. 2016

sonianearywellola

Sonia Neary

Company Profile

About Wellola

Established in Dublin in 2016 and Leeds in 2019, joining forces with experts across healthcare, technology, and academia, Wellola champions the transformative power of preventative and community-based healthcare. With a firm belief in the capabilities of digital innovation, Wellola has secured €4M in funding and has garnered trust within the healthcare community, evident in partnerships with notable organizations such as Leeds Teaching Hospital NHS Trust and Birmingham Community NHS Foundation Trust, who have deployed Wellola’s award-winning patient care and communication platform, Portasana®.

About Portasana®

Portasana® streamlines patient care by equipping individuals with the information needed for safer, quicker recovery and tailoring care for diverse needs, including language and learning barriers. It enhances communication between healthcare providers and patients, ensuring a wellinformed treatment journey, while also improving operational efficiencies and cutting costs. The platform supports patient education and self-management, particularly for chronic conditions, and offers patient-led follow-up options, promoting autonomy. This innovation shifts care from hospitals to communities, personalizing treatment pathways with its flexible, interoperable system.

Company Achievements to Date

n Secured four NHS Trust contracts - LTHT, BCHC, NELFT and BHFT NHS Trusts

n Secured large Private Hospital chain contract

n Built a standalone platform for the HSE, British Association of Counsellors and Psychotherapists and Nutricia Danone (170 Irish Care Homes)

n Integrated with NHS Login and NHS Smartcard; currently integrating with NHS App

n Secured a position on NHS procurement frameworks- Digital First Online Consultation Video Consultation Framework, G-Cloud 14, Sparks DPS Frameworks

n Secured NHS Digital approval to integrate with all three foundational GP systems

n Wellola is partnered with Electronic Record System Providers such as Access Group and IMS MAXIMS who offer established routes to market for Wellola

n Wellola is an Independent Software Vendor on the AWS Marketplace

n Wellola has secured ISO27001:13 and DCB0129 Compliance alongside DTAC, DPST and Cyber Essentials (Basic and Plus)

n Wellola has raised approx €4M since its inception

n Wellola secured EU Funding- EIT Health Bootcamp and EIT Bridgehead

Darren O’Reilly and Brian Carson co-founded Whole Supp with a shared mission to revolutionize nutrition through science-backed, whole-food-based solutions. Darren, with a background in professional rugby, brings firsthand experience in performance nutrition and business operations. Brian, a leading exercise physiologist and researcher, specializes in human performance and metabolic health. Together, they combined their expertise to create Whole Supp—a high-protein superfood shake designed for modern lifestyles. Their vision is to make complete, convenient, and gut-friendly nutrition accessible to everyone, from elite athletes to busy professionals, helping them perform at their best every day.

Expected employee numbers

15

18

Dublin

Est. 2022

darren-o-reilly

carsonbrian

Darren O’Reilly & Dr Brian Carson

Company Profile

Whole Supp is a high-protein superfood shake designed to fuel modern lifestyles with complete nutrition. Packed with 13 superfoods and whole foods, it delivers essential vitamins, minerals, and plant-based protein in one convenient shake. Formulated for athletes, professionals, and health-conscious individuals, Whole Supp supports performance, recovery, and overall wellbeing. With a commitment to quality and sustainability, it provides a delicious, gut-friendly formula free from artificial additives. Available across the UK, Ireland, and 28 other countries, Whole Supp is redefining convenience in nutrition, making it easier than ever to stay healthy on the go.

Company Achievements to Date

In 2024 Whole Supp was won Food & Drink Start Up of the year in 2024 and was a finalist for Enterprise Ireland’s High Potential Startup of the year. Whole Supp has also been voted best in class by Men’s Health and other publications.

Since its launch, Whole Supp has rapidly established itself as a real challenger brand in the nutrition space, delivering high-quality, plant-based superfood shakes to health-conscious consumers worldwide. The brand has successfully expanded its reach, now shipping to 28 countries, making premium, science-backed nutrition accessible on a global scale.

In a short period, Whole Supp has delivered over 350,000 meals across the UK and Ireland, reinforcing its commitment to improving everyday health and wellness. The company has also built strong retail partnerships, including its presence in Brown Thomas, BWG Meaghers Pharmacy, to name a few.

Dublin, London and Boston

Est. 2021

professor-frank-sullivan

The founding team of WHYZE Health comprises seasoned leaders with deep expertise in healthcare/reserach, technology, and business growth.

Frances Abeton (Co-Founder & CEO) led Firecrest, a subsidiary of ICON, scaling revenue from $5M to $50M and boosting product margins from 43% to 83%. She secured strategic partnerships with top pharma companies, demonstrating her ability to successfully scale life science tech businesses.

Prof. Frank Sullivan (Co-Founder & CMO) is an expert in radiation oncology with extensive experience in cancer management. He has held leadership roles in Ireland and the US, including the US National Cancer Institute, and co-founded multiple cancer-focused companies.

Phil Blackwell (Co-Founder & CTO) has led digital transformation initiatives at Liberty Global, Bank of Ireland, and Irish Times Media Group. His expertise in AI-driven cloud infrastructure and enterprise operations ensures WHYZE Health’s technology remains innovative and scalable.

Together, they drive WHYZE Health’s mission to transform real-world evidence into actionable health insights.

Expected employee numbers

francesabeton

Frances Abeton, Prof. Frank Sullivan & Phil Blackwell

Company Profile

WHYZE Health utilises an AI-driven platform to transform Real-World Evidence (RWE) into actionable health insights. Integrating clinical and patient-generated data connects patients, healthcare providers, and life science companies to measure the real-world effectiveness of treatments. The platform delivers real-time insights into treatment safety and efficacy, improving patient outcomes while streamlining clinical trial feasibility and recruitment.

Company Achievements to Date

WHYZE Health has made significant progress in transforming Real-World Evidence (RWE) into actionable healthcare insights. The company was selected for the Mayo Clinic Platform_ Accelerate program, validating its AI-driven approach to integrating clinical and patientgenerated data.

A key milestone includes its partnership with Elligo Health Research, enhancing access to diverse patient populations for clinical trials. WHYZE Health has also secured a strategic integration in the UK, providing access to data from 5 million secondary care patients, significantly expanding its research and patient engagement capabilities.

The company has established a physical presence in the UK, which supports its international expansion and strengthens collaborations with healthcare providers, patient groups, and life science companies.

The company is actively expanding into the US market, working with Synapto Ventures and engaging with multiple investors to scale its operations and technology.

WHYZE Health continues to push forward, advancing healthcare innovation, commercialisation, and global expansion.

Company Profile

Wrky combines AI-driven analytics with deep people insights to enhance employee and customer experiences. By integrating multiple data sources, we provide a comprehensive view of workforce engagement, culture, and retention—helping organisations optimise performance and navigate change with confidence.

Company Achievements to Date

Since spinning out of DCU, Wrky has

n Completed two rounds of funding totalling €3M

n Revenue growth of 150% year on year.

n Won clients in multiple verticals from retail, logistics, tech and recruitment

n Delivered our services across 4 continents.

n Selected from over 200 companies globally to work with Heineken Brewhouse.

Expected employee numbers

Dublin

Est. 2022

Brian Slattery - CEO & Co-Founder: previously a Tenured Assistant Professor to the Psychology Department in DCU. Brian brings his vast experience in psychology and people science to bear in delivering a world class product.

Barry Gordon - CTO & Co-Founder. Barry, a very accomplished software engineer. He has over 15 years’ experience building enterprise grade software platforms.

Paddy Doyle - A certified accountant by training, he brings over 20 years of experience to Wrky. He has built several businesses from the ground-up in both renewable energy and HR Technology. Most recently he founded Clinch Talent - acquired by Battery Ventures.

wrky

brian-slattery barrygordon

Dr Brian Slattery, Barry Gordon & Paddy Doyle doylepm

Company Profile

xWave Technologies is on a mission to save lives by ensuring patients get the best test first. The FDA estimates that 20%-50% of advanced imaging may be unnecessary for patients, leading to missed or delayed diagnoses, longer radiology wait times, and increased healthcare costs. To solve this, we developed xWave CDS, a cloud-based clinical decision support system that helps referrers order the best test first and enables radiology teams to vet referrals efficiently. Built in partnership with the European Society of Radiology (iGuide) and the Royal College of Radiologists (iRefer), xWave CDS provides evidence-based guidance at the point of care.

Company Achievements to Date

xWave Technologies was established in April 2020 by a group of leading Irish radiologists to solve the problem of patients being referred for inappropriate scans and to tackle the significant radiology workflow inefficiencies that exist around the globe.

xWave’s first clinical decision support software (xWave CDS) went live in the Royal Victoria Eye and Ear Hospital in February 2021. In 2024, xWave won contracts with public and private healthcare providers across both Ireland and the UK, resulting in €2.5m worth of contract wins and putting xWave at an annual recurring revenue (ARR) rate of €550,000 by December 2024. This included xWave winning contracts with our first 8 NHS Trusts: https://www.rte.ie/news/ business/2024/1104/1478963-xwave-technologies-secures-uk-contract/

Expected employee numbers

Mitchell O’Gorman - Chief Executive Officer

Mitchell O’Gorman is the Chief Executive Officer of xWave Technologies, bringing over 15 years of experience as an innovative business leader. His career spans both fast-paced start-ups and large, complex multinationals, where he has consistently driven growth and innovation. Before joining xWave, Mitchell was the Managing Director of Kantar Ireland, a global leader in research and data. His leadership at Kantar followed senior roles at Independent News and Media and Newmarket Consulting, which was later acquired by Crowe Horwath. As CEO of xWave Technologies, Mitchell is responsible for driving product development, sales, and marketing, building a world-class team, and ensuring good financial governance. His strategic vision and leadership are key to xWave’s growth and success in the healthcare technology sector.

xwave-technologies

Dublin

Est. 2020

mitchellogorman

Mitchell O’Gorman

Company Profile

Zarasyl’s mission is to become a global leader in providing innovative dermatological and wound care solutions for the veterinary market. We utilize patented silicate technology, originally developed from a human-use research project at the University of Cambridge. Silica, the third most abundant trace element, plays a crucial role in promoting healthy skin and connective tissue growth. Our products are free from steroids and antibiotics, aligning with the WHO’s One Health initiative to support holistic health.

Company Achievements to Date

Given our founders’ deep roots in the equine industry in Ireland, our first product was developed specifically for the equine community. Zarasyl Equine is now recommended by leading equine referral clinics across the world and several studies are underway at universities and leading equine hospitals across the USA. Zarasyl Equine can be found in professional equestrian first aid tool boxes and was included in several travelling to the Tokyo and Paris Olympics. Our companion animal solution is gaining popularity among veterinarians for managing a range of skin conditions in cats and dogs. We’ve been endorsed by leading veterinarians and dermatologists for the management of a variety of skin issues and wounds healing by second intention.

A clinical trial is currently in progress with University College Dublin, and we’re also collaborating with several prestigious U.S. universities and leading referral clinics on various field studies, including Cornell, Hagyard Equine Medical Institute, Virginia Tech, University of Pennsylvania, and UC Davis in California.

Zarasyl is distributed by leading veterinary distributors in Ireland, UK, USA, Switzerland and Australia. We are working with a number of distributors on plans to make Zarasyl available throughout Europe and the Middle East.

Expected employee numbers

Est. 2018

Before founding Zarasyl, Adrienne played a key role at a highly successful Irish technology company that introduced software to the global market. She was deeply inspired by their approach of combining a strong team with a groundbreaking idea to reach a global audience. Outside of her professional career, Adrienne was involved in the thoroughbred breeding industry with her husband. When the opportunity arose to explore the technology behind Zarasyl, she leveraged her tech experience to bring this innovation to market. As the driving force behind Zarasyl’s scientific research and product development, Adrienne leads a talented team of scientists, regulatory experts, marketers, and world-renowned veterinarians. With their support, she is committed to making Zarasyl’s groundbreaking technology available worldwide, improving the lives of animals and advancing the WHO One Health initiative.

Athboy, Co Meath

adrienne-magnier

Adrienne Magnier

Dublin Est. 2017

Thomas Coleman - CEO

thomas-coleman

david-coleman

Thomas is an award-winning CEO with over 23 years of leadership experience across industry giants in Digital Health, Telecoms, and eCommerce. A visionary executive, he also serves as Chairperson of the Connected Health & Wellbeing Cluster and is a sought-after keynote speaker, shaping the future of innovation and technology.

David Coleman- CTO

David is a trailblazer in Digital Health, renowned for developing cutting-edge solutions for prestigious institutions like Stanford University. As the driving force behind LifeMap Solutions’ engineering efforts, he played a pivotal role in the company’s success, culminating in its acquisition. With a proven track record of scaling multinational companies, David is a dynamic engineering leader with deep expertise across Digital Health, eCommerce, digital marketing, and fintech. His ability to build and lead high-performing teams has consistently propelled innovation and growth at the highest levels.

Expected employee numbers

Thomas Coleman &David Coleman

Company Profile

Zendra Health is a pioneering medical technology company revolutionising care coordination, patient pathways, and software-as-a-medical-device solutions through cutting-edge no-code technology.

Trusted by over 80 organisations, Zendra Health empowers healthcare providers to rapidly transform care pathways—making them more accessible, engaging, and data-driven. Their solutions support over 20 medical conditions, including mental health, chronic diseases, and elder care.

With a proven track record of innovation, Zendra Healths’s team has developed digital health solutions for world-renowned institutions such as Stanford University, Mount Sinai Hospital in New York, and Apple.

Company Achievements to Date

Strong Traction

Zendra’s product offerings are helping over 80 healthcare services and over 60,000 patients in the US, UK, and Ireland, with several projects operating at national and local community levels.

Excellent Team

Zendra is an ISO 13485:2016 certified company with years of experience in developing and selling software-as-a-medical-device, care coordination pathways, and virtual ward solutions. Over the past year, the team has expanded by 100%, and we anticipate significant growth in the coming years. Recently, we onboarded a Chief Medical Officer to further strengthen Zendra Health’s product and commercial roadmap

Industry Recognition

Zendra won the National Start-Up Award in 2020 for quickly leveraging its technology to assist care homes during the COVID-19 pandemic. Additionally, the company has been shortlisted in the Healthcare Collaboration and Sustainability and Excellence in Supply categories for the 2024 and 2022 HealthTech Ireland Awards, respectively.

Amazing Opportunity

The company is unveiling Navigator, a revolutionary breakthrough set to redefine care pathways. Built on deep expertise and cutting-edge innovation, this transformative technology is poised to disrupt the industry in ways never seen before.

Investors with vision will recognise the magnitude of what’s unfolding. The question is - will you be part of it?

eStation

Recent Successes

Offers corporate customers a complete EV fleet charging ecosystem.

Raised €1,466,350 in January 2025

Provasctec

Cell therapies for patients suffering from blocked lower-leg arteries.

Raised €1,041,930 in December 2024

ATXA Therapeutics

Clinical advancing its new drugs as novel therapies for heart and lung diseases.

Raised €2,710,682 in January 2024

Pure Ocean Algae

A biotechnology company which has developed seaweed harvesting and processing infrastructure.

Raised €1,249,261 in January 2025

Aveta Medical

Developed a technology to treat vaginal atrophy.

Raised €1,435,893 in July 2024

Aurigen Medical

Revolutionary medical device for chronic heart disease.

Raised €7,196,601 in December 2024

Wellbeing

Acquired a profitable nutritional supplements company.

Raised €2,090,257 in May 2024

Binarii Labs

Patented solution for online security.

Raised €1,850,000 in July 2023

Epitheal

Have developed a patentpending compound for treating skin damage and disease.

Raised €541,088 in December 2024

Pumpinheart

Developing a ‘cath lab’ implantable heart pump to treat advanced stage diastolic Heart Failure.

Raised €851,533 in November 2023

Ovagen

Developing innovative technology to develop and produce germ-free eggs critical to vaccine production.

Raised €3,233,900 in December 2023

xWave

Helping the referral and vetting process for radiology clinicians and their patients.

Raised €1,181,444 in December 2024

Altach Biomedical

Their objective to commercialize a collagen scaffold technology for cartilage repair.

Raised €1,125,415 in January 2024

Access Earth

Business & Travel review site for those living with disabilities

Raised €164,000 in February 2022

Galenband

ECG monitor which detects intermittent stroke-causing heart problems.

Raised €1,760,605 in December 2024

Unify Ordering

Ordering platform for the hospitality and wholesale food and drinks sector.

Raised €500,000 in May 2024

Net Feasa

Energy efficient sensors to locate shipping containers

Raised €2,311,651 in August 2024

Locker

Personalised Sport Content Platform

Raised €1,066,191 in April 2023

Moby Bikes

Electric Bikes for Bike Sharing Scheme

Raised €795,000 in December 2020

Digitally

Improves profit margins in food businesses

Raised €266,000 in September 2020